[{"medicine":"BCG vaccine","first_added":1977,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against tuberculosis","indication_count":1,"atc_codes":"L03AX03","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/205"},{"medicine":"Ebola vaccine","first_added":2025,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BX02","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/953"},{"medicine":"Japanese encephalitis vaccine","first_added":2007,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BA02, J07BA03","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/436"},{"medicine":"Medicines for COVID-19","first_added":2023,"main_section":"Medicines for COVID-19","sections":"Medicines for COVID-19","section_count":1,"indications":"COVID-19","indication_count":1,"atc_codes":null,"dosage_forms":"Refer to WHO living guidelines","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/905"},{"medicine":"abacavir","first_added":2002,"main_section":"Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors","sections":"Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AF06","dosage_forms":"Oral > Solid: 300 mg tablet (as sulfate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/315"},{"medicine":"abacavir + dolutegravir + lamivudine","first_added":2025,"main_section":"Fixed-dose combinations of antiretrovirals","sections":"Fixed-dose combinations of antiretrovirals","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AR13","dosage_forms":"Oral > Solid > tablet: 60 mg (as sulfate) + 5 mg + 30 mg (dispersible, scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/947"},{"medicine":"abacavir + lamivudine","first_added":2015,"main_section":"Fixed-dose combinations of antiretrovirals","sections":"Fixed-dose combinations of antiretrovirals","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AR02","dosage_forms":"Oral > Solid: 120 mg (as sulfate) + 60 mg tablet (dispersible, scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/316"},{"medicine":"abiraterone","first_added":2019,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of prostate","indication_count":1,"atc_codes":"L02BX03","dosage_forms":"Oral > Solid: 250 mg; 500 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/406"},{"medicine":"acamprosate calcium","first_added":2023,"main_section":"Medicines for alcohol use disorders","sections":"Medicines for alcohol use disorders","section_count":1,"indications":"Disorders due to use of alcohol","indication_count":1,"atc_codes":"N07BB03","dosage_forms":"Oral > Solid > tablet: 333 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/908"},{"medicine":"acenocoumarol","first_added":2025,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Venous thromboembolism; Cerebral ischaemic stroke due to embolic occlusion; Atrial fibrillation; Other specified diseases of arteries or arterioles","indication_count":4,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/979"},{"medicine":"acetazolamide","first_added":1977,"main_section":"Ophthalmological preparations > Miotics and antiglaucoma medicines","sections":"Ophthalmological preparations > Miotics and antiglaucoma medicines","section_count":1,"indications":"Primary open-angle glaucoma","indication_count":1,"atc_codes":"S01EC01","dosage_forms":"Oral > Solid: 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/234"},{"medicine":"acetic acid","first_added":2009,"main_section":"Ear, nose and throat medicines [c]","sections":"Ear, nose and throat medicines [c]","section_count":1,"indications":"Infectious diseases of external ear","indication_count":1,"atc_codes":"S02AA10","dosage_forms":"Local > Otological > drops: 2% solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/270"},{"medicine":"acetylcysteine","first_added":1999,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs","indication_count":1,"atc_codes":"V03AB23","dosage_forms":"Parenteral > General injections > IV: 200 mg per mL in 10 mL ampoule Oral > Liquid: 10%; 20%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/36"},{"medicine":"acetylsalicylic acid","first_added":1977,"main_section":"Medicines for acute migraine attacks","sections":"Medicines for acute migraine attacks; Anti-platelet medicines; Medicines for juvenile joint diseases; Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)","section_count":4,"indications":"Migraine; Acute myocardial infarction; Cerebral ischaemic stroke; Mucocutaneous lymph node syndrome; Juvenile idiopathic arthritis; Acute rheumatic fever without mention of heart involvement; Pain","indication_count":7,"atc_codes":"N02BA01, B01AC06","dosage_forms":"Oral > Solid: 300 to 500 mg; Oral > Solid: 100 mg; Local > Rectal > Suppository: 150 mg; 300 mg Oral > Solid > dispersible tablet: 75 mg; 300 mg; 500 mg Oral > Solid > tablet: 75 to 500 mg; Oral > Solid: 100 to 500 mg Local > Rectal > Suppository: 50 to 150 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/13"},{"medicine":"acetylsalicylic acid + atorvastatin + ramipril","first_added":2023,"main_section":"Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease","sections":"Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease","section_count":1,"indications":"Atherosclerotic chronic arterial occlusive disease; Chronic ischaemic heart disease; Cerebral ischaemic stroke","indication_count":3,"atc_codes":"C10BX06","dosage_forms":"Oral > Solid > tablet: 100 mg + 20 mg + 2.5 mg; 100 mg + 20 mg + 5 mg; 100 mg + 20 mg + 10 mg; 100 mg + 40 mg + 2.5 mg; 100 mg + 40 mg + 5 mg; 100 mg + 40 mg + 10 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/910"},{"medicine":"acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide","first_added":2023,"main_section":"Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease","sections":"Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease","section_count":1,"indications":"Atherosclerotic chronic arterial occlusive disease; Chronic ischaemic heart disease; Cerebral ischaemic stroke","indication_count":3,"atc_codes":null,"dosage_forms":"Oral > Solid > tablet: 100 mg + 20 mg + 5 mg + 50 mg + 12.5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/911"},{"medicine":"aciclovir","first_added":1997,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents; Antiherpes medicines; Medicines for viral central nervous system infections","section_count":3,"indications":"Herpes simplex keratitis; Zoster; Herpes simplex infections; Varicella","indication_count":4,"atc_codes":"S01AD03, J05AB01","dosage_forms":"Local > Ophthalmological > Ointment: 3% w/w; Parenteral > General injections > IV: 250 mg in vial powder for solution for infusion (as sodium dihydrate); 25 mg per mL in vial solution for infusion (as sodium) Oral > Liquid: 200 mg per 5 mL Oral > Solid: 200 mg tablet Parenteral > General injections > IV: 250 mg in vial powder for solution for infusion (as sodium diihydrate); 25 mg per mL in vial solution for infusion (as sodium)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/226"},{"medicine":"aclidinium","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Chronic obstructive pulmonary disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/674"},{"medicine":"activated charcoal","first_added":1977,"main_section":"Antidotes and other substances used in poisonings > Non-specific","sections":"Antidotes and other substances used in poisonings > Non-specific","section_count":1,"indications":"Unspecified injury, poisoning or certain other consequences of external causes","indication_count":1,"atc_codes":"A07BA01","dosage_forms":"Oral > Liquid: 50 mg granules for oral suspension","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/297"},{"medicine":"adalimumab","first_added":2019,"main_section":"Immunomodulators for non-malignant disease","sections":"Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases; Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":3,"indications":"Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriasis of unspecified type","indication_count":5,"atc_codes":"L04AB04","dosage_forms":"Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL; Parenteral > General injections > SC: 10 mg per 0.2 mL mL in pre-filled syringe or pre-filled pen.; 20 mg per 0.2 mL mL in pre-filled syringe or pre-filled pen.; 20 mg per 0.4 mL mL in pre-filled syringe or pre-filled pen.; 40 mg per 0.4 mL mL in pre-filled syringe or pre-filled pen.; 40 mg per 0.8 mL mL in pre-filled syringe or pre-filled pen.; 80 mg per 0.8 mL mL in pre-filled syringe or pre-filled pen.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/552"},{"medicine":"afatinib","first_added":2019,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Other specified malignant neoplasms of bronchus or lung","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/404"},{"medicine":"albendazole","first_added":1989,"main_section":"Intestinal anthelminthics","sections":"Intestinal anthelminthics; Cysticidal medicines; Antifilarials","section_count":3,"indications":"Echinococcosis; Cysticercosis; Hookworm diseases; Trichuriasis; Ascariasis; Enterobiasis; Other specified echinococcosis; Cysticercosis of central nervous system; Lymphatic filariasis","indication_count":9,"atc_codes":"P02CA03","dosage_forms":"Oral > Solid > tablet: 400 mg (chewable, scored); Oral > Solid > tablet: 400 mg (chewable, scored); 200 mg (chewable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/57"},{"medicine":"alcohol based hand rub","first_added":2015,"main_section":"Disinfectants","sections":"Disinfectants","section_count":1,"indications":"Denatured alcohol","indication_count":1,"atc_codes":"D08AX08","dosage_forms":"Local > Topical > Solution: 80% v/v ethanol; 75% v/v isopropyl alcohol","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/173"},{"medicine":"all-trans retinoic acid","first_added":2015,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Acute myeloid leukaemia with recurrent genetic abnormalities","indication_count":1,"atc_codes":"L01XF01","dosage_forms":"Oral > Solid: 10 mg capsule","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/70"},{"medicine":"allopurinol","first_added":1977,"main_section":"Medicines used to treat gout","sections":"Medicines used to treat gout; Supportive medicines","section_count":2,"indications":"Gout; Tumour lysis syndrome","indication_count":2,"atc_codes":"M04AA01","dosage_forms":"Oral > Solid: 100 mg; Parenteral > General injections > IV: 500 mg (as sodium) powder for injection Oral > Solid: 100 mg; 300 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/71"},{"medicine":"alprostadil (prostaglandin E1)","first_added":2009,"main_section":"Medicines administered to the neonate [c]","sections":"Medicines administered to the neonate [c]","section_count":1,"indications":"Other specified congenital anomaly of great arteries including arterial duct","indication_count":1,"atc_codes":"C01EA01","dosage_forms":"Parenteral > General injections > IV: 0.5 mg per mL in alcohol","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/273"},{"medicine":"alteplase","first_added":2019,"main_section":"Thrombolytic medicines","sections":"Thrombolytic medicines","section_count":1,"indications":"Cerebral ischaemic stroke","indication_count":1,"atc_codes":"B01AD02","dosage_forms":"Parenteral > General injections > IV: 10 mg in vial powder for injection; 20 mg in vial powder for injection; 50 mg in vial powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/482"},{"medicine":"amidotrizoate","first_added":1977,"main_section":"Diagnostic agents > Radiocontrast media","sections":"Diagnostic agents > Radiocontrast media","section_count":1,"indications":"Amidotrizoate","indication_count":1,"atc_codes":"V08AA01","dosage_forms":"Parenteral > General injections > unspecified: 140 to 420 mg iodine per mL in 20 mL ampoule (as sodium or meglumine salt)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/166"},{"medicine":"amikacin","first_added":1999,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents; Access group antibiotics; Antituberculosis medicines","section_count":3,"indications":"Other specified conjunctivitis; Infectious blepharitis; Acute pyelonephritis (severe); Neutropaenia (high-risk); Inflammatory or other diseases of prostate (severe); Multi-drug resistant Mycobacterium tuberculosis","indication_count":6,"atc_codes":"J01GB06","dosage_forms":"Parenteral > General injections > unspecified: 50 mg per mL in 2 mL vial (as sulfate); 250 mg per mL in 2 mL vial (as sulfate) Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate); 50 mg per mL in 2 mL vial (as sulfate) Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate); Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate)","combined_with":"cefotaxime; ceftriaxone","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/327"},{"medicine":"amiloride","first_added":1979,"main_section":"Diuretics","sections":"Diuretics","section_count":1,"indications":"Oedema; Ascites","indication_count":2,"atc_codes":"C03DB01","dosage_forms":"Oral > Solid: 5 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/176"},{"medicine":"amiodarone","first_added":2009,"main_section":"Antiarrhythmic medicines","sections":"Antiarrhythmic medicines","section_count":1,"indications":"Cardiac arrhythmia","indication_count":1,"atc_codes":"C01BD01","dosage_forms":"Parenteral > General injections > IV: 50 mg per mL in 3 ampoule (hydrochloride) Oral > Solid: 100 mg (hydrochloride); 200 mg (hydrochloride); 400 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/135"},{"medicine":"amitriptyline","first_added":1977,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Medicines for depressive disorders","section_count":2,"indications":"Palliative care; Depressive disorders","indication_count":2,"atc_codes":"N06AA09","dosage_forms":"Oral > Liquid: 25 mg per 5 mL Oral > Solid > tablet: 25 mg; 10 mg; 75 mg; Oral > Solid: 25 mg; 75 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/19"},{"medicine":"amlodipine","first_added":2005,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Essential hypertension","indication_count":1,"atc_codes":"C08CA01","dosage_forms":"Oral > Solid: 5 mg (as maleate, mesylate or besylate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/136"},{"medicine":"amodiaquine - sulfadoxine + pyrimethamine","first_added":2019,"main_section":"Antimalarial medicines > Medicines for chemoprevention","sections":"Antimalarial medicines > Medicines for chemoprevention","section_count":1,"indications":"Malaria","indication_count":1,"atc_codes":"P01BA06, P01BD51","dosage_forms":"Oral > Solid > dispersible tablet: 76.5 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] in co-package; 153 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] in co-package; 75 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] in co-package; 150 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] in co-package","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/564"},{"medicine":"amoxicillin","first_added":1989,"main_section":"Access group antibiotics","sections":"Access group antibiotics; Medicines for bacterial central nervous system infections","section_count":2,"indications":"Acute pharyngitis; Periapical abscess without sinus; Acute sinusitis; Acute otitis media; Chronic obstructive pulmonary disease with acute exacerbation; Sepsis without septic shock; Acute malnutrition in infants, children or adolescents (uncomplicated) [children]; Acute malnutrition in infants, children or adolescents (complicated) [children]; Bacterial pneumonia (Community-acquired pneumonia - mild to moderate); Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Bacterial meningitis","indication_count":11,"atc_codes":"J01CA04","dosage_forms":"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate) Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate) Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate) Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid; Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate) Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)","combined_with":"gentamicin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/299"},{"medicine":"amoxicillin + clavulanic acid","first_added":1997,"main_section":"Access group antibiotics","sections":"Access group antibiotics; Antituberculosis medicines","section_count":2,"indications":"Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Acute sinusitis; Other specified pneumonia (Hospital-acquired pneumonia); Chronic obstructive pulmonary disease with acute exacerbation; Neutropaenia (low-risk); Peritoneal abscess (mild-moderate); Peritonitis (mild-moderate); Infectious cystitis; Bacterial cellulitis, erysipelas or lymphangitis; Bacterial pneumonia (Community-acquired pneumonia - mild to moderate); Bacterial pneumonia (Community-acquired pneumonia - severe); Bacterial infection of joint; Acute otitis media; Other specified prophylactic measures; Osteomyelitis or osteitis; Multi-drug resistant Mycobacterium tuberculosis","indication_count":16,"atc_codes":"J01CR02","dosage_forms":"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); Oral > Liquid: 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid Oral > Solid > dispersible tablet: 250 (as trihydrate) + 62.5 (as potassium salt) Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/310"},{"medicine":"amphotericin B","first_added":1977,"main_section":"Antifungal medicines","sections":"Antifungal medicines; Antileishmaniasis medicines","section_count":2,"indications":"Candidosis; Blastomycosis; Cryptococcosis; Coccidioidomycosis; Aspergillosis; Sporotrichosis; Histoplasmosis; Visceral leishmaniasis","indication_count":8,"atc_codes":"J02AA01","dosage_forms":"Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/357"},{"medicine":"ampicillin","first_added":1977,"main_section":"Access group antibiotics","sections":"Access group antibiotics; Medicines for bacterial central nervous system infections","section_count":2,"indications":"Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Acute malnutrition in infants, children or adolescents (complicated) [children]; Sepsis without septic shock; Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Bacterial meningitis","indication_count":8,"atc_codes":"J01CA01","dosage_forms":"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous); Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection","combined_with":"gentamicin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/302"},{"medicine":"anastrozole","first_added":2015,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones; Ovulation inducers","section_count":2,"indications":"Malignant neoplasms of breast; Other specified malignant neoplasms of breast; Female infertility without specification whether primary or secondary","indication_count":3,"atc_codes":"L02BG03","dosage_forms":"Oral > Solid: 1 mg tablet","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/111"},{"medicine":"anidulafungin","first_added":2021,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Systemic or invasive candidosis","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/620"},{"medicine":"ansuvimab","first_added":2023,"main_section":"Medicines for Ebola virus disease","sections":"Medicines for Ebola virus disease","section_count":1,"indications":"Ebola virus disease","indication_count":1,"atc_codes":"J06BD04","dosage_forms":"Parenteral > General injections > IV: 400 mg powder for injection","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/900"},{"medicine":"anti-D immunoglobulin","first_added":1977,"main_section":"Human immunoglobulins","sections":"Human immunoglobulins","section_count":1,"indications":"Maternal care for red cell antibodies; Rh incompatibility reaction","indication_count":2,"atc_codes":"J06BB01","dosage_forms":"Parenteral > General injections > IV: 250 µg in single-dose vial Parenteral > General injections > IM: 250 µg in single-dose vial","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/460"},{"medicine":"anti-rabies immunoglobulin","first_added":1991,"main_section":"Human immunoglobulins","sections":"Human immunoglobulins","section_count":1,"indications":"Rabies","indication_count":1,"atc_codes":"J06BB05","dosage_forms":"Parenteral > General injections > IM: 150 IU per mL in vial Parenteral > Locoregional injections > Other: 150 IU per mL in vial","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/462"},{"medicine":"anti-rabies virus monoclonal antibodies","first_added":2021,"main_section":"Immunologicals > Sera, immunoglobulins and monoclonal antibodies","sections":"Immunologicals > Sera, immunoglobulins and monoclonal antibodies","section_count":1,"indications":"Rabies","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > Locoregional injections > Intradermal: 40 IU per mL in 1.25 mL vial (human); 40 IU per mL in 2.5 mL vial (human); 100 IU per mL in 2.5 mL vial (human); 300 IU per mL in 10 mL vial (murine); 600 IU per mL in 1 mL vial (murine); 600 IU per mL in 2.5 mL vial (murine); 600 IU per mL in 5 mL vial (murine)","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/604"},{"medicine":"anti-tetanus immunoglobulin","first_added":1984,"main_section":"Human immunoglobulins","sections":"Human immunoglobulins","section_count":1,"indications":"Tetanus","indication_count":1,"atc_codes":"J06BB02","dosage_forms":"Parenteral > General injections > IM: 500 IU in vial","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/464"},{"medicine":"antivenom immunoglobulin","first_added":2007,"main_section":"Immunologicals > Sera, immunoglobulins and monoclonal antibodies","sections":"Immunologicals > Sera, immunoglobulins and monoclonal antibodies","section_count":1,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > General injections > IV:","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/508"},{"medicine":"apixaban","first_added":2019,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Other specified atrial fibrillation; Venous thromboembolism","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/478"},{"medicine":"aprepitant","first_added":2019,"main_section":"Antiemetic medicines","sections":"Antiemetic medicines","section_count":1,"indications":"Nausea or vomiting","indication_count":1,"atc_codes":"A04AD12","dosage_forms":"Oral > Liquid: 125 mg powder for oral suspension (in sachet) Oral > Solid > capsule: 80 mg; 125 mg; 165 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/536"},{"medicine":"aripiprazole","first_added":2023,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > General injections > IM: 300 mg powder and solvent for suspension; 400 mg powder and solvent for suspension","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/921"},{"medicine":"arpraziquantel","first_added":2025,"main_section":"Antischistosomals and other antitrematode medicines","sections":"Antischistosomals and other antitrematode medicines","section_count":1,"indications":"Schistosomiasis","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid > dispersible tablet: 150 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/948"},{"medicine":"arsenic trioxide","first_added":2019,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Acute myeloid leukaemia with recurrent genetic abnormalities","indication_count":1,"atc_codes":"L01XX27","dosage_forms":"Parenteral > General injections > IV: 1 mg per mL concentrate for solution for infusion; 2 mg per mL concentrate for solution for infusion","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/554"},{"medicine":"artemether","first_added":1997,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":2,"atc_codes":"P01BE02","dosage_forms":"Parenteral > General injections > IM: 20 mg per mL in 1 mL ampoule (oily injection); 40 mg per mL in 1 mL ampoule (oily injection)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/372"},{"medicine":"artemether + lumefantrine","first_added":2002,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":2,"atc_codes":"P01BF01","dosage_forms":"Oral > Solid > dispersible tablet: 20 mg + 120 mg Oral > Solid > tablet: 20 mg + 120 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/373"},{"medicine":"artesunate","first_added":1999,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":2,"atc_codes":"P01BE03","dosage_forms":"Parenteral > General injections > IV: 60 mg in vial powder for injection; 30 mg in vial powder for injection; 120 mg in vial powder for injection Local > Rectal > Other: 100 mg capsules","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/374"},{"medicine":"artesunate + amodiaquine","first_added":2011,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":2,"atc_codes":"P01BF03","dosage_forms":"Oral > Solid > tablet: 25 mg + 67.5 mg; 50 mg + 135 mg; 100 mg + 270 mg Oral > Solid > tablet: 25 mg + 67.5 mg; 50 mg + 135 mg; 100 mg + 270 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/375"},{"medicine":"artesunate + mefloquine","first_added":2013,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":2,"atc_codes":"P01BF02","dosage_forms":"Oral > Solid > tablet: 25 mg + 50 mg (as hydrochloride); 100 mg + 200 mg (as hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/376"},{"medicine":"artesunate + pyronaridine","first_added":2017,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":2,"atc_codes":"P01BF06","dosage_forms":"Oral > Solid > tablet: 60 mg + 180 mg (tetraphosphate) Oral > Solid > granules: 20 mg + 60 mg (tetraphosphate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/377"},{"medicine":"artesunate - sulfadoxine + pyrimethamine","first_added":2025,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":2,"atc_codes":"P01BF09","dosage_forms":"Oral > Solid > tablet: 50 mg [3] + 500 mg + 25 mg [1] in copackage (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/978"},{"medicine":"ascorbic acid","first_added":1977,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Scurvy","indication_count":1,"atc_codes":"A11GA01","dosage_forms":"Oral > Solid: 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/259"},{"medicine":"asparaginase","first_added":1993,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Lymphoid leukaemia, not elsewhere classified","indication_count":1,"atc_codes":"L01XX02","dosage_forms":"Parenteral > General injections > unspecified: 10000 IU in vial powder for injection Powder for injection: 10 000 IU in vial.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/72"},{"medicine":"atazanavir + ritonavir","first_added":2017,"main_section":"Antiretrovirals > Protease inhibitors","sections":"Antiretrovirals > Protease inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AR23","dosage_forms":"Oral > Solid: 300 mg (as sulfate) + 100 mg tablet (heat stable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/283"},{"medicine":"atenolol","first_added":1991,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Essential hypertension","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid: 50 mg; 100 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/496"},{"medicine":"atezolizumab","first_added":2025,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"Other specified malignant neoplasms of bronchus or lung","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > General injections > IV: 840 mg per 14 mL in vial concentrate for solution for infusion; 1200 mg per 20 mL in vial concentrate for solution for infusion Parenteral > General injections > IV: 1.2 g per 20 mL concentrate solution for infusion","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/570"},{"medicine":"atoltivimab + maftivimab + odesivimab","first_added":2023,"main_section":"Medicines for Ebola virus disease","sections":"Medicines for Ebola virus disease","section_count":1,"indications":"Ebola virus disease","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > General injections > IV: 241.7 mg + 241.7 mg + 241.7 mg in 14.5 mL vial","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/901"},{"medicine":"atorvastatin","first_added":2021,"main_section":"Lipid-lowering agents","sections":"Lipid-lowering agents","section_count":1,"indications":"Mixed hyperlipidaemia; Coronary atherosclerosis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/529"},{"medicine":"atorvastatin + perindopril + amlodipine","first_added":2023,"main_section":"Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease","sections":"Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease","section_count":1,"indications":"Atherosclerotic chronic arterial occlusive disease; Chronic ischaemic heart disease; Cerebral ischaemic stroke","indication_count":3,"atc_codes":"C10BX11","dosage_forms":"Oral > Solid > tablet: 20 mg + 5 mg + 5 mg; 20 mg + 10 mg + 10 mg; 40 mg + 5 mg + 5 mg; 40 mg + 10 mg + 10 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/912"},{"medicine":"atracurium","first_added":2011,"main_section":"Muscle relaxants (peripherally-acting) and cholinesterase inhibitors","sections":"Muscle relaxants (peripherally-acting) and cholinesterase inhibitors","section_count":1,"indications":"Muscle relaxants","indication_count":1,"atc_codes":"M03AC04","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL (besylate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/222"},{"medicine":"atropine","first_added":1977,"main_section":"Diagnostic agents > Ophthalmic medicines","sections":"Diagnostic agents > Ophthalmic medicines; Ophthalmological preparations > Mydriatics; Antidotes and other substances used in poisonings > Specific; Preoperative medication and sedation for short-term procedures","section_count":4,"indications":"Cycloplegic drug; Anterior uveitis; Exposure to or harmful effects of undetermined intent of pesticides; Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics","indication_count":4,"atc_codes":"S01FA01, A03BA01","dosage_forms":"Local > Ophthalmological > Solution (eye drops): 0.1% (sulfate); 0.5% (sulfate); 1% (sulfate); Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule or vial (sulfate); Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule or vial (sulfate); 400 µg per mL in 1 mL ampoule or vial (sulfate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/10"},{"medicine":"azathioprine","first_added":1979,"main_section":"Disease-modifying anti-rheumatic drugs (DMARDs)","sections":"Disease-modifying anti-rheumatic drugs (DMARDs); Immunomodulators for non-malignant disease","section_count":2,"indications":"Rheumatoid arthritis, serology unspecified; Psoriatic arthritis; Failure or rejection of transplanted organs or tissues","indication_count":3,"atc_codes":"L04AX01","dosage_forms":"Oral > Solid > tablet: 50 mg (scored); Oral > Solid > tablet: 50 mg (scored) Parenteral > General injections > IV: 50 mg in vial powder for injection (as sodium salt); 100 mg in vial powder for injection (as sodium salt) Oral > Liquid: 10 mg per mL Oral > Solid > tablet: 25 mg; 50 mg (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/68"},{"medicine":"azithromycin","first_added":2003,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics; Ophthalmological preparations > Anti-infective agents","section_count":2,"indications":"Cholera; Cholera [children]; Paratyphoid fever; Chlamydia trachomatis; Typhoid fever; Yaws; Trachoma; Gonococcal infection; Infectious gastroenteritis or colitis without specification of infectious agent","indication_count":9,"atc_codes":"J01FA10, S01AA26","dosage_forms":"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous); Local > Ophthalmological > Solution (eye drops): 1.5% eye drops","combined_with":"ceftriaxone; cefixime","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/227"},{"medicine":"baclofen","first_added":2025,"main_section":"Medicines for cerebral palsy","sections":"Medicines for cerebral palsy","section_count":1,"indications":"Spastic cerebral palsy","indication_count":1,"atc_codes":"M03BX01","dosage_forms":"Oral > Liquid: 10 mg per 5 mL Parenteral > Locoregional injections > Intrathecal: 500 µg per mL in ampoule Oral > Solid > tablet: 10 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/971"},{"medicine":"barium sulfate","first_added":1977,"main_section":"Diagnostic agents > Radiocontrast media","sections":"Diagnostic agents > Radiocontrast media","section_count":1,"indications":"Barium sulfate with suspending agents","indication_count":1,"atc_codes":"V08BA01","dosage_forms":"Oral > Liquid: Aqueous suspension","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/167"},{"medicine":"beclometasone","first_added":1979,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":"Respiratory > Inhalation > aerosol: 50 µg per dose (dipropionate); 250 µg per dose (dipropionatae)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/250"},{"medicine":"beclometasone + formoterol","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/669"},{"medicine":"bedaquiline","first_added":2015,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":"J04AK05","dosage_forms":"Oral > Solid > tablet: 100 mg tablet; 20 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/279"},{"medicine":"bendamustine","first_added":2015,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Follicular lymphoma","indication_count":2,"atc_codes":"L01AA09","dosage_forms":"Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/73"},{"medicine":"benzathine benzylpenicillin","first_added":1977,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Congenital syphilis [children]; Syphilis","indication_count":2,"atc_codes":"J01CE08","dosage_forms":"Parenteral > General injections > IM: 1.2 million IU in vial (≈ 900 mg) powder for injection; 2.4 million IU in vial (≈ 1.8 g) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/311"},{"medicine":"benznidazole","first_added":1987,"main_section":"American trypanosomiasis","sections":"American trypanosomiasis","section_count":1,"indications":"Chagas disease","indication_count":1,"atc_codes":"P01CA02","dosage_forms":"Oral > Solid > tablet: 100 mg (scored); 50 mg (scored); 12.5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/391"},{"medicine":"benzoyl peroxide","first_added":1989,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Acne","indication_count":1,"atc_codes":"D10AE01","dosage_forms":"Local > Topical > Cream: 5% Local > Topical > Lotion: 5%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/157"},{"medicine":"benzyl benzoate","first_added":1977,"main_section":"Dermatological medicines > Scabicides and pediculicides","sections":"Dermatological medicines > Scabicides and pediculicides","section_count":1,"indications":"Pediculosis corporis; Pediculosis capitis; Pthiriasis; Scabies","indication_count":4,"atc_codes":"P03AX01","dosage_forms":"Local > Topical > Lotion: 25%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/162"},{"medicine":"benzylpenicillin","first_added":1977,"main_section":"Access group antibiotics","sections":"Access group antibiotics; Medicines for bacterial central nervous system infections","section_count":2,"indications":"Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Acute malnutrition in infants, children or adolescents (complicated) [children]; Sepsis without septic shock; Congenital syphilis [children]; Syphilis; Bacterial meningitis","indication_count":6,"atc_codes":"J01CE01","dosage_forms":"Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt) Parenteral > General injections > unspecified: 600 mg in vial powder for injection (= 1 million IU as sodium or potassium salt); 3 g in vial powder for injection (= 5 million IU as sodium or potassium salt); Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)","combined_with":"gentamicin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/303"},{"medicine":"beractant","first_added":2009,"main_section":"Medicines administered to the neonate [c]","sections":"Medicines administered to the neonate [c]","section_count":1,"indications":"Respiratory distress syndrome of newborn","indication_count":1,"atc_codes":"R07AA02","dosage_forms":"Respiratory > Suspension: 25 mg per mL for intratracheal instillation","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/274"},{"medicine":"betamethasone","first_added":1977,"main_section":"Dermatological medicines > Anti-inflammatory and antipruritic medicines","sections":"Dermatological medicines > Anti-inflammatory and antipruritic medicines","section_count":1,"indications":"Dermatitis or eczema; Pruritus due to skin disorder; Psoriasis of unspecified type; Lichen planus","indication_count":4,"atc_codes":"D07AC01","dosage_forms":"Local > Topical > Cream: 0.1% (as valerate) Local > Topical > Ointment: 0.1% (as valerate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/155"},{"medicine":"bevacizumab","first_added":2013,"main_section":"Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations","sections":"Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations","section_count":1,"indications":"Age-related macular degeneration","indication_count":1,"atc_codes":"S01LA08","dosage_forms":"Parenteral > Locoregional injections > Intravitreal: 25 mg per mL","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/238"},{"medicine":"bicalutamide","first_added":2015,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of prostate","indication_count":1,"atc_codes":"L02BB03","dosage_forms":"Oral > Solid: 50 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/112"},{"medicine":"biperiden","first_added":1982,"main_section":"Medicines for parkinsonism","sections":"Medicines for parkinsonism","section_count":1,"indications":"Parkinson disease","indication_count":1,"atc_codes":"N04AA02","dosage_forms":"Parenteral > General injections > IV: 5 mg per mL in 1 mL ampoule (lactate) Oral > Solid: 2 mg tablet (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/116"},{"medicine":"bisacodyl","first_added":2021,"main_section":"Laxatives","sections":"Laxatives","section_count":1,"indications":"Constipation","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/652"},{"medicine":"bisoprolol","first_added":2011,"main_section":"Antianginal medicines","sections":"Antianginal medicines; Antihypertensive medicines; Antiarrhythmic medicines; Medicines used in heart failure","section_count":4,"indications":"Angina pectoris; Essential hypertension; Cardiac arrhythmia; Heart failure","indication_count":4,"atc_codes":"C07AB07","dosage_forms":"Oral > Solid: 1.25 mg; 5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/130"},{"medicine":"bleomycin","first_added":1979,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Kaposi sarcoma of unspecified primary site; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Hodgkin lymphoma","indication_count":4,"atc_codes":"L01DC01","dosage_forms":"Parenteral > General injections > unspecified: 15000 IU in vial (as sulfate)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/74"},{"medicine":"blinatumomab","first_added":2025,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"B lymphoblastic leukaemia or lymphoma, not elsewhere classified","indication_count":1,"atc_codes":"L01FX07","dosage_forms":"Parenteral > General injections > IV: 35 µg in vial; 38.5 µg in vial","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/949"},{"medicine":"bortezomib","first_added":2019,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Plasma cell myeloma","indication_count":1,"atc_codes":"L01XG01","dosage_forms":"Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/407"},{"medicine":"bromocriptine","first_added":null,"main_section":"Medicines for disorders of the pituitary hormone system","sections":"Medicines for disorders of the pituitary hormone system","section_count":1,"indications":"Other specified benign neoplasm of endocrine glands","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/592"},{"medicine":"budesonide","first_added":2007,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease; Ear, nose and throat medicines [c]","section_count":2,"indications":"Asthma; Allergic rhinitis","indication_count":2,"atc_codes":"R03BA02, R01AD05","dosage_forms":"Respiratory > Inhalation > powder: 100 µg per actuation in dry powder inhaler; 200 µg per actuation in dry powder inhaler Respiratory > Inhalation > suspension: 100 µg per actuation in pressurized metered dose inhaler; 200 µg per actuation in pressurized metered dose inhaler; Local > Nasal > Spray: 32 µg per actuation; 64 µg per actuation","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/251"},{"medicine":"budesonide + formoterol","first_added":2017,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":"R03AK07","dosage_forms":"Respiratory > Inhalation > powder: 100 µg + 6 µg per dose actuation in dry powder inhaler; 200 µg + 6 µg per dose actuation in dry powder inhaler","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/252"},{"medicine":"budesonide + salmeterol","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/668"},{"medicine":"bumetanide","first_added":2023,"main_section":"Diuretics","sections":"Diuretics; Medicines used in heart failure","section_count":2,"indications":"Anuria or oliguria; Oedema; Heart failure","indication_count":3,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/648"},{"medicine":"bupivacaine","first_added":1977,"main_section":"Local anaesthetics","sections":"Local anaesthetics","section_count":1,"indications":"Local anaesthetics","indication_count":1,"atc_codes":"N01BB01","dosage_forms":"Parenteral > Locoregional injections > Spinal anaesthesia: 0.5% in 4 mL ampoule (hydrochloride) + 8% glucose solution Parenteral > General injections > unspecified: 0.25% (hydrochloride); 0.5% (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/7"},{"medicine":"buprenorphine","first_added":2005,"main_section":"Medicines for opioid use disorders","sections":"Medicines for opioid use disorders","section_count":1,"indications":"Opioid dependence","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/644"},{"medicine":"bupropion","first_added":2021,"main_section":"Medicines for nicotine use disorders","sections":"Medicines for nicotine use disorders","section_count":1,"indications":"Nicotine dependence","indication_count":1,"atc_codes":"N06AX12","dosage_forms":"Oral > Solid: 150 mg sustained-release (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/606"},{"medicine":"cabergoline","first_added":2023,"main_section":"Medicines for disorders of the pituitary hormone system","sections":"Medicines for disorders of the pituitary hormone system","section_count":1,"indications":"Other specified benign neoplasm of endocrine glands","indication_count":1,"atc_codes":"G02CB03","dosage_forms":"Oral > Solid > tablet: 0.5 mg; 1 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/593"},{"medicine":"caffeine citrate","first_added":2007,"main_section":"Medicines administered to the neonate [c]","sections":"Medicines administered to the neonate [c]","section_count":1,"indications":"Apnoea of newborn","indication_count":1,"atc_codes":"N06BC01","dosage_forms":"Parenteral > General injections > IV: 20 mg per mL (equivalent to 10 mg caffeine base per mL) Oral > Liquid: 20 mg per mL (equivalent to 10 mg caffeine base per mL)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/426"},{"medicine":"calamine","first_added":1982,"main_section":"Dermatological medicines > Anti-inflammatory and antipruritic medicines","sections":"Dermatological medicines > Anti-inflammatory and antipruritic medicines","section_count":1,"indications":"Pruritus","indication_count":1,"atc_codes":"D02AB","dosage_forms":"Local > Topical > Lotion:","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/156"},{"medicine":"calcipotriol","first_added":2021,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Psoriasis of unspecified type","indication_count":1,"atc_codes":"D05AX02","dosage_forms":"Local > Topical > Cream: 50 µg per mL (0.005%) Local > Topical > Lotion: 50 µg per mL (0.005%) Local > Topical > Ointment: 50 µg per mL (0.005%)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/609"},{"medicine":"calcitriol","first_added":2021,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Psoriasis of unspecified type","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/608"},{"medicine":"calcium","first_added":2013,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Calcium deficiency","indication_count":1,"atc_codes":"A12AA20","dosage_forms":"Oral > Solid: 500 mg (elemental calcium)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/260"},{"medicine":"calcium folinate (leucovorin calcium)","first_added":1979,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Burkitt lymphoma including Burkitt leukaemia; Osteosarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of rectum; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of colon; Malignant trophoblastic neoplasms of placenta","indication_count":6,"atc_codes":"V03AF03","dosage_forms":"Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule; 7.5 mg per mL in 2 mL ampoule; 10 mg per mL in 5 mL ampoule Oral > Solid > tablet: 15 mg; 5 mg; 25 mg Oral > Solid: 15 mg tablet Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/75"},{"medicine":"calcium gluconate","first_added":1977,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals; Antidotes and other substances used in poisonings > Specific","section_count":2,"indications":"Tetany due to acute calcium deficiency; Hypermagnesaemia","indication_count":2,"atc_codes":"A12AA03","dosage_forms":"Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule; Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule or vial (10%)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/37"},{"medicine":"canagliflozin","first_added":2021,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/612"},{"medicine":"capecitabine","first_added":2015,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Malignant neoplasms of rectum; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of colon; Other specified malignant neoplasms of breast","indication_count":4,"atc_codes":"L01BC06","dosage_forms":"Oral > Solid > tablet: 150 mg; 500 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/76"},{"medicine":"carbachol","first_added":2021,"main_section":"Ophthalmological preparations > Miotics and antiglaucoma medicines","sections":"Ophthalmological preparations > Miotics and antiglaucoma medicines","section_count":1,"indications":"Acute angle closure with pupillary block; Ocular hypertension; Primary open-angle glaucoma","indication_count":3,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/657"},{"medicine":"carbamazepine","first_added":1977,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines; Medicines for bipolar disorders","section_count":2,"indications":"Epilepsy or seizures; Bipolar or related disorders","indication_count":2,"atc_codes":"N03AF01","dosage_forms":"Oral > Liquid: 100 mg per 5 mL Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 100 mg (chewable); 200 mg (chewable); 400 mg (scored); Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 400 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/49"},{"medicine":"carbetocin","first_added":2019,"main_section":"Uterotonics","sections":"Uterotonics","section_count":1,"indications":"Postpartum haemorrhage","indication_count":1,"atc_codes":"H01BB03","dosage_forms":"Parenteral > General injections > IV: 100 µg per mL (heat stable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/425"},{"medicine":"carbimazole","first_added":2025,"main_section":"Thyroid hormones and antithyroid medicines","sections":"Thyroid hormones and antithyroid medicines","section_count":1,"indications":"Thyrotoxicosis","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/507"},{"medicine":"carboplatin","first_added":2009,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Other specified gliomas of brain; Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx; Malignant neoplasms of cervix uteri; Malignant neoplasms of hypopharynx; Malignant neoplasms of nasopharynx; Malignant neoplasms of oropharynx; Osteosarcoma of bone or articular cartilage of unspecified sites; Other specified malignant neoplasms of the ovary; Germ cell tumour of testis; Other specified carcinomas of ovary; Other specified malignant neoplasms of bronchus or lung; Malignant neoplasms of breast; Retinoblastoma; Malignant neoplasms of kidney, except renal pelvis","indication_count":14,"atc_codes":"L01XA02","dosage_forms":"Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/77"},{"medicine":"carvedilol","first_added":2011,"main_section":"Antianginal medicines","sections":"Antianginal medicines; Antihypertensive medicines; Antiarrhythmic medicines; Medicines used in heart failure","section_count":4,"indications":"Angina pectoris; Essential hypertension; Cardiac arrhythmia; Heart failure","indication_count":4,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/498"},{"medicine":"caspofungin","first_added":2021,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Systemic or invasive candidosis","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/619"},{"medicine":"cefalexin","first_added":2009,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Bacterial cellulitis, erysipelas or lymphangitis; Chronic obstructive pulmonary disease with acute exacerbation; Acute pharyngitis","indication_count":3,"atc_codes":"J01DB01","dosage_forms":"Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid Oral > Solid: 250 mg (as monohydrate); 500 mg (as monohydrate) Oral > Solid > dispersible tablet: 125 mg; 250 mg Oral > Solid: 250 mg (as monohydrate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/304"},{"medicine":"cefazolin","first_added":2007,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Other specified prophylactic measures; Bacterial infection of joint; Osteomyelitis or osteitis","indication_count":3,"atc_codes":"J01DB04","dosage_forms":"Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection","combined_with":"metronidazole","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/305"},{"medicine":"cefiderocol","first_added":2021,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli","indication_count":4,"atc_codes":"J01DI04","dosage_forms":"Parenteral > General injections > IV: 1 g in vial (as sulfate tosylate) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/611"},{"medicine":"cefixime","first_added":2005,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics","section_count":1,"indications":"Infectious gastroenteritis or colitis without specification of infectious agent; Gonococcal infection","indication_count":2,"atc_codes":"J01DD08","dosage_forms":"Oral > Liquid: 100 mg per 5 mL powder for oral liquid Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate)","combined_with":"azithromycin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/307"},{"medicine":"cefotaxime","first_added":2009,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics; Medicines for bacterial central nervous system infections","section_count":2,"indications":"Acute pyelonephritis (severe); Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Bacterial pneumonia (Community-acquired pneumonia - severe); Other specified pneumonia (Hospital-acquired pneumonia); Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Inflammatory or other diseases of prostate (severe); Bacterial meningitis; Acute pyelonephritis (mild to moderate); Sepsis without septic shock; Bacterial infection of joint; Inflammatory or other diseases of prostate (mild to moderate); Osteomyelitis or osteitis","indication_count":15,"atc_codes":"J01DD01","dosage_forms":"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt) Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)","combined_with":"metronidazole; amikacin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/312"},{"medicine":"ceftazidime","first_added":1995,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics","section_count":1,"indications":"Endophthalmitis; Pseudomonas aeruginosa resistant to other antibiotic","indication_count":2,"atc_codes":"J01DD02","dosage_forms":"Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/328"},{"medicine":"ceftazidime + avibactam","first_added":2019,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli","indication_count":4,"atc_codes":"J01DD52","dosage_forms":"Parenteral > General injections > IV: 2 g in vial + 0.5 g in vial powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/395"},{"medicine":"ceftolozane + tazobactam","first_added":2023,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Carbapenem-resistant Pseudomonas aeruginosa","indication_count":1,"atc_codes":"J01DI54","dosage_forms":"Parenteral > General injections > IV: 1 g + 0.5 g powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/398"},{"medicine":"ceftriaxone","first_added":1995,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics; Medicines for bacterial central nervous system infections","section_count":2,"indications":"Other specified pneumonia (Hospital-acquired pneumonia); Acute pyelonephritis (severe); Paratyphoid fever; Typhoid fever; Endophthalmitis; Bacterial pneumonia (Community-acquired pneumonia - severe); Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Necrotising fasciitis; Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Inflammatory or other diseases of prostate (severe); Gonococcal infection; Bacterial meningitis; Acute pyelonephritis (mild to moderate); Bacterial infection of joint; Sepsis without septic shock; Infectious gastroenteritis or colitis without specification of infectious agent; Inflammatory or other diseases of prostate (mild to moderate); Osteomyelitis or osteitis","indication_count":21,"atc_codes":"J01DD04","dosage_forms":"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt) Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt) Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt) Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)","combined_with":"metronidazole; amikacin; azithromycin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/314"},{"medicine":"cefuroxime","first_added":2019,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics","section_count":1,"indications":"Other specified prophylactic measures","indication_count":1,"atc_codes":"J01DC02","dosage_forms":"Parenteral > General injections > IV: 250 mg in vial (as sodium salt) powder for injection; 750 mg in vial (as sodium salt) powder for injection; 1.5 g in vial (as sodium salt) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/401"},{"medicine":"cemiplimab","first_added":2025,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"Other specified malignant neoplasms of bronchus or lung","indication_count":1,"atc_codes":"L01FF06","dosage_forms":"Parenteral > General injections > IV: 50 mg per mL in 7 mL vial concentrate for solution for infusion","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/937"},{"medicine":"certolizumab pegol","first_added":2023,"main_section":"Immunomodulators for non-malignant disease","sections":"Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases; Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":3,"indications":"Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriasis of unspecified type","indication_count":5,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/550"},{"medicine":"cetirizine","first_added":2025,"main_section":"Antiallergics and medicines used in anaphylaxis","sections":"Antiallergics and medicines used in anaphylaxis","section_count":1,"indications":"Allergic or hypersensitivity conditions of unspecified type","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/633"},{"medicine":"chlorambucil","first_added":1979,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Chronic lymphocytic leukaemia or small lymphocytic lymphoma","indication_count":1,"atc_codes":"L01AA02","dosage_forms":"Oral > Solid: 2 mg tablet","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/78"},{"medicine":"chloramphenicol","first_added":1977,"main_section":"Access group antibiotics","sections":"Access group antibiotics; Medicines for bacterial central nervous system infections","section_count":2,"indications":"Bacterial meningitis","indication_count":1,"atc_codes":"J01BA01","dosage_forms":"Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate) Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection Oral > Liquid: 150 mg per 5 mL (as palmitate) Oral > Solid: 250 mg capsule; Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate) Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/332"},{"medicine":"chlorhexidine","first_added":1979,"main_section":"Medicines administered to the neonate [c]","sections":"Medicines administered to the neonate [c]; Antiseptics","section_count":2,"indications":"Omphalitis of newborn; Chlorhexidine","indication_count":2,"atc_codes":"D08AC02","dosage_forms":"Local > Topical > Solution: 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine) Local > Topical > Gel: 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine); Local > Topical > Solution: 5% (digluconate) for dilution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/170"},{"medicine":"chlorine base compound","first_added":1997,"main_section":"Disinfectants","sections":"Disinfectants","section_count":1,"indications":"Disinfectant, not elsewhere classified","indication_count":1,"atc_codes":"V07AV","dosage_forms":"Local > Topical > Powder: 0.1% available chlorine for solution Local > Topical > Liquid: 0.1% available chlorine for solution Local > Topical > Solid: 0.1% available chlorine for solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/174"},{"medicine":"chloroquine","first_added":1977,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment; Disease-modifying anti-rheumatic drugs (DMARDs); Antimalarial medicines > Medicines for chemoprophylaxis in travellers","section_count":3,"indications":"Malaria due to Plasmodium vivax; Rheumatoid arthritis","indication_count":2,"atc_codes":"P01BA01","dosage_forms":"Parenteral > General injections > IV: 40 mg per mL in 5 mL ampoule (as hydrochloride, phosphate or sulfate) Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate) Oral > Solid: 150 mg tablet (as phosphate or sulfate); 100 mg tablet (as phosphate or sulfate) Oral > Liquid: 50 mg per 5 mL (base) Oral > Solid > tablet: 150 mg (base); Oral > Solid: 100 mg tablet (as phosphate or sulfate); 150 mg tablet (as phosphate or sulfate); Oral > Liquid: 50 mg per 5 mL (base) Oral > Solid > tablet: 150 mg (base)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/275"},{"medicine":"chlorothiazide","first_added":2021,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines; Medicines used in heart failure","section_count":2,"indications":"Essential hypertension; Heart failure","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/645"},{"medicine":"chloroxylenol","first_added":1997,"main_section":"Disinfectants","sections":"Disinfectants","section_count":1,"indications":"Phenol disinfectant, not elsewhere classified","indication_count":1,"atc_codes":"D08AE05","dosage_forms":"Local > Topical > Solution: 4.8%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/175"},{"medicine":"chlorpromazine","first_added":1977,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Liquid: 25 mg per 5 mL (hydrochloride) Oral > Solid: 100 mg (hydrochloride) Oral > Solid: 100 mg (hydrochloride); 10 mg (hydrochloride); 25 mg (hydrochloride); 50 mg (hydrochloride) Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/244"},{"medicine":"chlortalidone","first_added":2021,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines; Medicines used in heart failure","section_count":2,"indications":"Essential hypertension; Heart failure","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/646"},{"medicine":"chlortetracycline","first_added":2021,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents","section_count":1,"indications":"Other specified conjunctivitis; Infectious keratitis; Infectious blepharitis; Trachoma","indication_count":4,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/655"},{"medicine":"cholera vaccine","first_added":2007,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against cholera alone","indication_count":1,"atc_codes":"J07AE01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/435"},{"medicine":"ciclesonide","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/664"},{"medicine":"ciclosporin","first_added":1991,"main_section":"Immunomodulators for non-malignant disease","sections":"Immunomodulators for non-malignant disease","section_count":1,"indications":"Failure or rejection of transplanted organs or tissues","indication_count":1,"atc_codes":"L04AD01","dosage_forms":"Parenteral > General injections > IV: 50 mg per mL in 1 mL ampoule concentrate for injection Oral > Liquid: 100 mg per mL Oral > Solid > capsule: 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/69"},{"medicine":"ciprofloxacin","first_added":1991,"main_section":"Ear, nose and throat medicines [c]","sections":"Ear, nose and throat medicines [c]; Watch group antibiotics","section_count":2,"indications":"Infectious diseases of external ear; Acute pyelonephritis (mild to moderate); Paratyphoid fever; Typhoid fever; Infectious gastroenteritis or colitis without specification of infectious agent; Neutropaenia (low-risk); Inflammatory or other diseases of prostate (mild to moderate); Cholera; Cholera [children]; Peritoneal abscess (mild-moderate); Peritonitis (mild-moderate)","indication_count":11,"atc_codes":"S02AA15, J01MA02","dosage_forms":"Local > Otological > drops: 0.3% (as hydrochloride); Parenteral > General injections > IV: 2 mg per mL (as hyclate) Oral > Liquid: 250 mg per 5 mL (anhydrous) Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride) Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride) Oral > Solid: 250 mg (as hydrochloride)","combined_with":"metronidazole","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/271"},{"medicine":"cisplatin","first_added":1984,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Other specified gliomas of brain; Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx; Malignant neoplasms of cervix uteri; Malignant neoplasms of hypopharynx; Malignant neoplasms of oropharynx; Malignant neoplasms of nasopharynx; Germ cell tumour of testis; Osteosarcoma of bone or articular cartilage of unspecified sites; Other specified malignant neoplasms of the ovary; Other specified malignant neoplasms of bronchus or lung","indication_count":10,"atc_codes":"L01XA01","dosage_forms":"Parenteral > General injections > IV: 10 mg per 10 mL; 20 mg per 20 mL; 50 mg per 50 mL; 100 mg per 100 mL Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/79"},{"medicine":"citalopram","first_added":2023,"main_section":"Medicines for anxiety disorders","sections":"Medicines for anxiety disorders","section_count":1,"indications":"Generalised anxiety disorder","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/659"},{"medicine":"cladribine","first_added":2023,"main_section":"Medicines for multiple sclerosis","sections":"Medicines for multiple sclerosis","section_count":1,"indications":"Multiple sclerosis","indication_count":1,"atc_codes":"L04AA40","dosage_forms":"Oral > Solid > tablet: 10 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/903"},{"medicine":"clarithromycin","first_added":2011,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics","section_count":1,"indications":"Bacterial pneumonia (Community-acquired pneumonia - severe); Acute pharyngitis; Helicobacter pylori associated gastric ulcer","indication_count":3,"atc_codes":"J01FA09","dosage_forms":"Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid Parenteral > General injections > unspecified: 500 mg in vial powder for injection Oral > Solid > dosage form: 500 mg; 250 mg Oral > Solid > dosage form: 500 mg","combined_with":"cefotaxime; ceftriaxone; amoxicillin + clavulanic acid","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/317"},{"medicine":"clindamycin","first_added":1991,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Necrotising fasciitis; Bacterial infection of joint; Osteomyelitis or osteitis","indication_count":3,"atc_codes":"J01FF01","dosage_forms":"Parenteral > General injections > IV: 150 mg per mL (as phosphate); 600 mg per 4 mL (as phosphate); 900 mg per 6 mL (as phosphate) Oral > Liquid: 75 mg per 5 mL powder for oral liquid (as palmitate hydrochloride) Oral > Solid: 150 mg (as hydrochloride) Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride) Oral > Solid: 150 mg (as hydrochloride) capsule Parenteral > General injections > unspecified: 150 mg per mL (as phosphate) injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/309"},{"medicine":"clofazimine","first_added":1977,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines; Antileprosy medicines","section_count":2,"indications":"Multi-drug resistant Mycobacterium tuberculosis; Leprosy","indication_count":2,"atc_codes":"J04BA01","dosage_forms":"Oral > Solid > dosage form: 100 mg; 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/292"},{"medicine":"clomifene","first_added":1979,"main_section":"Ovulation inducers","sections":"Ovulation inducers","section_count":1,"indications":"Female infertility without specification whether primary or secondary","indication_count":1,"atc_codes":"G03GB02","dosage_forms":"Oral > Solid: 50 mg (citrate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/198"},{"medicine":"clomipramine","first_added":1993,"main_section":"Medicines for obsessive compulsive disorders","sections":"Medicines for obsessive compulsive disorders","section_count":1,"indications":"Obsessive-compulsive disorder","indication_count":1,"atc_codes":"N06AA04","dosage_forms":"Oral > Solid: 10 mg (hydrochloride); 25 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/249"},{"medicine":"clopidogrel","first_added":2015,"main_section":"Anti-platelet medicines","sections":"Anti-platelet medicines","section_count":1,"indications":"Acute ischaemic heart disease; Presence of coronary angioplasty implant or graft","indication_count":2,"atc_codes":"B01AC04","dosage_forms":"Oral > Solid: 75 mg; 300 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/146"},{"medicine":"clotrimazole","first_added":2005,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Vulvovaginal candidosis","indication_count":1,"atc_codes":"G01AF02","dosage_forms":"Local > Topical > Other: 1% vaginal cream; 10% vaginal cream; 100 mg vaginal tablet; 500 mg vaginal tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/358"},{"medicine":"cloxacillin","first_added":1977,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock","indication_count":4,"atc_codes":"J01CF02","dosage_forms":"Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid; 250 mg per 5 mL (as sodium salt) powder for oral liquid Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 250 mg in vial (as sodium salt) powder for injection Oral > Solid > capsule: 500 mg (as sodium salt); 1 g (as sodium salt); 250 mg (as sodium salt) Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid Oral > Solid: 500 mg (as sodium salt) capsule; 1 g (as sodium salt) capsule Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/306"},{"medicine":"clozapine","first_added":2013,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":"N05AH02","dosage_forms":"Oral > Solid: 25 mg; 50 mg; 100 mg; 200 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/247"},{"medicine":"coagulation factor IX complex","first_added":2025,"main_section":"Coagulation factors","sections":"Coagulation factors","section_count":1,"indications":"Coagulation defects, purpura or other haemorrhagic or related conditions; Haemophilia B","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/940"},{"medicine":"coagulation factor IX, plasma-derived","first_added":1979,"main_section":"Coagulation factors","sections":"Coagulation factors","section_count":1,"indications":"Coagulation defects, purpura or other haemorrhagic or related conditions; Haemophilia B","indication_count":2,"atc_codes":"B02BD01, B02BD04","dosage_forms":"Parenteral > General injections > IV: 500 IU in vial powder for injection; 1000 IU in vial powder for injection","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/468"},{"medicine":"coagulation factor IX, recombinant","first_added":2025,"main_section":"Coagulation factors","sections":"Coagulation factors","section_count":1,"indications":"Haemophilia B","indication_count":1,"atc_codes":"B02BD04","dosage_forms":"Parenteral > General injections > IV: 250 IU per mL in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/951"},{"medicine":"coagulation factor VIII, plasma-derived","first_added":1979,"main_section":"Coagulation factors","sections":"Coagulation factors","section_count":1,"indications":"Haemophilia A","indication_count":1,"atc_codes":"B02BD02","dosage_forms":"Parenteral > General injections > IV: 250 IU in vial powder for injection; 500 IU in vial powder for injection; 1000 IU in vial powder for injection","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/466"},{"medicine":"coagulation factor VIII, recombinant","first_added":2025,"main_section":"Coagulation factors","sections":"Coagulation factors","section_count":1,"indications":"Haemophilia A","indication_count":1,"atc_codes":"B02BD02","dosage_forms":"Parenteral > General injections > IV: 250 IU in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/950"},{"medicine":"coal tar","first_added":1977,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Psoriasis of unspecified type","indication_count":1,"atc_codes":"D05AA","dosage_forms":"Local > Topical > Solution: 5%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/158"},{"medicine":"codeine","first_added":1977,"main_section":"Opioid analgesics","sections":"Opioid analgesics","section_count":1,"indications":"Pain","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid: 30 mg tablet (codeine phosphate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/16"},{"medicine":"colecalciferol","first_added":2007,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Calcium deficiency; Vitamin D deficiency","indication_count":2,"atc_codes":"A11CC05","dosage_forms":"Oral > Liquid: 400 IU per mL Oral > Solid: 400 IU; 1000 IU","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/261"},{"medicine":"colistin (injection)","first_added":2017,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Carbapenem resistant Acinetobacter baumannii; Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli","indication_count":5,"atc_codes":"J01XB01","dosage_forms":"Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) (equivalent to 34 mg colistin base activity)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/348"},{"medicine":"compound sodium lactate solution","first_added":1977,"main_section":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","sections":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","section_count":1,"indications":"Hypovolaemic shock; Other specified disorders of fluid, electrolyte or acid-base balance","indication_count":2,"atc_codes":"B05BB01","dosage_forms":"Parenteral > General injections > IV: injectable solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/544"},{"medicine":"condoms","first_added":1987,"main_section":"Barrier methods","sections":"Barrier methods","section_count":1,"indications":"Contact with health services for contraceptive management","indication_count":1,"atc_codes":null,"dosage_forms":"-","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/422"},{"medicine":"copper-containing intrauterine device","first_added":1987,"main_section":"Intrauterine devices","sections":"Intrauterine devices","section_count":1,"indications":"Contact with health services for insertion of contraceptive device","indication_count":1,"atc_codes":"G02BA02","dosage_forms":"-","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/421"},{"medicine":"cryoprecipitate (native)","first_added":2023,"main_section":"Blood and blood components","sections":"Blood and blood components","section_count":1,"indications":"Coagulation defects, purpura or other haemorrhagic or related conditions; Obstetric haemorrhage","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/914"},{"medicine":"cryoprecipitate (pathogen-reduced)","first_added":2023,"main_section":"Blood and blood components","sections":"Blood and blood components","section_count":1,"indications":"Coagulation defects, purpura or other haemorrhagic or related conditions; Obstetric haemorrhage","indication_count":2,"atc_codes":"B05AA02","dosage_forms":"Injection: frozen liquid in bag or lyophilized powder in vial containing: > 50 IU Factor VIII > 100 IU vWF > 140 mg clottable fibrinogen per unit","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/915"},{"medicine":"cyclizine","first_added":2009,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care","section_count":1,"indications":"Palliative care","indication_count":1,"atc_codes":"R06AE03","dosage_forms":"Parenteral > General injections > unspecified: 50 mg per mL (lactate) Oral > Solid > tablet: 50 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/20"},{"medicine":"cyclopentolate","first_added":2021,"main_section":"Diagnostic agents > Ophthalmic medicines","sections":"Diagnostic agents > Ophthalmic medicines; Ophthalmological preparations > Mydriatics","section_count":2,"indications":"Cycloplegic drug; Anterior uveitis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/651"},{"medicine":"cyclophosphamide","first_added":1977,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Diffuse large B-cell lymphoma, not otherwise specified; Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Plasma cell myeloma; Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Other specified gliomas of brain; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Rhabdomyosarcoma primary site; Malignant neoplasms of breast; Other specified malignant neoplasms of breast; Hodgkin lymphoma; Malignant trophoblastic neoplasms of placenta; Follicular lymphoma; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis","indication_count":16,"atc_codes":"L01AA01","dosage_forms":"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection Oral > Solid > dosage form: 25 mg; 50 mg Oral > Solid: 25 mg tablet Parenteral > General injections > unspecified: 500 mg in vial powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/80"},{"medicine":"cycloserine","first_added":1999,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":"J04AB01","dosage_forms":"Oral > Solid > dosage form: 250 mg; 125 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/350"},{"medicine":"cytarabine","first_added":1979,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Acute myeloid leukaemia with recurrent genetic abnormalities; Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Myeloid leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis","indication_count":7,"atc_codes":"L01BC01","dosage_forms":"Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per mL in vial Parenteral > General injections > unspecified: 100 mg in vial powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/81"},{"medicine":"cytisine (cytisinicline)","first_added":2025,"main_section":"Medicines for nicotine use disorders","sections":"Medicines for nicotine use disorders","section_count":1,"indications":"Nicotine dependence","indication_count":1,"atc_codes":"N07BA04","dosage_forms":"Oral > Solid > tablet: 1.5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/952"},{"medicine":"dabigatran","first_added":2019,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Other specified atrial fibrillation; Venous thromboembolism","indication_count":2,"atc_codes":"B01AE07","dosage_forms":"Oral > Solid: 110 mg; 150 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/479"},{"medicine":"dacarbazine","first_added":1989,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Hodgkin lymphoma","indication_count":1,"atc_codes":"L01AX04","dosage_forms":"Parenteral > General injections > IV: 100 mg in vial powder for injection; 200 mg in vial powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/82"},{"medicine":"daclatasvir","first_added":2015,"main_section":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","sections":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","section_count":1,"indications":"Chronic hepatitis C","indication_count":1,"atc_codes":"J05AP07","dosage_forms":"Oral > Solid > tablet: 30 mg (as dihydrochloride); 60 mg (as dihydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/295"},{"medicine":"daclatasvir + sofosbuvir","first_added":2021,"main_section":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","sections":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","section_count":1,"indications":"Chronic hepatitis C","indication_count":1,"atc_codes":"J05AP07, J05AP08","dosage_forms":"Oral > Solid > tablet: 60 mg (as dihydrochloride) + 400 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/626"},{"medicine":"dactinomycin","first_added":1984,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Rhabdomyosarcoma primary site; Malignant trophoblastic neoplasms of placenta; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis","indication_count":4,"atc_codes":"L01DA01","dosage_forms":"Parenteral > General injections > IV: 500 µg in vial powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/83"},{"medicine":"dalteparin","first_added":2015,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Acute ischaemic heart disease; Venous thromboembolism","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/414"},{"medicine":"dapagliflozin","first_added":2021,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/613"},{"medicine":"dapsone","first_added":1977,"main_section":"Antileprosy medicines","sections":"Antileprosy medicines","section_count":1,"indications":"Leprosy","indication_count":1,"atc_codes":"J04BA02","dosage_forms":"Oral > Solid: 100 mg tablet; 50 mg tablet; 25 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/293"},{"medicine":"darbepoetin alfa","first_added":2017,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Anaemia due to chronic disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/418"},{"medicine":"darunavir","first_added":2015,"main_section":"Antiretrovirals > Protease inhibitors","sections":"Antiretrovirals > Protease inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AE10","dosage_forms":"Oral > Solid: 75 mg; 400 mg; 600 mg; 800 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/458"},{"medicine":"dasatinib","first_added":2017,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Chronic myelogenous leukaemia, BCR-ABL1-positive","indication_count":1,"atc_codes":"L01EA02","dosage_forms":"Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/84"},{"medicine":"daunorubicin","first_added":1999,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Acute myeloid leukaemia with recurrent genetic abnormalities; Lymphoid leukaemia, not elsewhere classified; Myeloid leukaemia","indication_count":3,"atc_codes":"L01DB02","dosage_forms":"Parenteral > General injections > IV: 50 mg in vial (as hydrochloride) powder for injection; 20 mg in vial (as hydrochloride) powder for injection; 2 mg per mL in vial (as hydrochloride); 5 mg per mL in vial (as hydrochloride)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/85"},{"medicine":"deferasirox","first_added":2023,"main_section":"Medicines for haemoglobinopathies","sections":"Medicines for haemoglobinopathies","section_count":1,"indications":"Other specified sickle cell disorders or other haemoglobinopathies; Thalassaemias","indication_count":2,"atc_codes":"V03AC03","dosage_forms":"Oral > Solid > dispersible tablet: 100 mg; 125 mg; 250 mg; 400 mg; 500 mg Oral > Solid > tablet: 90 mg; 180 mg; 360 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/643"},{"medicine":"deferiprone","first_added":2023,"main_section":"Medicines for haemoglobinopathies","sections":"Medicines for haemoglobinopathies","section_count":1,"indications":"Other specified sickle cell disorders or other haemoglobinopathies; Thalassaemias","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/916"},{"medicine":"deferoxamine","first_added":1979,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific; Medicines for haemoglobinopathies","section_count":2,"indications":"Harmful effects of drugs, medicaments or biological substances, not elsewhere classified; Other specified sickle cell disorders or other haemoglobinopathies; Thalassaemias","indication_count":3,"atc_codes":"V03AC01","dosage_forms":"Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/40"},{"medicine":"delamanid","first_added":2015,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":"J04AK06","dosage_forms":"Oral > Solid > dispersible tablet: 25 mg Oral > Solid > tablet: 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/280"},{"medicine":"dengue vaccine","first_added":2019,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BX04","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/434"},{"medicine":"desmopressin","first_added":1991,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Haemophilia A; Von Willebrand disease","indication_count":2,"atc_codes":"H01BA02","dosage_forms":"Parenteral > General injections > IV: 4 µg per mL in 1 mL ampoule (acetate) Local > Nasal > Spray: 150 µg per actuation (acetate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/129"},{"medicine":"dexamethasone","first_added":1977,"main_section":"Other medicines administered to the mother","sections":"Other medicines administered to the mother; Hormones and antihormones; Antiallergics and medicines used in anaphylaxis; Medicines for other common symptoms in palliative care; Antiemetic medicines","section_count":5,"indications":"Respiratory distress syndrome of the newborn, altered by maternal corticosteroid therapy; Anaplastic large cell lymphoma, ALK-negative; Lymphoid leukaemia, not elsewhere classified; Plasma cell myeloma; Burkitt lymphoma including Burkitt leukaemia; Anaplastic large cell lymphoma, ALK-positive; Allergic or hypersensitivity conditions of unspecified type; Palliative care; Nausea or vomiting","indication_count":9,"atc_codes":"H02AB02, L01AA01, C05AA09","dosage_forms":"Parenteral > General injections > unspecified: 4 mg per mL (dexamethasone phosphate (as sodium)); Oral > Liquid: 2 mg per 5 mL Oral > Solid: 2 mg; 4 mg Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (as disodium phosophate salt) Oral > Liquid: 2 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base) Oral > Solid > tablet: 2 mg (as dexamethasone base); 4 mg (as dexamethasone base) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base Oral > Solid > tablet: 4 mg (as dexamethasone base); Oral > Liquid: 0.5 mg per 5 mL (as sodium phosphate); 2 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base) Oral > Solid > tablet: 0.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); 2 mg (as dexamethasone base); 4 mg (as dexamethasone base); Oral > Liquid: 2 mg per 5 mL (as sodium phosphate); 0.5 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule (dexamethasone phosphate (as sodium phosphate) equialent to 3.3 mg dexamethasone base) Oral > Solid > tablet: 2 mg (as dexamethasone base); 4 mg (as dexamethasone base); 0.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); Oral > Liquid: 0.5 mg per 5 mL (as sodium phosphate); 2 mg per 5 mL (as sodium phosphate) Parenteral > General injections > unspecified: 4 mg per mL in 1 mL ampoule dexamethasone phosphate (as sodium phosphate, equivalent to 3.3 mg/mL dexamethasone base) Oral > Solid > tablet: 0.5 mg (as dexamethasone base); 0.75 mg (as dexamethasone base); 1.5 mg (as dexamethasone base); 4 mg (as dexamethasone base); 2 mg (as dexamethasone base)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/21"},{"medicine":"dextran 70","first_added":1979,"main_section":"Plasma substitutes","sections":"Plasma substitutes","section_count":1,"indications":"Hypovolaemia","indication_count":1,"atc_codes":"B05AA05","dosage_forms":"Parenteral > General injections > IV: 6% injectable solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/472"},{"medicine":"diaphragms","first_added":1987,"main_section":"Barrier methods","sections":"Barrier methods","section_count":1,"indications":"Contact with health services for contraceptive management","indication_count":1,"atc_codes":null,"dosage_forms":"-","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/423"},{"medicine":"diazepam","first_added":1977,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines; Medicines for other common symptoms in palliative care; Medicines for anxiety disorders","section_count":3,"indications":"Status epilepticus; Palliative care; Anxiety","indication_count":3,"atc_codes":"N05BA01","dosage_forms":"Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube; Oral > Liquid: 2 mg per 5 mL Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube Parenteral > General injections > unspecified: 5 mg per mL Oral > Solid > tablet: 5 mg (scored); 10 mg (scored); 2 mg (scored); Oral > Solid: 5 mg (scored); 2 mg (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/22"},{"medicine":"diazoxide","first_added":2019,"main_section":"Medicines for hypoglycaemia","sections":"Medicines for hypoglycaemia","section_count":1,"indications":"Persistent hyperinsulinaemic hypoglycaemia of infancy","indication_count":1,"atc_codes":"V03AH01","dosage_forms":"Oral > Liquid: 50 mg per mL Oral > Solid: 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/505"},{"medicine":"dicloxacillin","first_added":2023,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock","indication_count":4,"atc_codes":"J01CF02","dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/724"},{"medicine":"diethylcarbamazine","first_added":1979,"main_section":"Antifilarials","sections":"Antifilarials","section_count":1,"indications":"Lymphatic filariasis","indication_count":1,"atc_codes":"P02CB02","dosage_forms":"Oral > Solid: 50 mg tablet (dihydrogen citrate); 100 mg tablet (dihydrogen citrate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/64"},{"medicine":"digoxin","first_added":1977,"main_section":"Antiarrhythmic medicines","sections":"Antiarrhythmic medicines; Medicines used in heart failure","section_count":2,"indications":"Cardiac arrhythmia; Heart failure","indication_count":2,"atc_codes":"C01AA05","dosage_forms":"Parenteral > General injections > IV: 250 µg per mL in 2 mL ampoule Oral > Liquid: 50 µg per mL Oral > Solid: 62.5 µg; 250 µg; Parenteral > General injections > IV: 250 µg per mL in 2 mL ampoule; 100 µg per mL in 1 mL ampoule Oral > Liquid: 50 µg per mL Oral > Solid > tablet: 62.5 µg; 250 µg; 125 µg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/134"},{"medicine":"dihydroartemisinin + piperaquine","first_added":2017,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":2,"atc_codes":"P01BF05","dosage_forms":"Oral > Solid > dispersible tablet: 20 mg + 160 mg (phosphate); 40 mg + 320 mg (phosphate) Oral > Solid > tablet: 40 mg + 320 mg (phosphate); 20 mg + 160 mg (phosphate); 60 mg + 480 (phosphate); 80 mg + 640 mg (phosphate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/378"},{"medicine":"diloxanide","first_added":1977,"main_section":"Antiamoebic and antigiardiasis medicines","sections":"Antiamoebic and antigiardiasis medicines","section_count":1,"indications":"Amoebiasis","indication_count":1,"atc_codes":"P01AC01","dosage_forms":"Oral > Solid: 500 mg (furoate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/363"},{"medicine":"dimercaprol","first_added":1977,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified","indication_count":1,"atc_codes":"V03AB09","dosage_forms":"Parenteral > General injections > IM: 50 mg per mL in 2 mL ampoule; 100 mg per mL in 3 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/41"},{"medicine":"dinoprostone (prostaglandin E2)","first_added":2009,"main_section":"Medicines administered to the neonate [c]","sections":"Medicines administered to the neonate [c]","section_count":1,"indications":"Other specified congenital anomaly of great arteries including arterial duct","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > General injections > IV: 1 mg per mL","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/428"},{"medicine":"diphtheria antitoxin","first_added":1977,"main_section":"Immunologicals > Sera, immunoglobulins and monoclonal antibodies","sections":"Immunologicals > Sera, immunoglobulins and monoclonal antibodies","section_count":1,"indications":"Need for immunization against diphtheria alone","indication_count":1,"atc_codes":"J06AA01","dosage_forms":"Parenteral > General injections > IM: 10000 IU in vial; 20000 IU in vial","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/511"},{"medicine":"diphtheria vaccine","first_added":1999,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against diphtheria alone","indication_count":1,"atc_codes":"J07AF01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/430"},{"medicine":"docetaxel","first_added":2011,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Malignant neoplasms of breast; Other specified malignant neoplasms of breast; Malignant neoplasms of prostate","indication_count":3,"atc_codes":"L01CD02","dosage_forms":"Parenteral > General injections > IV: 20 mg per mL; 40 mg per mL","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/86"},{"medicine":"docusate sodium","first_added":2009,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care","section_count":1,"indications":"Palliative care","indication_count":1,"atc_codes":"A06AA02","dosage_forms":"Oral > Liquid: 50 mg per 5 mL; 12.5 mg per 5 mL Oral > Solid > capsule: 100 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/23"},{"medicine":"dolasetron","first_added":2025,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Antiemetic medicines","section_count":2,"indications":"Palliative care; Nausea or vomiting","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/629"},{"medicine":"dolutegravir","first_added":2017,"main_section":"Antiretrovirals > Integrase inhibitors","sections":"Antiretrovirals > Integrase inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AJ03","dosage_forms":"Oral > Solid: 50 mg tablet; 10 mg tablet (dispersible, scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/278"},{"medicine":"dolutegravir + lamivudine + tenofovir","first_added":2019,"main_section":"Fixed-dose combinations of antiretrovirals","sections":"Fixed-dose combinations of antiretrovirals","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AR27","dosage_forms":"Oral > Solid: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/483"},{"medicine":"dopamine","first_added":1977,"main_section":"Medicines used in heart failure","sections":"Medicines used in heart failure","section_count":1,"indications":"Cardiogenic shock; Heart failure","indication_count":2,"atc_codes":"C01CA04","dosage_forms":"Parenteral > General injections > IV: 40 mg per mL in 5 mL vial (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/145"},{"medicine":"doxorubicin","first_added":1977,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Diffuse large B-cell lymphoma, not otherwise specified; Plasma cell myeloma; Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Osteosarcoma of bone or articular cartilage of unspecified sites; Kaposi sarcoma of unspecified primary site; Malignant neoplasms of breast; Other specified malignant neoplasms of breast; Hodgkin lymphoma; Follicular lymphoma; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis","indication_count":14,"atc_codes":"L01DB01, L01AA01","dosage_forms":"Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per mL in 5 mL vial (hydrochloride); 2 mg per mL in 25 mL vial (hydrochloride) Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/87"},{"medicine":"doxorubicin (as pegylated liposomal)","first_added":2023,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Kaposi sarcoma of unspecified primary site","indication_count":1,"atc_codes":"L01DB01","dosage_forms":"Parenteral > General injections > IV: 2 mg per mL in 10 mL vial (hydrochloride); 2 mg per mL in 25 mL vial (hydrochloride)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/906"},{"medicine":"doxycycline","first_added":1977,"main_section":"Access group antibiotics","sections":"Access group antibiotics; Antimalarial medicines > Medicines for chemoprophylaxis in travellers","section_count":2,"indications":"Cholera; Chlamydia trachomatis; Bacterial pneumonia (Community-acquired pneumonia - mild to moderate); Cholera [children]; Chronic obstructive pulmonary disease with acute exacerbation; Malaria due to Plasmodium falciparum","indication_count":6,"atc_codes":"J01AA02","dosage_forms":"Oral > Liquid: 25 mg per 5 mL powder for oral liquid (monohydrate); 50 mg per 5 mL (calcium) Parenteral > General injections > unspecified: 100 mg in vial powder for injection Oral > Solid > dispersible tablet: 100 mg (as monohydrate) Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate) Oral > Solid > dosage form: 100 mg (as hyclate) Oral > Liquid: 25 mg per 5 mL (anhydrous); 50 mg per 5 mL (anhydrous) Oral > Solid: 100 mg (as hyclate); 50 mg (as hyclate); Oral > Liquid: 50 mg per 5 mL (calcium); 25 mg per 5 mL (monohydrate) powder for oral liquid Oral > Solid > dispersible tablet: 100 mg (as monohydrate) Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/318"},{"medicine":"dulaglutide","first_added":null,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/972"},{"medicine":"edoxaban","first_added":2019,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Other specified atrial fibrillation; Venous thromboembolism","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/480"},{"medicine":"efavirenz","first_added":2002,"main_section":"Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors","sections":"Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AG03","dosage_forms":"Oral > Solid: 600 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/450"},{"medicine":"efavirenz + emtricitabine + tenofovir","first_added":2007,"main_section":"Fixed-dose combinations of antiretrovirals","sections":"Fixed-dose combinations of antiretrovirals","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AR06","dosage_forms":"Oral > Solid: 600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/463"},{"medicine":"efavirenz + lamivudine + tenofovir","first_added":2017,"main_section":"Fixed-dose combinations of antiretrovirals","sections":"Fixed-dose combinations of antiretrovirals","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AR11","dosage_forms":"Oral > Solid: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate, equivalent to 245 mg tenofovir disoproxil)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/285"},{"medicine":"eflornithine","first_added":1991,"main_section":"Medicines for the treatment of 2nd stage African trypanosomiasis","sections":"Medicines for the treatment of 2nd stage African trypanosomiasis","section_count":1,"indications":"Gambiense trypanosomiasis","indication_count":1,"atc_codes":"P01CX03","dosage_forms":"Parenteral > General injections > IV: 200 mg per mL in 50 mL bottle (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/388"},{"medicine":"eletriptan","first_added":2025,"main_section":"Medicines for acute migraine attacks","sections":"Medicines for acute migraine attacks","section_count":1,"indications":"Migraine","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid > tablet: 40 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/990"},{"medicine":"elexacaftor + tezacaftor + ivacaftor","first_added":2025,"main_section":"Medicines for cystic fibrosis","sections":"Medicines for cystic fibrosis","section_count":1,"indications":"Cystic fibrosis","indication_count":1,"atc_codes":"R07AX32","dosage_forms":"Oral > Solid > tablet: 50 mg + 25 mg + 37.5 mg; 100 mg + 50 mg + 75 mg Oral > Solid > granules: 80 mg + 40 mg + 60 mg in sachet; 100 mg + 50 mg + 75 mg in sachet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/954"},{"medicine":"emicizumab","first_added":2025,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Haemophilia A","indication_count":1,"atc_codes":"B02BX06","dosage_forms":"Parenteral > General injections > SC: 12 mg per 0.4 mL in vial; 30 mg per mL in mL vial; 60 mg per 0.4 mL in vial; 105 mg per 0.7 mL in vial; 150 mg per mL in vial; 300 mg per 2 mL in vial","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/955"},{"medicine":"empagliflozin","first_added":2021,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":"A10BK03","dosage_forms":"Oral > Solid: 10 mg; 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/614"},{"medicine":"emtricitabine + tenofovir","first_added":2007,"main_section":"Fixed-dose combinations of antiretrovirals","sections":"Fixed-dose combinations of antiretrovirals","section_count":1,"indications":"Contact with or exposure to human immunodeficiency virus; Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":2,"atc_codes":"J05AR03","dosage_forms":"Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/467"},{"medicine":"enalapril","first_added":2003,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines; Medicines used in heart failure","section_count":2,"indications":"Essential hypertension; Heart failure","indication_count":2,"atc_codes":"C09AA02","dosage_forms":"Oral > Liquid: 1 mg per mL (as hydrogen maleate) Oral > Solid > tablet: 2.5 mg (as hydrogen maleate); 5 mg (as hydrogen maleate); 10 mg (as hydrogen maleate); Oral > Solid > tablet: 2.5 mg (as hydrogen maleate); 5 mg (as hydrogen maleate); 10 mg (as hydrogen maleate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/137"},{"medicine":"enoxaparin","first_added":2015,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Acute ischaemic heart disease; Venous thromboembolism","indication_count":2,"atc_codes":"B01AB05","dosage_forms":"Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/123"},{"medicine":"entecavir","first_added":2015,"main_section":"Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors","sections":"Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors","section_count":1,"indications":"Chronic hepatitis B","indication_count":1,"atc_codes":"J05AF10","dosage_forms":"Oral > Liquid: 0.05 mg per mL Oral > Solid: 0.5 mg; 1 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/490"},{"medicine":"enzalutamide","first_added":null,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of prostate","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid: 40 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/455"},{"medicine":"ephedrine","first_added":1997,"main_section":"Local anaesthetics","sections":"Local anaesthetics","section_count":1,"indications":"Cardiac complications of anaesthesia during labour or delivery","indication_count":1,"atc_codes":"C01CA26","dosage_forms":"Parenteral > Locoregional injections > Spinal anaesthesia: 30 mg per mL in 1 mL ampoule (ephedrine hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/9"},{"medicine":"epinephrine","first_added":1977,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease; Antiallergics and medicines used in anaphylaxis; Antiarrhythmic medicines; Ophthalmological preparations > Mydriatics","section_count":4,"indications":"Chronic obstructive pulmonary disease; Asthma; Anaphylaxis; Cardiac arrest; Primary open-angle glaucoma","indication_count":5,"atc_codes":"R03AA01, C01CA24, S01EA01","dosage_forms":"Parenteral > General injections > unspecified: 1 mg per mL in ampoule (as hydrochloride or hydrogen tartrate); Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (as hydrochloride or hydrogen tartrate); Parenteral > General injections > IV: 100 µg per mL in 10 mL ampoule (as acid tartrate or hydrochloride); Local > Ophthalmological > Solution (eye drops): 2% (as hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/32"},{"medicine":"epoetin alfa","first_added":2017,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Anaemia due to chronic disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/415"},{"medicine":"epoetin beta","first_added":2017,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Anaemia due to chronic disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/416"},{"medicine":"epoetin theta","first_added":2017,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Anaemia due to chronic disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/417"},{"medicine":"equine rabies immunoglobulin","first_added":2021,"main_section":"Immunologicals > Sera, immunoglobulins and monoclonal antibodies","sections":"Immunologicals > Sera, immunoglobulins and monoclonal antibodies","section_count":1,"indications":"Rabies","indication_count":1,"atc_codes":"J06BB05","dosage_forms":"Parenteral > Locoregional injections > Intradermal: 150 IU per mL in vial; 200 IU per mL in vial; 300 IU per mL in vial; 400 IU per mL in vial","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/605"},{"medicine":"ergocalciferol","first_added":1977,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Calcium deficiency; Vitamin D deficiency","indication_count":2,"atc_codes":"A11CC01","dosage_forms":"Oral > Liquid: 250 µg per mL (10 000 IU per mL) Oral > Solid: 1.25 mg (50 000 IU)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/262"},{"medicine":"ergometrine","first_added":1977,"main_section":"Uterotonics","sections":"Uterotonics","section_count":1,"indications":"Postpartum haemorrhage","indication_count":1,"atc_codes":"G02AB03","dosage_forms":"Parenteral > General injections > unspecified: 200 µg in 1 mL ampoule (hydrogen maleate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/239"},{"medicine":"erlotinib","first_added":2019,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Other specified malignant neoplasms of bronchus or lung","indication_count":1,"atc_codes":"L01EB02","dosage_forms":"Oral > Solid: 100 mg; 150 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/405"},{"medicine":"erythromycin","first_added":1977,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics; Ophthalmological preparations > Anti-infective agents","section_count":2,"indications":"Acute pharyngitis; Chlamydial conjunctivitis; Gonococcal infection of eye","indication_count":3,"atc_codes":"J01FA09, S01AA17","dosage_forms":"Parenteral > General injections > IV: 500 mg in vial powder for injection (as lactobionate) Oral > Liquid: 125 mg per 5 mL (as stearate or ethylsuccinate) Oral > Solid: 250 mg (as stearate or ethylsuccinate); Local > Ophthalmological > Ointment: 0.5%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/228"},{"medicine":"erythropoiesis-stimulating agents","first_added":2017,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Anaemia due to chronic disease","indication_count":1,"atc_codes":"B03XA03, B03XA01, B03XA02","dosage_forms":"Parenteral > General injections > unspecified: 1000 IU per 0.5 mL pre-filled syringe; 2000 IU per 0.5 mL pre-filled syringe; 3000 IU per 0.3 mL pre-filled syringe; 4000 IU per 0.4 mL pre-filled syringe; 5000 IU per 0.5 mL pre-filled syringe; 6000 IU per 0.6 mL pre-filled syringe; 8000 IU per 0.8 mL pre-filled syringe; 10000 IU per 1 mL pre-filled syringe; 20000 IU per 0.5 mL pre-filled syringe; 40000 IU per 1 mL pre-filled syringe","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/122"},{"medicine":"escitalopram","first_added":2023,"main_section":"Medicines for anxiety disorders","sections":"Medicines for anxiety disorders","section_count":1,"indications":"Generalised anxiety disorder","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/660"},{"medicine":"estradiol cypionate + medroxyprogesterone acetate","first_added":2007,"main_section":"Injectable hormonal contraceptives","sections":"Injectable hormonal contraceptives","section_count":1,"indications":"Contact with health services for reasons associated with reproduction","indication_count":1,"atc_codes":"G03AA08","dosage_forms":"Parenteral > General injections > IM: 5 mg + 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/188"},{"medicine":"etanercept","first_added":2023,"main_section":"Immunomodulators for non-malignant disease","sections":"Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases; Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":3,"indications":"Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriasis of unspecified type","indication_count":5,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/548"},{"medicine":"ethambutol","first_added":1977,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculosis","indication_count":1,"atc_codes":"J04AK02","dosage_forms":"Parenteral > General injections > IV: 1000 mg per 10 mL; 2000 mg per 20 mL Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 100 mg (hydrochloride); 400 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/321"},{"medicine":"ethambutol + isoniazid + pyrazinamide + rifampicin","first_added":1999,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculosis","indication_count":1,"atc_codes":"J04AM06","dosage_forms":"Oral > Solid: 275 mg + 75 mg + 400 mg + 150 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/323"},{"medicine":"ethambutol + isoniazid + rifampicin","first_added":2007,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculosis","indication_count":1,"atc_codes":"J04AK02, J04AC01, J04AB02","dosage_forms":"Oral > Solid: 275 mg + 75 mg + 150 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/324"},{"medicine":"ethanol","first_added":1999,"main_section":"Antiseptics","sections":"Antiseptics","section_count":1,"indications":"Denatured alcohol","indication_count":1,"atc_codes":"D08AX08","dosage_forms":"Local > Topical > Solution: 70% (denatured)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/171"},{"medicine":"ethinylestradiol + etonogestrel","first_added":2021,"main_section":"Intravaginal contraceptives","sections":"Intravaginal contraceptives","section_count":1,"indications":"Contact with health services for contraceptive management","indication_count":1,"atc_codes":"G02BB01","dosage_forms":"Local > Vaginal > vaginal ring: 2.7 mg + 11.7 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/677"},{"medicine":"ethinylestradiol + levonorgestrel","first_added":1979,"main_section":"Oral hormonal contraceptives","sections":"Oral hormonal contraceptives","section_count":1,"indications":"Contact with health services for contraceptive management","indication_count":1,"atc_codes":"G03AA07","dosage_forms":"Oral > Solid: 50 µg + 250 µg [4] Oral > Solid: 30 µg + 150 µg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/184"},{"medicine":"ethinylestradiol + norethisterone","first_added":1977,"main_section":"Oral hormonal contraceptives","sections":"Oral hormonal contraceptives","section_count":1,"indications":"Contact with health services for contraceptive management","indication_count":1,"atc_codes":"G03AA05","dosage_forms":"Oral > Solid: 35 µg + 1 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/185"},{"medicine":"ethionamide","first_added":1982,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculous meningitis; Multi-drug resistant Mycobacterium tuberculosis","indication_count":2,"atc_codes":"J04AD03","dosage_forms":"Oral > Solid > dispersible tablet: 125 mg Oral > Solid > tablet: 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/351"},{"medicine":"ethosuximide","first_added":1977,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines","section_count":1,"indications":"Absence seizures, typical","indication_count":1,"atc_codes":"N03AD01","dosage_forms":"Oral > Liquid: 250 mg per 5 mL Oral > Solid: 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/56"},{"medicine":"etonogestrel-releasing implant","first_added":2015,"main_section":"Implantable contraceptives","sections":"Implantable contraceptives","section_count":1,"indications":"Contact with health services for insertion of contraceptive device","indication_count":1,"atc_codes":"G03AC08","dosage_forms":"Implant > Subdermal: 68 mg single rod","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/192"},{"medicine":"etoposide","first_added":1984,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Myeloid leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Germ cell tumour of testis; Osteosarcoma of bone or articular cartilage of unspecified sites; Other specified malignant neoplasms of the ovary; Other specified malignant neoplasms of bronchus or lung; Hodgkin lymphoma; Malignant trophoblastic neoplasms of placenta; Retinoblastoma; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis","indication_count":14,"atc_codes":"L01CB01","dosage_forms":"Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate) Oral > Solid: 100 mg capsule; 50 mg capsule Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule Oral > Solid: 100 mg capsule","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/88"},{"medicine":"everolimus","first_added":2021,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Other specified gliomas of brain","indication_count":1,"atc_codes":"L01EG02","dosage_forms":"Oral > Solid > dispersible tablet: 2 mg; 3 mg; 5 mg Oral > Solid > tablet: 2.5 mg; 5 mg; 7.5 mg; 10 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/615"},{"medicine":"fentanyl","first_added":2017,"main_section":"Opioid analgesics","sections":"Opioid analgesics","section_count":1,"indications":"Chronic cancer pain","indication_count":1,"atc_codes":"N01AH01","dosage_forms":"Oral > Solid: 100 to 800 µg sub-lingual tablet (as citrate); 200 to 1600 µg lozenge (as citrate) Oral > Other: 200 to 1200 µg buccal film (as citrate) Local > Topical > Transdermal patch: 12 µg/hour; 25 µg/hour; 50 µg/hour; 75 µg/hour; 100 µg/hour","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/17"},{"medicine":"ferrous salt","first_added":1977,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Iron deficiency anaemia","indication_count":1,"atc_codes":"B03AA07, B03AA02","dosage_forms":"Oral > Liquid: 25 mg per mL elemental iron; 9 mg per mL elemental iron Oral > Solid > tablet: 60 to 65 mg elemental iron","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/118"},{"medicine":"ferrous salt + folic acid","first_added":1982,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Iron deficiency anaemia; Spina bifida; Clefts of lip, alveolus or palate; Anencephaly or similar anomalies","indication_count":4,"atc_codes":"B03AD03, B03AD02, B03AD05","dosage_forms":"Oral > Solid: 60 mg iron + 2.8 mg Oral > Solid > tablet: 60 mg elemental iron + 400 µg tablet; 60 mg elemental iron + 2.8 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/394"},{"medicine":"fexinidazole","first_added":2019,"main_section":"Medicines for the treatment of 1st stage African trypanosomiasis","sections":"Medicines for the treatment of 1st stage African trypanosomiasis; Medicines for the treatment of 2nd stage African trypanosomiasis","section_count":2,"indications":"Rhodesiense trypanosomiasis; Gambiense trypanosomiasis","indication_count":2,"atc_codes":"P01CA03","dosage_forms":"Oral > Solid > tablet: 600 mg Oral > Solid: 600 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/557"},{"medicine":"fexofenadine","first_added":2025,"main_section":"Antiallergics and medicines used in anaphylaxis","sections":"Antiallergics and medicines used in anaphylaxis","section_count":1,"indications":"Allergic or hypersensitivity conditions of unspecified type","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/634"},{"medicine":"filgrastim","first_added":2015,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"Acquired neutropaenia","indication_count":1,"atc_codes":"L03AA02","dosage_forms":"Parenteral > General injections > SC: 120 µg per 0.2 mL in prefilled syringe; 300 µg per 0.5 mL in prefilled syringe; 480 µg per 0.8 mL in prefilled syringe; 300 µg per mL in 1 mL vial; 480 µg per 1.6 mL in 1.6 mL vial","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/89"},{"medicine":"flucloxacillin","first_added":2023,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock","indication_count":4,"atc_codes":"J01CF02","dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/732"},{"medicine":"fluconazole","first_added":1999,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Cryptococcosis; Candidosis","indication_count":2,"atc_codes":"J02AC01","dosage_forms":"Parenteral > General injections > IV: 2 mg per mL in vial Oral > Liquid: 50 mg per 5 mL; 50 mg per 5 mL powder for oral liquid Oral > Solid > capsule: 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/359"},{"medicine":"flucytosine","first_added":1977,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Cryptococcosis","indication_count":1,"atc_codes":"J02AX01","dosage_forms":"Parenteral > General injections > IV: 2.5 g per 250 mL infusion Oral > Solid: 250 mg capsule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/360"},{"medicine":"fludarabine","first_added":2015,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Chronic lymphocytic leukaemia or small lymphocytic lymphoma","indication_count":1,"atc_codes":"L01BB05","dosage_forms":"Parenteral > General injections > IV: 50 mg in vial (fludarabine phosphate) powder for injection Oral > Solid: 10 mg tablet (fludarabine phosphate)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/90"},{"medicine":"fludrocortisone","first_added":1977,"main_section":"Adrenal hormones and synthetic substitutes","sections":"Adrenal hormones and synthetic substitutes","section_count":1,"indications":"Adrenocortical insufficiency","indication_count":1,"atc_codes":"H02AA02","dosage_forms":"Oral > Liquid: 100 µg per mL Oral > Solid > tablet: 100 µg (acetate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/182"},{"medicine":"fluorescein","first_added":1979,"main_section":"Diagnostic agents > Ophthalmic medicines","sections":"Diagnostic agents > Ophthalmic medicines","section_count":1,"indications":"Fluorescein","indication_count":1,"atc_codes":"S01JA01","dosage_forms":"Local > Ophthalmological > Solution (eye drops): 1% (sodium salt)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/164"},{"medicine":"fluoride","first_added":1979,"main_section":"Dental medicines and preparations","sections":"Dental medicines and preparations","section_count":1,"indications":"Dental caries","indication_count":1,"atc_codes":"A01AA01, A01AA04","dosage_forms":"Local > Dental > Gel: 2500 to 12500 ppm fluoride (any type) Local > Dental > Toothpaste, cream or gel: 1000 to 1500 ppm fluoride (any type) Local > Dental > Mouthrinse: 230 to 900 ppm fluoride (any type) Local > Dental > Varnish: 22500 ppm fluoride (any type)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/268"},{"medicine":"fluorouracil","first_added":1977,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation; Cytotoxic medicines","section_count":2,"indications":"Plantar warts; Malignant neoplasms of nasopharynx; Malignant neoplasms of rectum; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of breast; Malignant neoplasms of colon","indication_count":6,"atc_codes":"L01BC02","dosage_forms":"Local > Topical > Ointment: 5%; Parenteral > General injections > IV: 50 mg per mL in vial Parenteral > General injections > IV: 50 mg per mL in 5 mL ampoule","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/91"},{"medicine":"fluoxetine","first_added":2007,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Medicines for depressive disorders; Medicines for anxiety disorders; Medicines for obsessive compulsive disorders","section_count":4,"indications":"Palliative care; Depressive disorders; Generalised anxiety disorder; Social anxiety disorder; Panic disorder; Obsessive-compulsive disorder","indication_count":6,"atc_codes":"N06AB03","dosage_forms":"Oral > Solid: 20 mg (as hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/24"},{"medicine":"fluphenazine","first_added":1977,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":"N05AB02","dosage_forms":"Parenteral > General injections > IM: 25 mg per mL in ampoule (decanoate); 25 mg per mL in ampoule (enanthate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/245"},{"medicine":"flutamide","first_added":2021,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of prostate","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/640"},{"medicine":"fluticasone","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/666"},{"medicine":"fluticasone + formoterol","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/671"},{"medicine":"fluticasone furoate + vilanterol","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/672"},{"medicine":"fluvastatin","first_added":2021,"main_section":"Lipid-lowering agents","sections":"Lipid-lowering agents","section_count":1,"indications":"Mixed hyperlipidaemia; Coronary atherosclerosis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/528"},{"medicine":"fluvoxamine","first_added":2023,"main_section":"Medicines for anxiety disorders","sections":"Medicines for anxiety disorders","section_count":1,"indications":"Generalised anxiety disorder","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/661"},{"medicine":"folic acid","first_added":1977,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Cephalocele; Anencephaly or similar anomalies; Spina bifida; Folate deficiency anaemia","indication_count":4,"atc_codes":"B03BB01","dosage_forms":"Oral > Solid: 400 µg Oral > Liquid: 1 mg per mL Oral > Solid: 1 mg tablet; 5 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/120"},{"medicine":"fomepizole","first_added":2013,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified","indication_count":1,"atc_codes":"V03AB34","dosage_forms":"Parenteral > General injections > IV: 5 mg per mL in 20 mL ampoule or vial (sulfate); 1 g per mL in 1.5 mL ampoule or vial (base)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/46"},{"medicine":"fosfomycin (injection)","first_added":2017,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Carbapenem resistant Acinetobacter baumannii; Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales","indication_count":3,"atc_codes":"J01XX01","dosage_forms":"Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/343"},{"medicine":"fresh-frozen plasma","first_added":2013,"main_section":"Blood and blood components","sections":"Blood and blood components","section_count":1,"indications":"Blood transfusion without reported diagnosis","indication_count":1,"atc_codes":"B05AX03","dosage_forms":"Parenteral > General injections > IV:","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/454"},{"medicine":"furosemide","first_added":1977,"main_section":"Diuretics","sections":"Diuretics; Medicines used in heart failure","section_count":2,"indications":"Anuria or oliguria; Oedema; Heart failure","indication_count":3,"atc_codes":"C03CA01","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL in 2 mL ampoule; 10 mg per mL in 5 mL ampoule Oral > Liquid: 20 mg per 5 mL; 50 mg per 5 mL Oral > Solid > tablet: 40 mg; 20 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/143"},{"medicine":"gefitinib","first_added":2019,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Other specified malignant neoplasms of bronchus or lung","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/403"},{"medicine":"gemcitabine","first_added":2015,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Other specified carcinomas of ovary; Other specified malignant neoplasms of bronchus or lung","indication_count":2,"atc_codes":"L01BC05","dosage_forms":"Parenteral > General injections > IV: 200 mg in vial powder for injection; 1 g in vial powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/92"},{"medicine":"gentamicin","first_added":1977,"main_section":"Access group antibiotics","sections":"Access group antibiotics; Ophthalmological preparations > Anti-infective agents; Medicines for bacterial central nervous system infections","section_count":3,"indications":"Acute malnutrition in infants, children or adolescents (complicated) [children]; Neonatal meningitis; Sepsis without septic shock; Bacterial pneumonia (Community-acquired pneumonia - severe) [children]; Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Other specified prophylactic measures; Gonococcal infection; Other specified conjunctivitis; Infectious blepharitis","indication_count":12,"atc_codes":"J01GB03, S02AA14","dosage_forms":"Parenteral > General injections > unspecified: 10 mg per mL in 2 mL vial (as sulfate); 40 mg per mL in 2 mL vial (as sulfate); Local > Ophthalmological > Solution (eye drops): 0.3% (gentamicin sulfate)","combined_with":"benzylpenicillin; ampicillin; amoxicillin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/229"},{"medicine":"glass ionomer cement","first_added":2021,"main_section":"Dental medicines and preparations","sections":"Dental medicines and preparations","section_count":1,"indications":"Dental caries","indication_count":1,"atc_codes":null,"dosage_forms":"Local > Dental > Powder + liquid: Single-use capsules: 0.4 g powder + 0.09 mL liquid; Multi-use bottle: powder + liquid","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/616"},{"medicine":"glatiramer acetate","first_added":2023,"main_section":"Medicines for multiple sclerosis","sections":"Medicines for multiple sclerosis","section_count":1,"indications":"Multiple sclerosis","indication_count":1,"atc_codes":"L03AX13","dosage_forms":"Parenteral > General injections > SC: 20 mg per mL; 40 mg per mL Parenteral > General injections > SC: 20 mg per mL in pre-filled syringe; 40 mg per mL in pre-filled syringe","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/568"},{"medicine":"glecaprevir + pibrentasvir","first_added":2019,"main_section":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","sections":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","section_count":1,"indications":"Chronic hepatitis C","indication_count":1,"atc_codes":"J05AP57","dosage_forms":"Oral > Solid: 50 mg + 20 mg granules Oral > Solid > tablet: 100 mg + 40 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/491"},{"medicine":"gliclazide","first_added":2013,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":"A10BB09","dosage_forms":"Oral > Solid: 30 mg controlled-release; 60 mg controlled-release; 80 mg controlled-release","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/194"},{"medicine":"glucagon","first_added":2011,"main_section":"Medicines for hypoglycaemia","sections":"Medicines for hypoglycaemia","section_count":1,"indications":"Hypoglycaemia in the context of diabetes","indication_count":1,"atc_codes":"H04AA01","dosage_forms":"Parenteral > General injections > unspecified: 1 mg per mL as powder and diluent","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/195"},{"medicine":"glucose","first_added":1977,"main_section":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","sections":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","section_count":1,"indications":"Hypoglycaemia without associated diabetes; Other specified disorders of fluid, electrolyte or acid-base balance","indication_count":2,"atc_codes":"B05CX01","dosage_forms":"Parenteral > General injections > IV: 50% hypertonic Parenteral > General injections > IV: 5% isotonic; 10% hypertonic","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/256"},{"medicine":"glucose + sodium chloride","first_added":1979,"main_section":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","sections":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","section_count":1,"indications":"Other specified disorders of fluid, electrolyte or acid-base balance","indication_count":1,"atc_codes":"B05BB02","dosage_forms":"Parenteral > General injections > IV: 4% + 0.18% (equivalent to Na+ 30 mmol/L and Cl- 30 mmol/L; 5% + 0.9% (equivalent to Na+ 150 mmol/L and Cl- 150 mmol/L); 5% + 0.45% (equivalent to Na+ 75 mmol/L and Cl- 75 mmol/L)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/542"},{"medicine":"glutaral","first_added":1991,"main_section":"Disinfectants","sections":"Disinfectants","section_count":1,"indications":"Glutaral nonmedicinal","indication_count":1,"atc_codes":"V07AV","dosage_forms":"Local > Topical > Solution: 2%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/525"},{"medicine":"glycerol","first_added":2025,"main_section":"Dermatological medicines > Moisturizers","sections":"Dermatological medicines > Moisturizers","section_count":1,"indications":"Atopic eczema","indication_count":1,"atc_codes":null,"dosage_forms":"Local > Topical > Cream: 15 to 20%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/956"},{"medicine":"glyceryl trinitrate","first_added":1977,"main_section":"Antianginal medicines","sections":"Antianginal medicines","section_count":1,"indications":"Angina pectoris","indication_count":1,"atc_codes":"C01DA02","dosage_forms":"Oral > Solid: 500 µg sublingual tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/131"},{"medicine":"glycopyrronium","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Chronic obstructive pulmonary disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/675"},{"medicine":"golimumab","first_added":2023,"main_section":"Immunomodulators for non-malignant disease","sections":"Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases","section_count":2,"indications":"Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis","indication_count":4,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/551"},{"medicine":"goserelin","first_added":2021,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of breast; Malignant neoplasms of prostate","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/873"},{"medicine":"granisetron","first_added":2025,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Antiemetic medicines","section_count":2,"indications":"Palliative care; Nausea or vomiting","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/630"},{"medicine":"griseofulvin","first_added":1977,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Dermatophytosis","indication_count":1,"atc_codes":"D01BA01","dosage_forms":"Oral > Liquid: 125 mg per 5 mL Oral > Solid: 125 mg; 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/361"},{"medicine":"haemophilus influenzae type b vaccine","first_added":2007,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against single bacterial diseases","indication_count":1,"atc_codes":"J07AG01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/206"},{"medicine":"haloperidol","first_added":1977,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Medicines for psychotic disorders","section_count":2,"indications":"Palliative care; Schizophrenia or other primary psychotic disorders","indication_count":2,"atc_codes":"N05AD01","dosage_forms":"Oral > Liquid: 2 mg per mL Oral > Solid: 0.5 mg; 2 mg; 5 mg Parenteral > General injections > unspecified: 5 mg per mL in 1-mL ampoule; Parenteral > General injections > IM: 5 mg per mL in ampoule Oral > Solid: 2 mg; 5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/25"},{"medicine":"haloperidol decanoate","first_added":2023,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/924"},{"medicine":"heparin sodium","first_added":1977,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Acute ischaemic heart disease; Unstable angina; Venous thromboembolism","indication_count":3,"atc_codes":"B01AB01","dosage_forms":"Parenteral > General injections > IV: 1000 IU per mL in 1 mL ampoule or vial; 20000 IU per mL in 1 mL ampoule or vial; 5000 IU per mL in 1 mL ampoule or vial","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/124"},{"medicine":"hepatitis A vaccine","first_added":2007,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against viral hepatitis","indication_count":1,"atc_codes":"J07BC02","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/217"},{"medicine":"hepatitis B vaccine","first_added":1987,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against viral hepatitis","indication_count":1,"atc_codes":"J07BC01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/207"},{"medicine":"hepatitis E vaccine","first_added":2025,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against viral hepatitis","indication_count":1,"atc_codes":null,"dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/957"},{"medicine":"homatropine","first_added":1977,"main_section":"Ophthalmological preparations > Mydriatics","sections":"Ophthalmological preparations > Mydriatics","section_count":1,"indications":"Anterior uveitis","indication_count":1,"atc_codes":null,"dosage_forms":"Local > Ophthalmological > Solution (eye drops): 2% (hydrobromide)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/512"},{"medicine":"human papilloma virus (HPV) vaccine","first_added":2015,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BM01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/208"},{"medicine":"hydralazine","first_added":1977,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Gestational hypertension","indication_count":1,"atc_codes":"C02DB02","dosage_forms":"Parenteral > General injections > IV: 20 mg in ampoule powder for injection (hydrochloride) Oral > Solid: 50 mg tablet; 25 mg tablet (hydrochloride) Oral > Solid: 50 mg (hydrochloride); 25 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/138"},{"medicine":"hydrochlorothiazide","first_added":1977,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines; Diuretics; Medicines used in heart failure","section_count":3,"indications":"Essential hypertension; Oedema; Heart failure","indication_count":3,"atc_codes":"C03AA03","dosage_forms":"Oral > Liquid: 50 mg per 5 mL Oral > Solid: 25 mg; 12.5 mg; Oral > Solid > dosage form: 25 mg; 12.5 mg; Oral > Liquid: 50 mg per 5 mL Oral > Solid: 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/139"},{"medicine":"hydrocortisone","first_added":1977,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones; Antiallergics and medicines used in anaphylaxis; Anti-inflammatory medicines; Dermatological medicines > Anti-inflammatory and antipruritic medicines; Adrenal hormones and synthetic substitutes","section_count":5,"indications":"Lymphoid leukaemia, not elsewhere classified; Burkitt lymphoma including Burkitt leukaemia; Anaphylaxis; Crohn disease site; Ulcerative colitis; Dermatitis or eczema; Pruritus due to skin disorder; Psoriasis of unspecified type; Lichen planus; Adrenocortical insufficiency","indication_count":10,"atc_codes":"H02AB09, A07EA02, D07AA02","dosage_forms":"Parenteral > General injections > unspecified: 100 mg in vial (as sodium succinate); Parenteral > General injections > unspecified: 100 mg in vial powder for injection (as sodium succinate); Local > Rectal > Suppository: 25 mg (acetate) Local > Rectal > Retention enema: 100 mg per 60 mL; Local > Topical > Cream: 1% (acetate) Local > Topical > Ointment: 1% (acetate); Oral > Solid > tablet: 5 mg; 10 mg; 20 mg Oral > Solid > granules: 0.5 mg in capsule; 1 mg in capsule; 2 mg in capsule; 5 mg in capsule","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/33"},{"medicine":"hydromorphone","first_added":2025,"main_section":"Opioid analgesics","sections":"Opioid analgesics","section_count":1,"indications":"Pain","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/560"},{"medicine":"hydroxocobalamin","first_added":1979,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Megaloblastic anaemia due to vitamin B12 deficiency","indication_count":1,"atc_codes":"B03BA03","dosage_forms":"Parenteral > General injections > IM: 1 mg per mL in 1 mL ampoule (as acetate); 1 mg per mL in 1 mL ampoule (as hydrochloride); 1 mg per mL in 1 mL ampoule (as sulfate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/121"},{"medicine":"hydroxychloroquine","first_added":2011,"main_section":"Disease-modifying anti-rheumatic drugs (DMARDs)","sections":"Disease-modifying anti-rheumatic drugs (DMARDs)","section_count":1,"indications":"Systemic lupus erythematosus; Cutaneous lupus erythematosus of unspecified type","indication_count":2,"atc_codes":"P01BA02","dosage_forms":"Oral > Solid: 200 mg (as sulfate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/276"},{"medicine":"hydroxyurea (hydroxycarbamide)","first_added":2009,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines; Medicines for haemoglobinopathies","section_count":2,"indications":"Chronic myeloid leukaemia, not elsewhere classified; Other specified sickle cell disorders or other haemoglobinopathies","indication_count":2,"atc_codes":"L01XX05","dosage_forms":"Oral > Solid: 200 mg; 250 mg; 300 mg; 400 mg; 500 mg; 1 g Oral > Solid > dosage form: 200 mg; 300 mg; 400 mg; 500 mg; 1 g; 100 mg; Oral > Solid > dosage form: 200 mg; 500 mg; 1 g; 100 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/93"},{"medicine":"hyoscine butylbromide","first_added":2013,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care","section_count":1,"indications":"Palliative care","indication_count":1,"atc_codes":"A03BB01","dosage_forms":"Parenteral > General injections > unspecified: 20 mg per mL injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/26"},{"medicine":"hyoscine hydrobromide","first_added":2009,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care","section_count":1,"indications":"Palliative care","indication_count":1,"atc_codes":"A04AD01","dosage_forms":"Local > Topical > Transdermal patch: 1 mg per 72 hours transdermal patch Parenteral > General injections > unspecified: 400 µg per mL injection; 600 µg per mL injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/281"},{"medicine":"hypochlorous acid","first_added":2025,"main_section":"Disinfectants","sections":"Disinfectants","section_count":1,"indications":"Disinfectant, not elsewhere classified","indication_count":1,"atc_codes":"V07AV","dosage_forms":"Solution (aqueous): containing hypochlorous acid ≥ 150 parts per million","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/875"},{"medicine":"ibrutinib","first_added":2021,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Chronic lymphocytic leukaemia or small lymphocytic lymphoma","indication_count":1,"atc_codes":"L01EL01","dosage_forms":"Oral > Solid: 140 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/618"},{"medicine":"ibuprofen","first_added":1977,"main_section":"Medicines for acute migraine attacks","sections":"Medicines for acute migraine attacks; Medicines administered to the neonate [c]; Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)","section_count":3,"indications":"Migraine; Patent arterial duct; Pain","indication_count":3,"atc_codes":"M01AE01, C01EB16","dosage_forms":"Oral > Liquid: 100 mg per 5 mL; 200 mg per 5 mL Oral > Solid > tablet: 200 mg; 400 mg; Parenteral > General injections > IV: 5 mg per mL; Oral > Liquid: 200 mg per 5 mL; 100 mg per 5 mL Oral > Solid > tablet: 200 mg; 400 mg; 600 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/14"},{"medicine":"ifosfamide","first_added":2009,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Burkitt lymphoma including Burkitt leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Rhabdomyosarcoma primary site; Osteosarcoma of bone or articular cartilage of unspecified sites; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis","indication_count":9,"atc_codes":"L01AA06","dosage_forms":"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/94"},{"medicine":"imatinib","first_added":2015,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1; Chronic myeloid leukaemia, not elsewhere classified; Gastrointestinal stromal tumour of unspecified gastrointestinal sites","indication_count":3,"atc_codes":"L01EA01","dosage_forms":"Oral > Solid: 100 mg; 400 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/95"},{"medicine":"imipenem + cilastatin","first_added":1997,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics; Antituberculosis medicines","section_count":2,"indications":"Peritoneal abscess (severe); Neutropaenia (high-risk); Peritonitis (severe); Multi-drug resistant Mycobacterium tuberculosis","indication_count":4,"atc_codes":"J01DH02","dosage_forms":"Parenteral > General injections > IV: 250 mg (as monohydrate) + 250 mg (as sodium salt) powder for injection; 500 mg (as monohydrate) + 500 mg (as sodium salt) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/600"},{"medicine":"indapamide","first_added":2021,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines; Medicines used in heart failure","section_count":2,"indications":"Essential hypertension; Heart failure","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/647"},{"medicine":"indometacin","first_added":2021,"main_section":"Medicines administered to the neonate [c]","sections":"Medicines administered to the neonate [c]","section_count":1,"indications":"Patent arterial duct","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/427"},{"medicine":"infliximab","first_added":2023,"main_section":"Immunomodulators for non-malignant disease","sections":"Immunomodulators for non-malignant disease; Medicines for juvenile joint diseases; Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":3,"indications":"Axial spondyloarthritis; Crohn disease site; Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriasis of unspecified type","indication_count":5,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/549"},{"medicine":"influenza vaccine (seasonal)","first_added":1979,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against influenza","indication_count":1,"atc_codes":"J07BB01, J07BB02, J07BB03","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/439"},{"medicine":"insulin (analogue, long-acting)","first_added":2021,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 2 diabetes mellitus; Type 1 diabetes mellitus","indication_count":2,"atc_codes":"A10AE06, A10AE05, A10AE04","dosage_forms":"Parenteral > General injections > SC: 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution; 100 IU per mL in 10 mL vial solution","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/622"},{"medicine":"insulin (analogue, rapid-acting)","first_added":2025,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 1 diabetes mellitus; Type 2 diabetes mellitus","indication_count":2,"atc_codes":"A10AB05, A10AB06, A10AB04","dosage_forms":"Parenteral > General injections > SC: 100 IU per 1 mL in 10 mL vial; 100 IU per 1 mL in 3 mL cartridge; 100 IU per 1 mL in 3 mL pre-filled pen","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/958"},{"medicine":"insulin (human, intermediate-acting)","first_added":1977,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 2 diabetes mellitus; Type 1 diabetes mellitus","indication_count":2,"atc_codes":"A10AC01","dosage_forms":"Parenteral > General injections > SC: 40 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL cartridge as compound insulin zinc suspension or isophane insulin; 100 IU per mL in 3 mL pre-filled pen as compound insulin zinc suspension or isophane insulin","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/197"},{"medicine":"insulin (human, short-acting)","first_added":1977,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 2 diabetes mellitus; Type 1 diabetes mellitus","indication_count":2,"atc_codes":"A10AC01","dosage_forms":"Parenteral > General injections > SC: 40 IU per mL in 10 mL vial solution; 100 IU per mL in 10 mL vial solution; 100 IU per mL in 3 mL cartridge solution; 100 IU per mL in 3 mL pre-filled pen solution","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/196"},{"medicine":"insulin aspart","first_added":2025,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 1 diabetes mellitus; Type 2 diabetes mellitus","indication_count":2,"atc_codes":null,"dosage_forms":"Parenteral > General injections > SC: 100 IU per mL in 110 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/965"},{"medicine":"insulin degludec","first_added":null,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 2 diabetes mellitus; Type 1 diabetes mellitus","indication_count":2,"atc_codes":null,"dosage_forms":"Parenteral > General injections > SC: 100 units per mL","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/575"},{"medicine":"insulin detemir","first_added":null,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 2 diabetes mellitus; Type 1 diabetes mellitus","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/574"},{"medicine":"insulin glargine","first_added":null,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 2 diabetes mellitus; Type 1 diabetes mellitus","indication_count":2,"atc_codes":null,"dosage_forms":"Parenteral > General injections > SC: 100 units per mL","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/573"},{"medicine":"insulin glulisine","first_added":2025,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 1 diabetes mellitus; Type 2 diabetes mellitus","indication_count":2,"atc_codes":null,"dosage_forms":"Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/966"},{"medicine":"insulin lispro","first_added":2025,"main_section":"Insulins","sections":"Insulins","section_count":1,"indications":"Type 1 diabetes mellitus; Type 2 diabetes mellitus","indication_count":2,"atc_codes":null,"dosage_forms":"Parenteral > General injections > SC: 100 IU per mL in 10 mL vial; 100 IU per mL in 3 mL cartridge; 100 IU per mL in 3 mL pre-filled pen","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/964"},{"medicine":"intraperitoneal dialysis solution","first_added":1977,"main_section":"Peritoneal dialysis solution","sections":"Peritoneal dialysis solution","section_count":1,"indications":"Care involving peritoneal dialysis","indication_count":1,"atc_codes":null,"dosage_forms":"Solution: of appropriate composition in accordance with local clinical guidelines.","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/429"},{"medicine":"iodine","first_added":1989,"main_section":"Antiseptics","sections":"Antiseptics; Vitamins and minerals","section_count":2,"indications":"Povidone iodine; Iodine deficiency","indication_count":2,"atc_codes":"H03CA","dosage_forms":"Parenteral > General injections > IM: 480 mg per mL in 10 mL ampoule or vial iodized oil (oral or injectable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/263"},{"medicine":"iodine + potassium iodide (Lugol's solution)","first_added":2007,"main_section":"Thyroid hormones and antithyroid medicines","sections":"Thyroid hormones and antithyroid medicines","section_count":1,"indications":"Thyrotoxicosis","indication_count":1,"atc_codes":"H03CA","dosage_forms":"Oral > Liquid: 5% w/v + 10% w/v (aqueous)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/202"},{"medicine":"iohexol","first_added":1984,"main_section":"Diagnostic agents > Radiocontrast media","sections":"Diagnostic agents > Radiocontrast media","section_count":1,"indications":"X-ray contrast media, iodinated","indication_count":1,"atc_codes":"V08AB02","dosage_forms":"Parenteral > General injections > unspecified: 140 to 350 mg iodine per mL in 5 mL ampoule; 140 to 350 mg iodine per mL in 10 mL ampoule; 140 to 350 mg iodine per mL in 20 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/168"},{"medicine":"ipratropium bromide","first_added":1997,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Chronic obstructive pulmonary disease; Asthma","indication_count":2,"atc_codes":"R03BB01","dosage_forms":"Respiratory > Inhalation > solution: 20 µg per actuation in pressurized metered dose inhaler","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/253"},{"medicine":"irinotecan","first_added":2015,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Rhabdomyosarcoma primary site; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of kidney, except renal pelvis","indication_count":3,"atc_codes":"L01CE02","dosage_forms":"Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/96"},{"medicine":"isoflurane","first_added":2011,"main_section":"General anaesthetics and oxygen > Inhalational medicines","sections":"General anaesthetics and oxygen > Inhalational medicines","section_count":1,"indications":"Anaesthetics and therapeutic gases","indication_count":1,"atc_codes":"N01AB06","dosage_forms":"Respiratory > Inhalation > liquid:","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/2"},{"medicine":"isoniazid","first_added":1977,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculosis","indication_count":1,"atc_codes":"J04AC01","dosage_forms":"Parenteral > General injections > IV: 100 mg per mL Oral > Solid > dispersible tablet: 100 mg (scored) Oral > Solid > tablet: 100 mg; 300 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/325"},{"medicine":"isoniazid + pyrazinamide + rifampicin","first_added":1997,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculosis","indication_count":1,"atc_codes":"J04AM05","dosage_forms":"Oral > Solid > dispersible tablet: 50 mg + 150 mg + 75 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/326"},{"medicine":"isoniazid + pyridoxine + sulfamethoxazole + trimethoprim","first_added":2017,"main_section":"Medicines for prevention of HIV-related opportunistic infections","sections":"Medicines for prevention of HIV-related opportunistic infections","section_count":1,"indications":"Other specified prophylactic measures","indication_count":1,"atc_codes":"J04AC51","dosage_forms":"Oral > Solid: 300 mg + 25 mg + 800 mg + 160 mg tablet (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/286"},{"medicine":"isoniazid + rifampicin","first_added":1989,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculosis","indication_count":1,"atc_codes":"J04AM02","dosage_forms":"Oral > Solid > dispersible tablet: 50 mg + 75 mg Oral > Solid > tablet: 75 mg + 150 mg; 150 mg + 300 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/330"},{"medicine":"isoniazid + rifapentine","first_added":2021,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Latent tuberculosis","indication_count":1,"atc_codes":"J04AC51","dosage_forms":"Oral > Solid: 300 mg + 300 mg tablet (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/627"},{"medicine":"isosorbide dinitrate","first_added":1977,"main_section":"Antianginal medicines","sections":"Antianginal medicines","section_count":1,"indications":"Angina pectoris","indication_count":1,"atc_codes":"C01DA08","dosage_forms":"Oral > Solid: 5 mg sublingual tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/132"},{"medicine":"itraconazole","first_added":2017,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Chronic pulmonary aspergillosis; Paracoccidioidomycosis; Sporotrichosis; Histoplasmosis; Talaromycosis; Chromoblastomycosis","indication_count":6,"atc_codes":"J02AC02","dosage_forms":"Oral > Liquid: 10 mg per mL Oral > Solid: 100 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/287"},{"medicine":"ivacaftor","first_added":2025,"main_section":"Medicines for cystic fibrosis","sections":"Medicines for cystic fibrosis","section_count":1,"indications":"Cystic fibrosis","indication_count":1,"atc_codes":"R07AX02","dosage_forms":"Oral > Solid > tablet: 75 mg; 150 mg Oral > Solid > granules: 59.5 mg; 75 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/959"},{"medicine":"ivermectin","first_added":1987,"main_section":"Intestinal anthelminthics","sections":"Intestinal anthelminthics; Antifilarials; Medicines for ectoparasitic infections","section_count":3,"indications":"Hookworm diseases; Strongyloidiasis; Trichuriasis; Ancylostomiasis; Ascariasis; Lymphatic filariasis; Onchocerciasis; Scabies","indication_count":8,"atc_codes":"P02CF01","dosage_forms":"Oral > Solid > tablet: 3 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/58"},{"medicine":"kanamycin","first_added":2021,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents","section_count":1,"indications":"Other specified conjunctivitis; Infectious blepharitis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/876"},{"medicine":"ketamine","first_added":1984,"main_section":"General anaesthetics and oxygen > Injectable medicines","sections":"General anaesthetics and oxygen > Injectable medicines","section_count":1,"indications":"Anaesthetics and therapeutic gases","indication_count":1,"atc_codes":"N01AX03","dosage_forms":"Parenteral > General injections > unspecified: 10 mg per mL in vial (as hydrochloride); 50 mg per mL in vial (as hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/5"},{"medicine":"lactulose","first_added":2011,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care","section_count":1,"indications":"Palliative care","indication_count":1,"atc_codes":"A06AD11","dosage_forms":"Oral > Liquid: 3.3 to 3.4 g per 5 mL oral liquid","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/27"},{"medicine":"lamivudine","first_added":2002,"main_section":"Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors","sections":"Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AF05","dosage_forms":"Oral > Liquid: 50 mg per 5 mL Oral > Solid: 150 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/364"},{"medicine":"lamivudine + tenofovir","first_added":2021,"main_section":"Fixed-dose combinations of antiretrovirals","sections":"Fixed-dose combinations of antiretrovirals","section_count":1,"indications":"Contact with or exposure to human immunodeficiency virus; Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/638"},{"medicine":"lamivudine + zidovudine","first_added":2007,"main_section":"Fixed-dose combinations of antiretrovirals","sections":"Fixed-dose combinations of antiretrovirals","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AR01","dosage_forms":"Oral > Solid: 30 mg + 60 mg Tablet; 150 mg + 300 mg Tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/470"},{"medicine":"lamotrigine","first_added":2017,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines","section_count":1,"indications":"Epilepsy or seizures","indication_count":1,"atc_codes":"N03AX09","dosage_forms":"Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet; 200 mg tablet; 2 mg tablet (chewable, dispersible); 5 mg tablet (chewable, dispersible); 25 mg tablet (chewable, dispersible); 50 mg tablet (chewable, dispersible); 100 mg tablet (chewable, dispersible); 200 mg tablet (chewable, dispersible)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/50"},{"medicine":"latanoprost","first_added":2013,"main_section":"Ophthalmological preparations > Miotics and antiglaucoma medicines","sections":"Ophthalmological preparations > Miotics and antiglaucoma medicines","section_count":1,"indications":"Primary open-angle glaucoma","indication_count":1,"atc_codes":"S01EE01","dosage_forms":"Local > Ophthalmological > Solution (eye drops): 50 µg per mL eye drops","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/235"},{"medicine":"ledipasvir + sofosbuvir","first_added":2015,"main_section":"Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations","sections":"Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations","section_count":1,"indications":"Chronic hepatitis C","indication_count":1,"atc_codes":"J05AP51","dosage_forms":"Oral > Solid: 90 mg + 400 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/495"},{"medicine":"lenalidomide","first_added":2019,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"Plasma cell myeloma","indication_count":1,"atc_codes":"L04AX04","dosage_forms":"Oral > Solid: 25 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/408"},{"medicine":"letrozole","first_added":2023,"main_section":"Ovulation inducers","sections":"Ovulation inducers","section_count":1,"indications":"Female infertility without specification whether primary or secondary","indication_count":1,"atc_codes":"L02BG04","dosage_forms":"Oral > Solid > dosage form: 2.5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/917"},{"medicine":"leuprorelin","first_added":2015,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of breast; Malignant neoplasms of prostate","indication_count":2,"atc_codes":"L02AE02","dosage_forms":"Parenteral > General injections > IM: 7.5 mg in prefilled syringe; 22.5 mg in prefilled syringe","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/113"},{"medicine":"levamisole","first_added":1987,"main_section":"Intestinal anthelminthics","sections":"Intestinal anthelminthics","section_count":1,"indications":"Ascariasis","indication_count":1,"atc_codes":"P02CE01","dosage_forms":"Oral > Solid > tablet: 50 mg (as hydrochloride); 150 mg (as hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/59"},{"medicine":"levetiracetam","first_added":2023,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines","section_count":1,"indications":"Epilepsy or seizures; Status epilepticus","indication_count":2,"atc_codes":"N03AX14","dosage_forms":"Oral > Liquid: 100 mg per mL Oral > Solid > tablet: 250 mg; 500 mg; 750 mg; 1000 mg Parenteral > General injections > IV: 100 mg per mL in 5 mL ampoule or vial; 5 mg per mL in 100 mL bag; 10 mg per mL in 100 mL bag; 15 mg per mL in 100 mL bag","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/902"},{"medicine":"levodopa + benserazide","first_added":2021,"main_section":"Medicines for parkinsonism","sections":"Medicines for parkinsonism","section_count":1,"indications":"Parkinson disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/642"},{"medicine":"levodopa + carbidopa","first_added":1977,"main_section":"Medicines for parkinsonism","sections":"Medicines for parkinsonism","section_count":1,"indications":"Parkinson disease","indication_count":1,"atc_codes":"N04BA02","dosage_forms":"Oral > Solid: 100 mg + 10 mg tablet; 250 mg + 25 mg tablet; 100 mg + 25 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/393"},{"medicine":"levofloxacin","first_added":1999,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":"J01MA12","dosage_forms":"Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 250 mg; 500 mg; 750 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/353"},{"medicine":"levonorgestrel","first_added":1995,"main_section":"Oral hormonal contraceptives","sections":"Oral hormonal contraceptives; Intrauterine devices","section_count":2,"indications":"Contact with health services for postcoital contraception; Contact with health services for contraceptive management; Contact with health services for insertion of contraceptive device","indication_count":3,"atc_codes":"G03AD01, G03AC03, G02BA03","dosage_forms":"Oral > Solid: 750 µg [2]; 1.5 mg [1] Oral > Solid: 30 µg; Intrauterine system with reservoir containing 52 mg of levonorgestrel.","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/186"},{"medicine":"levonorgestrel-releasing implant","first_added":2007,"main_section":"Implantable contraceptives","sections":"Implantable contraceptives","section_count":1,"indications":"Contact with health services for insertion of contraceptive device","indication_count":1,"atc_codes":"G03AC03","dosage_forms":"Implant > Subdermal: 75 mg per rod (two-rods)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/424"},{"medicine":"levothyroxine","first_added":1977,"main_section":"Thyroid hormones and antithyroid medicines","sections":"Thyroid hormones and antithyroid medicines","section_count":1,"indications":"Hypothyroidism","indication_count":1,"atc_codes":"H03AA01","dosage_forms":"Oral > Solid: 50 µg (sodium salt); 100 µg (sodium salt); 25 µg (sodium salt)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/199"},{"medicine":"lidocaine","first_added":1977,"main_section":"Antiarrhythmic medicines","sections":"Antiarrhythmic medicines; Local anaesthetics","section_count":2,"indications":"Ventricular tachyarrhythmia; Local anaesthetics","indication_count":2,"atc_codes":"C01BB01, N01BB02","dosage_forms":"Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule (hydrochloride); Parenteral > Locoregional injections > Spinal anaesthesia: 5% in 2 mL ampoule (hydrochloride) + 7.5% glucose solution Parenteral > Locoregional injections > Other: 1% (hydrochloride); 2% (hydrochloride); 0.5% (hydrochloride) Local > Topical > unspecified: 2 to 4% (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/8"},{"medicine":"lidocaine + epinephrine","first_added":2002,"main_section":"Local anaesthetics","sections":"Local anaesthetics","section_count":1,"indications":"Local anaesthetics","indication_count":1,"atc_codes":"N01BB52","dosage_forms":"Parenteral > Locoregional injections > Other: 1% (lidocaine hydrochloride OR lidocaine sulfate) + 1:200 000 epinephrine; 2% (lidocaine hydrochloride OR lidocaine sulfate) + 1:200 000 epinephrine Local > Dental > Cartridge: 2% (lidocaine hydrochloride) + 1:80 000 epinephrine","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/277"},{"medicine":"linezolid","first_added":2015,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics; Antituberculosis medicines","section_count":2,"indications":"Methicillin resistant Staphylococcus aureus; Vancomycin resistant Staphylococcus aureus; Vancomycin resistant Enterococcus; Multi-drug resistant Mycobacterium tuberculosis","indication_count":4,"atc_codes":"J01XX08","dosage_forms":"Parenteral > General injections > IV: 2 mg per mL in 300 mL bag Oral > Liquid: 100 mg per 5 mL powder for oral liquid Oral > Solid: 400 mg tablet; 600 mg tablet Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 600 mg; Oral > Solid > dispersible tablet: 150 mg (scored) Oral > Solid > tablet: 600 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/345"},{"medicine":"liraglutide","first_added":null,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/932"},{"medicine":"lisinopril + amlodipine","first_added":2019,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Essential hypertension","indication_count":1,"atc_codes":"C09BB03","dosage_forms":"Oral > Solid: 10 mg + 5 mg; 20 mg + 5 mg; 20 mg + 10 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/531"},{"medicine":"lisinopril + hydrochlorothiazide","first_added":2019,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Essential hypertension","indication_count":1,"atc_codes":"C09BA03","dosage_forms":"Oral > Solid: 10 mg + 12.5 mg; 20 mg + 12.5 mg; 20 mg + 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/532"},{"medicine":"lithium carbonate","first_added":1977,"main_section":"Medicines for bipolar disorders","sections":"Medicines for bipolar disorders","section_count":1,"indications":"Bipolar or related disorders","indication_count":1,"atc_codes":"N05AN01","dosage_forms":"Oral > Solid: 300 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/248"},{"medicine":"loperamide","first_added":2013,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care","section_count":1,"indications":"Palliative care","indication_count":1,"atc_codes":"A07DA03","dosage_forms":"Oral > Solid > dosage form: 2 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/28"},{"medicine":"lopinavir + ritonavir","first_added":2002,"main_section":"Antiretrovirals > Protease inhibitors","sections":"Antiretrovirals > Protease inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AR10","dosage_forms":"Oral > Solid > tablet: 100 mg + 25 mg tablet (heat-stable); 200 mg + 50 mg tablet (heat-stable) Oral > Solid > dosage form: 40 mg + 10 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/453"},{"medicine":"loratadine","first_added":2013,"main_section":"Antiallergics and medicines used in anaphylaxis","sections":"Antiallergics and medicines used in anaphylaxis","section_count":1,"indications":"Allergic or hypersensitivity conditions of unspecified type","indication_count":1,"atc_codes":"R06AX13","dosage_forms":"Oral > Liquid: 1 mg per mL Oral > Solid > tablet: 10 mg; 5 mg (chewable); 10 mg (chewable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/34"},{"medicine":"lorazepam","first_added":2009,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines; Medicines for anxiety disorders","section_count":2,"indications":"Status epilepticus; Anxiety","indication_count":2,"atc_codes":"N05BA06","dosage_forms":"Parenteral > General injections > IV: 2 mg per mL in 1 mL ampoule; 4 mg per mL in 1 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/51"},{"medicine":"losartan","first_added":2017,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines; Medicines used in heart failure","section_count":2,"indications":"Essential hypertension; Heart failure","indication_count":2,"atc_codes":"C09CA01","dosage_forms":"Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/141"},{"medicine":"lovastatin","first_added":2021,"main_section":"Lipid-lowering agents","sections":"Lipid-lowering agents","section_count":1,"indications":"Mixed hyperlipidaemia; Coronary atherosclerosis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/527"},{"medicine":"magnesium sulfate","first_added":1995,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines","section_count":1,"indications":"Severe pre-eclampsia; Eclampsia","indication_count":2,"atc_codes":"B05XA05","dosage_forms":"Parenteral > General injections > IV: 500 mg per mL in 2 mL ampoule (equivalent to 1 g in 2 mL; 50% weight/volume) Parenteral > General injections > IM: 500 mg per mL in 10 mL ampoule (equivalent to 5 g in 10 mL; 50% weight/volume)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/52"},{"medicine":"malaria vaccine","first_added":2025,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain specified single infectious diseases","indication_count":1,"atc_codes":"J07XA01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/969"},{"medicine":"mannitol","first_added":1977,"main_section":"Diuretics","sections":"Diuretics","section_count":1,"indications":"Ocular hypertension; Cerebral oedema","indication_count":2,"atc_codes":"B05BC01","dosage_forms":"Parenteral > General injections > IV: 10% solution; 20% solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/177"},{"medicine":"measles vaccine","first_added":1977,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against measles alone","indication_count":1,"atc_codes":"J07BD01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/209"},{"medicine":"mebendazole","first_added":1977,"main_section":"Intestinal anthelminthics","sections":"Intestinal anthelminthics; Cysticidal medicines","section_count":2,"indications":"Hookworm diseases; Trichuriasis; Ascariasis; Enterobiasis; Other specified echinococcosis","indication_count":5,"atc_codes":"P02CA01","dosage_forms":"Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/60"},{"medicine":"medroxyprogesterone acetate","first_added":1984,"main_section":"Injectable hormonal contraceptives","sections":"Injectable hormonal contraceptives; Progestogens","section_count":2,"indications":"Contact with health services for reasons associated with reproduction; Excessive menstruation with irregular cycle","indication_count":2,"atc_codes":"G03AC06, G03DA02","dosage_forms":"Parenteral > General injections > IM: 150 mg per mL in 1 mL vial Parenteral > General injections > SC: 104 mg per 0.65 mL in pre-filled syringe; 104 mg per 0.65 mL in single dose injection delivery system; Oral > Solid: 5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/189"},{"medicine":"mefloquine","first_added":1987,"main_section":"Antimalarial medicines > Medicines for chemoprophylaxis in travellers","sections":"Antimalarial medicines > Medicines for chemoprophylaxis in travellers","section_count":1,"indications":"Malaria due to Plasmodium falciparum","indication_count":1,"atc_codes":"P01BC02","dosage_forms":"Oral > Solid > tablet: 250 mg (scored) (as hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/379"},{"medicine":"meglumine antimoniate","first_added":1987,"main_section":"Antileishmaniasis medicines","sections":"Antileishmaniasis medicines","section_count":1,"indications":"Visceral leishmaniasis; Mucocutaneous leishmaniasis; Cutaneous leishmaniasis","indication_count":3,"atc_codes":"P01CB01","dosage_forms":"Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/370"},{"medicine":"meglumine iotroxate","first_added":1984,"main_section":"Diagnostic agents > Radiocontrast media","sections":"Diagnostic agents > Radiocontrast media","section_count":1,"indications":"X-ray contrast media, iodinated","indication_count":1,"atc_codes":"V08AC02","dosage_forms":"Parenteral > General injections > IV: 5 to 8 g iodine (as meglumine) in 100 to 250 mL","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/169"},{"medicine":"melarsoprol","first_added":1977,"main_section":"Medicines for the treatment of 2nd stage African trypanosomiasis","sections":"Medicines for the treatment of 2nd stage African trypanosomiasis","section_count":1,"indications":"Gambiense trypanosomiasis; Rhodesiense trypanosomiasis","indication_count":2,"atc_codes":"P01CD01","dosage_forms":"Parenteral > General injections > IV: 3.6% in 5 mL ampoule solution (180 mg of active compound)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/389"},{"medicine":"melphalan","first_added":2019,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Plasma cell myeloma","indication_count":1,"atc_codes":"L01AA03","dosage_forms":"Parenteral > General injections > IV: 50 mg in vial powder for injection Oral > Solid: 2 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/556"},{"medicine":"meningococcal meningitis vaccine","first_added":1979,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against single bacterial diseases","indication_count":1,"atc_codes":"J07AH01, J07AH02, J07AH03, J07AH04, J07AH05, J07AH06, J07AH07, J07AH08, J07AH09, J07AH10","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/438"},{"medicine":"mercaptopurine","first_added":1984,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Lymphoid leukaemia, not elsewhere classified; Acute myeloid leukaemia with recurrent genetic abnormalities; Langerhans cell histiocytosis","indication_count":3,"atc_codes":"L01BB02","dosage_forms":"Oral > Liquid: 20 mg per mL Oral > Solid: 50 mg tablet","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/97"},{"medicine":"meropenem","first_added":2017,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics; Medicines for bacterial central nervous system infections; Antituberculosis medicines","section_count":3,"indications":"Neonatal meningitis; Peritoneal abscess (severe); Neutropaenia (high-risk); Peritonitis (severe); Multi-drug resistant Mycobacterium tuberculosis","indication_count":5,"atc_codes":"J01DH02","dosage_forms":"Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/329"},{"medicine":"meropenem + vaborbactam","first_added":2019,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Carbapenem-resistant Pseudomonas aeruginosa; Carbapenem resistant Acinetobacter baumannii; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli","indication_count":5,"atc_codes":"J01DH52","dosage_forms":"Parenteral > General injections > IV: 1 g in vial + 1 g in vial powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/396"},{"medicine":"mesalazine","first_added":2021,"main_section":"Anti-inflammatory medicines","sections":"Anti-inflammatory medicines","section_count":1,"indications":"Crohn disease site; Ulcerative colitis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/547"},{"medicine":"mesna","first_added":2009,"main_section":"Supportive medicines","sections":"Supportive medicines","section_count":1,"indications":"Rhabdomyosarcoma primary site; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Osteosarcoma of bone or articular cartilage of unspecified sites; Ewing sarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of kidney, except renal pelvis; Burkitt lymphoma including Burkitt leukaemia","indication_count":7,"atc_codes":"V03AF01","dosage_forms":"Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule; 100 mg per mL in 2 mL ampoule Oral > Solid > tablet: 400 mg; 600 mg Oral > Other: 600 mg Oral > Solid > tablet: 400 mg Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule Oral > Solid: 400 mg; 600 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/98"},{"medicine":"metformin","first_added":1997,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":"A10BA02","dosage_forms":"Oral > Solid: 500 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/191"},{"medicine":"methadone","first_added":2005,"main_section":"Medicines for opioid use disorders","sections":"Medicines for opioid use disorders; Opioid analgesics","section_count":2,"indications":"Opioid dependence; Chronic cancer pain","indication_count":2,"atc_codes":"N07BC02","dosage_forms":"Oral > Liquid: 5 mg per 5 mL (methadone hydrochloride); 10 mg per 5 mL (methadone hydrochloride); 5 mg per mL concentrate for oral liquid (methadone hydrochloride); 10 mg per mL concentrate for oral liquid (methadone hydrochloride); Oral > Liquid: 5 mg per 5 mL (methadone hydrochloride); 25 mg per 5 mL (methadone hydrochloride); 50 mg per 5 mL concentrate for oral liquid (methadone hydrochloride); 10 mg per mL concentrate for oral liquid (methadone hydrochloride) Oral > Solid > tablet: 5 mg (methadone hydrochloride); 10 mg (methadone hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/18"},{"medicine":"methimazole","first_added":2019,"main_section":"Thyroid hormones and antithyroid medicines","sections":"Thyroid hormones and antithyroid medicines","section_count":1,"indications":"Thyrotoxicosis","indication_count":1,"atc_codes":"H03BB02","dosage_forms":"Oral > Solid > tablet: 5 mg; 10 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/506"},{"medicine":"methotrexate","first_added":1977,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines; Dermatological medicines > Medicines affecting skin differentiation and proliferation; Disease-modifying anti-rheumatic drugs (DMARDs); Medicines for juvenile joint diseases","section_count":4,"indications":"Lymphoid leukaemia, not elsewhere classified; Acute myeloid leukaemia with recurrent genetic abnormalities; Burkitt lymphoma including Burkitt leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis; Osteosarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of breast; Malignant trophoblastic neoplasms of placenta; Psoriasis of unspecified type; Rheumatoid arthritis, serology unspecified; Juvenile idiopathic arthritis","indication_count":12,"atc_codes":"L01BA01, L04AX03","dosage_forms":"Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection Oral > Solid: 2.5 mg (as sodium salt) Parenteral > General injections > IV: 50 mg in vial (as sodium salt); Oral > Solid > tablet: 2.5 mg (as sodium salt); 10 mg (as sodium salt); Oral > Solid > tablet: 2.5 mg (as sodium salt)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/99"},{"medicine":"methoxy polyethylene glycol-epoetin beta","first_added":2017,"main_section":"Antianaemia medicines","sections":"Antianaemia medicines","section_count":1,"indications":"Anaemia due to chronic disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/419"},{"medicine":"methyldopa","first_added":1977,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Gestational hypertension","indication_count":1,"atc_codes":"C02AB01","dosage_forms":"Oral > Solid: 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/140"},{"medicine":"methylergometrine","first_added":2021,"main_section":"Uterotonics","sections":"Uterotonics","section_count":1,"indications":"Postpartum haemorrhage","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/658"},{"medicine":"methylprednisolone","first_added":2011,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified","indication_count":2,"atc_codes":"H02AB04","dosage_forms":"Parenteral > General injections > IV: 40 mg in vial (as sodium succinate); 125 mg in vial (as sodium succinate) Parenteral > General injections > IV: 40 mg in vial (as sodium succinate) powder for injection; 125 mg in vial (as sodium succinate) powder for injection","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/114"},{"medicine":"methylthioninium chloride","first_added":1979,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Acquired methaemoglobinaemia","indication_count":1,"atc_codes":"V03AB17","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL in 10 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/38"},{"medicine":"meticillin","first_added":2023,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock","indication_count":4,"atc_codes":"J01CF02","dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/818"},{"medicine":"metoclopramide","first_added":1982,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Antiemetic medicines","section_count":2,"indications":"Palliative care; Nausea or vomiting","indication_count":2,"atc_codes":"A03FA01","dosage_forms":"Oral > Liquid: 5 mg per 5 mL Oral > Solid: 10 mg (hydrochloride) Parenteral > General injections > unspecified: 5 mg per mL in 2 mL ampoule (hydrochloride); Oral > Liquid: 5 mg per 5 mL Oral > Solid: 10 mg (scored) (hydrochloride) Parenteral > General injections > unspecified: 5 mg per mL in 2 mL ampoule (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/29"},{"medicine":"metoprolol","first_added":2011,"main_section":"Antianginal medicines","sections":"Antianginal medicines; Antihypertensive medicines; Antiarrhythmic medicines; Medicines used in heart failure","section_count":4,"indications":"Angina pectoris; Essential hypertension; Cardiac arrhythmia; Heart failure","indication_count":4,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/497"},{"medicine":"metronidazole","first_added":1977,"main_section":"Antiamoebic and antigiardiasis medicines","sections":"Antiamoebic and antigiardiasis medicines; Access group antibiotics","section_count":2,"indications":"Amoebiasis; Trichomoniasis; Intestinal infections due to Clostridioides difficile; Necrotising fasciitis; Peritoneal abscess (mild-moderate); Peritoneal abscess (severe); Peritonitis (mild-moderate); Peritonitis (severe); Other specified prophylactic measures","indication_count":9,"atc_codes":"P01AB01, A01AB17, J01XD01","dosage_forms":"Oral > Liquid: 200 mg per 5 mL (as benzoate) Parenteral > General injections > unspecified: 500 mg in 100 mL vial Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg; Oral > Liquid: 200 mg per 5 mL (as benzoate) Local > Rectal > Suppository: 500 mg; 1 g Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg Oral > Solid > tablet: 500 mg; 200 mg; 250 mg; 400 mg Oral > Solid: 200 to 500 mg tablet Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection","combined_with":"cefotaxime; ceftriaxone; cefazolin; ciprofloxacin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/313"},{"medicine":"micafungin","first_added":2021,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Systemic or invasive candidosis","indication_count":1,"atc_codes":"J02AX05","dosage_forms":"Parenteral > General injections > IV: 50 mg in vial (as sodium) powder for injection; 100 mg in vial (as sodium) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/621"},{"medicine":"miconazole","first_added":1977,"main_section":"Dermatological medicines > Antifungal medicines","sections":"Dermatological medicines > Antifungal medicines","section_count":1,"indications":"Fungal infection of the skin","indication_count":1,"atc_codes":"D01AC02","dosage_forms":"Local > Topical > Cream: 2% (nitrate) Local > Topical > Ointment: 2% (nitrate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/149"},{"medicine":"midazolam","first_added":2009,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines; Medicines for other common symptoms in palliative care; Preoperative medication and sedation for short-term procedures","section_count":3,"indications":"Status epilepticus; Palliative care; Sedative-hypnotic and anxiolytic drugs","indication_count":3,"atc_codes":"N05CD08","dosage_forms":"Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial (for buccal administration); 5 mg per mL in 1 mL vial (for buccal administration); 5 mg per mL in 3 mL vial (for buccal administration) Local > Buccal > Solution: 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); Oral > Liquid: 2 mg per mL Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial; 5 mg per mL in 1 mL vial; 5 mg per mL in 3 mL vial Local > Buccal > Solution: ; 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) Oral > Solid > dosage form: 7.5 mg; 15 mg; Parenteral > General injections > IV: 1 mg per mL in 5 vial; 5 mg per mL in 1 mL vial; 5 mg per mL in 3 mL vial Oral > Liquid: 2 mg per mL Oral > Solid > dosage form: 15 mg; 7.5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/11"},{"medicine":"mifepristone - misoprostol","first_added":2005,"main_section":"Medicines for medical abortion","sections":"Medicines for medical abortion","section_count":1,"indications":"Unspecified time of fetal death, cause not specified; Induced abortion","indication_count":2,"atc_codes":"G03XB51","dosage_forms":"Oral > Solid > tablet: 200 mg + 200 µg; 200 mg [1] + 200 µg [4] in co-package","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/242"},{"medicine":"miltefosine","first_added":2011,"main_section":"Antileishmaniasis medicines","sections":"Antileishmaniasis medicines","section_count":1,"indications":"Visceral leishmaniasis; Cutaneous leishmaniasis; Mucocutaneous leishmaniasis","indication_count":3,"atc_codes":"P01CX04","dosage_forms":"Oral > Solid: 10 mg; 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/367"},{"medicine":"misoprostol","first_added":2005,"main_section":"Uterotonics","sections":"Uterotonics; Medicines for medical abortion","section_count":2,"indications":"Unspecified obstetric condition; Postpartum haemorrhage; Spontaneous abortion, incomplete, without complication","indication_count":3,"atc_codes":"G02AD06","dosage_forms":"Local > Vaginal > tablet: 25 µg Oral > Solid: 200 µg; Oral > Solid > tablet: 200 µg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/240"},{"medicine":"mometasone","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/667"},{"medicine":"mometasone + formoterol","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Asthma","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/670"},{"medicine":"morphine","first_added":1977,"main_section":"Opioid analgesics","sections":"Opioid analgesics; Preoperative medication and sedation for short-term procedures","section_count":2,"indications":"Pain; Opioids or related analgesics and agents affecting opioid receptors","indication_count":2,"atc_codes":"N02AA01","dosage_forms":"Oral > Liquid: 5 mg per 5 mL (morphine hydrochloride or morphine sulfate); 10 mg per 5 mL (morphine hydrochloride or morphine sulfate) Parenteral > General injections > unspecified: 1 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 2 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 10 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate) Oral > Solid > tablet: 10 mg immediate release (morphine sulfate) Oral > Solid > dosage form: 30 mg slow-release (morphine hydrochloride or morphine sulfate); 200 mg slow-release (morphine hydrochloride or morphine sulfate); 100 mg slow-release (morphine hydrochloride or morphine sulfate); 60 mg slow-release (morphine hydrochloride or morphine sulfate); 10 mg slow-release (morphine hydrochloride or morphine sulfate); 5 mg slow-release (morphine hydrochloride or morphine sulfate) Oral > Solid > granules: 20 mg (morphine sulfate); 30 mg (morphine sulfate); 60 mg (morphine sulfate); 100 mg (morphine sulfate); 200 mg (morphine sulfate); Parenteral > General injections > IV: 1 mg in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 2 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate); 10 mg per mL in 1 mL ampoule (morphine hydrochloride or morphine sulfate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/12"},{"medicine":"moxidectin","first_added":2025,"main_section":"Antifilarials","sections":"Antifilarials","section_count":1,"indications":"Lymphatic filariasis; Onchocerciasis","indication_count":2,"atc_codes":null,"dosage_forms":"Oral > Solid > tablet: 2 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/963"},{"medicine":"moxifloxacin","first_added":2017,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis; Tuberculosis","indication_count":2,"atc_codes":"J01MA14","dosage_forms":"Oral > Solid > dispersible tablet: 100 mg Oral > Solid > tablet: 400 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/354"},{"medicine":"mpox vaccine","first_added":2025,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BX01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/960"},{"medicine":"multiple micronutrient powder","first_added":2019,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Iron deficiency anaemia","indication_count":1,"atc_codes":"A11AA01","dosage_forms":"Sachets containing: - iron (elemental) 12.5 mg (as coated ferrous fumarate) - zinc (elemental) 5 mg - vitamin A 300 micrograms - with or without other micronutrients at recommended daily values","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/546"},{"medicine":"multiple micronutrient supplement","first_added":2021,"main_section":"Other medicines administered to the mother","sections":"Other medicines administered to the mother","section_count":1,"indications":"Maternal care for other specified conditions predominantly related to pregnancy","indication_count":1,"atc_codes":"A11AA01","dosage_forms":"Tablet containing: Vit A: 800 mcg retinol activity equivalent Vit C: 70 mg Vit D: 5 mcg (200 IU) Vit E: 10 mg alpha tocopherol equivalent Vit B1: 1.4 mg Vit B2: 1.4 mg Vit B3: 18 mg niacin equivalent Vit B6: 1.9 mg Folic acid: 400 mcg Vit B12: 2.6 mcg Iron: 30 mg Iodine: 150 mcg Zinc: 15 mg Selenium: 65 mcg Copper: 2 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/624"},{"medicine":"mumps vaccine","first_added":1999,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against mumps alone","indication_count":1,"atc_codes":"J07BE01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/220"},{"medicine":"mupirocin","first_added":1989,"main_section":"Dermatological medicines > Anti-infective medicines","sections":"Dermatological medicines > Anti-infective medicines","section_count":1,"indications":"Superficial bacterial folliculitis; Impetigo","indication_count":2,"atc_codes":"D06AX09","dosage_forms":"Local > Topical > Cream: 2% (as mupirocin calcium) Local > Topical > Ointment: 2%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/152"},{"medicine":"nadroparin","first_added":2015,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Acute ischaemic heart disease; Venous thromboembolism","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/413"},{"medicine":"nafcillin","first_added":2023,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock","indication_count":4,"atc_codes":"J01CF02","dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/751"},{"medicine":"naloxone","first_added":1977,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Unintentional exposure to or harmful effects of opioids or related analgesics","indication_count":1,"atc_codes":"V03AB15","dosage_forms":"Parenteral > General injections > unspecified: 400 µg per 1 mL in ampoule (naloxone hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/39"},{"medicine":"naltrexone","first_added":2023,"main_section":"Medicines for alcohol use disorders","sections":"Medicines for alcohol use disorders","section_count":1,"indications":"Disorders due to use of alcohol","indication_count":1,"atc_codes":"N07BB04","dosage_forms":"Parenteral > General injections > IM: 380 mg in vial (extended-release) Oral > Solid > tablet: 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/909"},{"medicine":"naproxen","first_added":2025,"main_section":"Medicines for acute migraine attacks","sections":"Medicines for acute migraine attacks","section_count":1,"indications":"Migraine","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/977"},{"medicine":"natamycin","first_added":2017,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents","section_count":1,"indications":"Infectious keratitis","indication_count":1,"atc_codes":"S01AA10","dosage_forms":"Local > Ophthalmological > Suspension: 5% eye drops","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/230"},{"medicine":"neostigmine","first_added":1977,"main_section":"Muscle relaxants (peripherally-acting) and cholinesterase inhibitors","sections":"Muscle relaxants (peripherally-acting) and cholinesterase inhibitors; Medicines for myasthenia gravis","section_count":2,"indications":"Anticholinesterase reversible; Myasthenia gravis","indication_count":2,"atc_codes":"N07AA01","dosage_forms":"Parenteral > General injections > unspecified: 0.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate); 2.5 mg per mL in 1 mL ampoule (neostigmine metilsulfate) Oral > Solid > tablet: 15 mg (neostigmine bromide)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/223"},{"medicine":"netilmicin","first_added":2021,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents","section_count":1,"indications":"Other specified conjunctivitis; Infectious blepharitis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/653"},{"medicine":"nevirapine","first_added":1999,"main_section":"Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors","sections":"Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AG01","dosage_forms":"Oral > Liquid: 50 mg per 5 mL Oral > Solid > dispersible tablet: 50 mg Oral > Solid > tablet: 200 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/451"},{"medicine":"niclosamide","first_added":1977,"main_section":"Intestinal anthelminthics","sections":"Intestinal anthelminthics","section_count":1,"indications":"Hymenolepiasis; Diphyllobothriasis; Taeniasis due to Taenia saginata; Taeniasis due to Taenia solium","indication_count":4,"atc_codes":"P02DA01","dosage_forms":"Oral > Solid: 500 mg tablet (chewable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/61"},{"medicine":"nicotinamide","first_added":1979,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Pellagra","indication_count":1,"atc_codes":"A11HA01","dosage_forms":"Oral > Solid: 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/264"},{"medicine":"nicotine replacement therapy","first_added":2009,"main_section":"Medicines for nicotine use disorders","sections":"Medicines for nicotine use disorders","section_count":1,"indications":"Nicotine dependence","indication_count":1,"atc_codes":"N07BA01","dosage_forms":"Local > Topical > Transdermal patch: 5 to 30 mg per 16 hour; 7 to 21 mg per 24 hour Oral > Solid > lozenge: 2 mg; 4 mg lozenge Local > Buccal > Oral spray: 1 mg per actuation Local > Buccal > Chewing gum: 2 mg; 4 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/530"},{"medicine":"nifedipine","first_added":1987,"main_section":"Antioxytocics (tocolytics)","sections":"Antioxytocics (tocolytics)","section_count":1,"indications":"Preterm labour without delivery","indication_count":1,"atc_codes":"C08CA05","dosage_forms":"Oral > Solid: 10 mg (immediate-release)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/243"},{"medicine":"nifurtimox","first_added":1977,"main_section":"American trypanosomiasis","sections":"American trypanosomiasis; Medicines for the treatment of 2nd stage African trypanosomiasis","section_count":2,"indications":"Chagas disease; Gambiense trypanosomiasis","indication_count":2,"atc_codes":"P01CC01","dosage_forms":"Oral > Solid > tablet: 30 mg (scored); 120 mg (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/390"},{"medicine":"nilotinib","first_added":2017,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Chronic myelogenous leukaemia, BCR-ABL1-positive","indication_count":1,"atc_codes":"L01EA03","dosage_forms":"Oral > Solid > capsule: 150 mg; 200 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/100"},{"medicine":"nilutamide","first_added":2021,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of prostate","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/641"},{"medicine":"nitrofurantoin","first_added":1979,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Infectious cystitis","indication_count":1,"atc_codes":"J01XE01","dosage_forms":"Oral > Liquid: 25 mg per 5 mL oral liquid Oral > Solid > dosage form: 100 mg; 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/301"},{"medicine":"nitrous oxide","first_added":1977,"main_section":"General anaesthetics and oxygen > Inhalational medicines","sections":"General anaesthetics and oxygen > Inhalational medicines","section_count":1,"indications":"Anaesthetics and therapeutic gases","indication_count":1,"atc_codes":"N01AX13","dosage_forms":"Respiratory > Inhalation:","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/3"},{"medicine":"nivolumab","first_added":2019,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"Melanoma of skin","indication_count":1,"atc_codes":"L01FF01","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL concentrate solution for infusion Parenteral > General injections > IV: 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion; 10 mg per mL in 24 mL vial concentrate solution for infusion Parenteral > General injections > IV: 10 mg per mL in 24 mL vial concentrate solution for infusion; 10 mg per mL in 4 mL vial concentrate solution for infusion; 10 mg per mL in 10 mL vial concentrate solution for infusion; 10 mg per mL in 12 mL vial concentrate solution for infusion","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/566"},{"medicine":"norethisterone","first_added":1977,"main_section":"Progestogens","sections":"Progestogens","section_count":1,"indications":"Excessive menstruation with irregular cycle","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid: 5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/420"},{"medicine":"norethisterone enantate","first_added":1984,"main_section":"Injectable hormonal contraceptives","sections":"Injectable hormonal contraceptives","section_count":1,"indications":"Contact with health services for reasons associated with reproduction","indication_count":1,"atc_codes":"G03AC01","dosage_forms":"Parenteral > General injections > IM: 200 mg per mL in 1 mL ampoule oily solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/190"},{"medicine":"normal immunoglobulin","first_added":1977,"main_section":"Human immunoglobulins","sections":"Human immunoglobulins; Medicines for Guillain-Barré syndrome","section_count":2,"indications":"Primary immunodeficiencies; Mucocutaneous lymph node syndrome; Langerhans cell histiocytosis; Acute inflammatory demyelinating polyneuropathy","indication_count":4,"atc_codes":"J06BA02","dosage_forms":"Parenteral > General injections > IV: 5% protein solution; 10% protein solution Parenteral > General injections > IM: 16% protein solution Parenteral > General injections > SC: 15% protein solution; 16% protein solution; Parenteral > General injections > IV: 5% protein solution; 10% protein solution","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/465"},{"medicine":"nystatin","first_added":1979,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Candidosis","indication_count":1,"atc_codes":"A07AA02","dosage_forms":"Oral > Liquid: 100000 IU per mL Local > Topical > Other: 100000 IU pessary Oral > Solid > dosage form: 500000 IU Oral > Solid > lozenge: 100000 IU","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/362"},{"medicine":"octreotide","first_added":2023,"main_section":"Medicines for disorders of the pituitary hormone system","sections":"Medicines for disorders of the pituitary hormone system","section_count":1,"indications":"Acromegaly or pituitary gigantism","indication_count":1,"atc_codes":"H01CB02","dosage_forms":"Parenteral > General injections > IM: 20 mg in vial (modified-release, as acetate) plus diluent Parenteral > General injections > SC: 0.05 mg per mL in 1 mL vial (immediate-release, as acetate); 0.1 mg per mL in 1 mL vial (immediate-release, as acetate); 0.5 mg per mL in 1 mL vial (immediate-release, as acetate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/913"},{"medicine":"ofloxacin","first_added":1999,"main_section":"Ear, nose and throat medicines [c]","sections":"Ear, nose and throat medicines [c]; Ophthalmological preparations > Anti-infective agents","section_count":2,"indications":"Infectious diseases of external ear; Other specified conjunctivitis; Infectious keratitis","indication_count":3,"atc_codes":"S01AE01","dosage_forms":"Local > Ophthalmological > Solution (eye drops): 0.3%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/231"},{"medicine":"olanzapine","first_added":2023,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":"N05AH03","dosage_forms":"Parenteral > General injections > IM: 10 mg in vial powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/918"},{"medicine":"omeprazole","first_added":2009,"main_section":"Antiulcer medicines","sections":"Antiulcer medicines","section_count":1,"indications":"Gastrointestinal bleeding; Peptic ulcer, site unspecified; Gastro-oesophageal reflux disease","indication_count":3,"atc_codes":"A02BC01","dosage_forms":"Parenteral > General injections > IV: 40 mg in vial Oral > Liquid: 1 mg per mL powder for oral liquid; 4 mg per mL powder for oral liquid Oral > Solid > dosage form: 10 mg; 20 mg; 40 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/178"},{"medicine":"ondansetron","first_added":2009,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Antiemetic medicines","section_count":2,"indications":"Palliative care; Nausea or vomiting","indication_count":2,"atc_codes":"A04AA01","dosage_forms":"Parenteral > General injections > IV: 2 mg per mL in 2 mL ampoule (as hydrochloride dihydrate); 2 mg per mL in 4 mL ampoule (as hydrochloride dihydrate) Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate) Oral > Solid: 4 mg (as hydrochloride dihydrate); 8 mg (as hydrochloride dihydrate); Parenteral > General injections > IV: 2 mg per mL in 2 mL ampoule (as hydrochloride dihydrate); 2 mg per mL in 4 mL ampoule Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate) Oral > Solid > dosage form: 4 mg (as hydrochloride dihydrate); 8 mg (as hydrochloride dihydrate); 24 mg (as hydrochloride dihydrate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/30"},{"medicine":"oral rehydration salts","first_added":1977,"main_section":"Solutions correcting water, electrolyte and acid-base disturbances > Oral","sections":"Solutions correcting water, electrolyte and acid-base disturbances > Oral; Oral rehydration","section_count":2,"indications":"Other specified disorders of fluid, electrolyte or acid-base balance; Diarrhoea","indication_count":2,"atc_codes":"A07CA","dosage_forms":"Powder for dilution in 200 mL, 500 mL, 1 L: - glucose 75 mEq or mmol/L - sodium 75 mEq or mmol/L - chloride 65 mEq or mmol/L - potassium 20 mEq or mmol/L - citrate 10 mEq or mmol/L - osmolarity 245 mOsm/L - glucose 13.5 g/L - sodium chloride 2.6 g/L - potassium chloride 1.5 g/L - trisodium citrate dihydrate 2.9 g/L","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/540"},{"medicine":"oral rehydration salts - zinc sulfate","first_added":2019,"main_section":"Medicines used in diarrhoea","sections":"Medicines used in diarrhoea","section_count":1,"indications":"Diarrhoea","indication_count":1,"atc_codes":"A07CA","dosage_forms":"Oral > Other: ORS powder for dilution and zinc sulfate dispersible tablet 20 mg (co-packaged)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/541"},{"medicine":"oseltamivir","first_added":2011,"main_section":"Other antivirals","sections":"Other antivirals","section_count":1,"indications":"Influenza due to identified seasonal influenza virus","indication_count":1,"atc_codes":"J05AH02","dosage_forms":"Oral > Liquid: 6 mg per mL (as phosphate) powder for oral liquid Oral > Solid: 30 mg capsule (as phosphate); 45 mg capsule (as phosphate); 75 mg capsule (as phosphate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/291"},{"medicine":"oxacillin","first_added":2023,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Bacterial infection of joint; Osteomyelitis or osteitis; Bacterial cellulitis, erysipelas or lymphangitis; Sepsis without septic shock","indication_count":4,"atc_codes":"J01CF02","dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/756"},{"medicine":"oxaliplatin","first_added":2015,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Malignant neoplasm metastasis in large intestine; Malignant neoplasms of colon","indication_count":2,"atc_codes":"L01XA03","dosage_forms":"Parenteral > General injections > IV: 50 mg in vial powder for injection; 100 mg in vial powder for injection; 50 mg per 10 mL in 10 mL vial; 100 mg per 20 mL in 20 mL vial; 200 mg per 40 mL in 40 mL vial","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/101"},{"medicine":"oxamniquine","first_added":1977,"main_section":"Antischistosomals and other antitrematode medicines","sections":"Antischistosomals and other antitrematode medicines","section_count":1,"indications":"Schistosomiasis due to Schistosoma mansoni","indication_count":1,"atc_codes":"P02BA02","dosage_forms":"Oral > Liquid: 250 mg per 5 mL Oral > Solid > capsule: 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/66"},{"medicine":"oxycodone","first_added":2025,"main_section":"Opioid analgesics","sections":"Opioid analgesics","section_count":1,"indications":"Pain","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/559"},{"medicine":"oxygen","first_added":1979,"main_section":"General anaesthetics and oxygen > Inhalational medicines","sections":"General anaesthetics and oxygen > Inhalational medicines; Medical gases","section_count":2,"indications":"Anaesthetics and therapeutic gases; Respiratory failure as acute or chronic","indication_count":2,"atc_codes":"V03AN01","dosage_forms":"Respiratory > Inhalation: (medical gas); Respiratory > Inhalation:","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/4"},{"medicine":"oxytetracycline","first_added":2021,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents","section_count":1,"indications":"Other specified conjunctivitis; Infectious keratitis; Infectious blepharitis; Trachoma","indication_count":4,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/656"},{"medicine":"oxytocin","first_added":1977,"main_section":"Uterotonics","sections":"Uterotonics","section_count":1,"indications":"Postpartum haemorrhage","indication_count":1,"atc_codes":"H01BB02","dosage_forms":"Parenteral > General injections > unspecified: 10 IU per mL","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/241"},{"medicine":"p-aminosalicylate sodium","first_added":2023,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":"J04AA01","dosage_forms":"Oral > Liquid: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) powder for oral solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/904"},{"medicine":"paclitaxel","first_added":2011,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Malignant neoplasms of cervix uteri; Kaposi sarcoma of unspecified primary site; Other specified malignant neoplasms of the ovary; Malignant neoplasms of nasopharynx; Other specified carcinomas of ovary; Other specified malignant neoplasms of bronchus or lung; Other specified malignant neoplasms of breast; Malignant neoplasms of breast","indication_count":8,"atc_codes":"L01CD01","dosage_forms":"Parenteral > General injections > IV: 6 mg per mL","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/102"},{"medicine":"paliperidone","first_added":2021,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":"N05AX13","dosage_forms":"Parenteral > General injections > IM: 25 mg in pre-filled syringe (as palmitate); 50 mg in pre-filled syringe (as palmitate); 75 mg in pre-filled syringe (as palmitate); 100 mg in pre-filled syringe (as palmitate); 150 mg in pre-filled syringe (as palmitate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/623"},{"medicine":"palonosetron","first_added":2025,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Antiemetic medicines","section_count":2,"indications":"Palliative care; Nausea or vomiting","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/631"},{"medicine":"pancreatic enzymes","first_added":2009,"main_section":"Gastrointestinal medicines","sections":"Gastrointestinal medicines; Medicines for cystic fibrosis","section_count":2,"indications":"Enzyme intestinal; Cystic fibrosis","indication_count":2,"atc_codes":"A09AA02","dosage_forms":"Capsule (modified release): 10 000 lipase units + 8000 amylase units + 600 protease units; 25 000 lipase units + 18 000 amylase units + 1000 protease units. *Units expressed in Ph. Eur","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/514"},{"medicine":"paracetamol (acetaminophen)","first_added":1977,"main_section":"Medicines for acute migraine attacks","sections":"Medicines for acute migraine attacks; Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)","section_count":2,"indications":"Migraine; Pain","indication_count":2,"atc_codes":"N02BE01","dosage_forms":"Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL Local > Rectal > Suppository: 250 mg Oral > Solid > dispersible tablet: 100 mg; 250 mg Oral > Solid > tablet: 250 mg; 325 mg; 500 mg; Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL Local > Rectal > Suppository: 100 mg; 250 mg Oral > Solid > dispersible tablet: 100 mg; 250 mg Oral > Solid > tablet: 250 mg; 325 mg; 500 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/15"},{"medicine":"paromomycin","first_added":1977,"main_section":"Antileishmaniasis medicines","sections":"Antileishmaniasis medicines","section_count":1,"indications":"Visceral leishmaniasis","indication_count":1,"atc_codes":"A07AA06","dosage_forms":"Parenteral > General injections > IM: 750 mg paromomycin base (as sulfate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/368"},{"medicine":"paroxetine","first_added":2023,"main_section":"Medicines for anxiety disorders","sections":"Medicines for anxiety disorders","section_count":1,"indications":"Generalised anxiety disorder","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/662"},{"medicine":"pegaspargase","first_added":2019,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Lymphoid leukaemia, not elsewhere classified","indication_count":1,"atc_codes":"L01XX24","dosage_forms":"Parenteral > General injections > IV: 3750 units per 5 mL in vial; 3750 units in vial powder for injection","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/558"},{"medicine":"pegfilgrastim","first_added":2023,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"Acquired neutropaenia","indication_count":1,"atc_codes":"L03AA13","dosage_forms":"Parenteral > General injections > SC: 6 mg per 0.6 mL in pre-filled syringe","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/907"},{"medicine":"pembrolizumab","first_added":2025,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"Melanoma of skin; Other specified malignant neoplasms of large intestine; Malignant neoplasms of cervix uteri; Other specified malignant neoplasms of bronchus or lung","indication_count":4,"atc_codes":"L01FF02","dosage_forms":"Parenteral > General injections > IV: 25 mg per mL in 4 mL vial Parenteral > General injections > IV: 25 mg per mL in 4 mL vial concentrate for solution for infusion Parenteral > General injections > IV: 25 mg per mL in 4 mL vial powder for injection","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/565"},{"medicine":"penicillamine","first_added":1979,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific; Disease-modifying anti-rheumatic drugs (DMARDs)","section_count":2,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified; Rheumatoid arthritis, serology unspecified","indication_count":2,"atc_codes":"M01CC01","dosage_forms":"Oral > Solid: 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/42"},{"medicine":"pentamidine","first_added":1977,"main_section":"Medicines for the treatment of 1st stage African trypanosomiasis","sections":"Medicines for the treatment of 1st stage African trypanosomiasis; Antipneumocystosis and antitoxoplasmosis medicines","section_count":2,"indications":"Gambiense trypanosomiasis; Pneumocystosis","indication_count":2,"atc_codes":"P01CX01","dosage_forms":"Parenteral > General injections > IM: 300 mg in vial (as isetionate) powder for injection; Oral > Solid > tablet: 200 mg (as isethionate); 300 mg (as isethionate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/386"},{"medicine":"perindopril + amlodipine + indapamide","first_added":2025,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Essential hypertension","indication_count":1,"atc_codes":"C09BX01","dosage_forms":"Oral > Solid > dosage form: 5 mg (arginine) + 5 mg + 1.25 mg; 5 mg (arginine) + 10 mg + 1.25 mg; 10 mg (arginine) + 5 mg + 2.5 mg; 10 mg (arginine) + 10 mg + 2.5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/961"},{"medicine":"permethrin","first_added":1989,"main_section":"Dermatological medicines > Scabicides and pediculicides","sections":"Dermatological medicines > Scabicides and pediculicides","section_count":1,"indications":"Pediculosis corporis; Pediculosis capitis; Scabies","indication_count":3,"atc_codes":"P03AC04","dosage_forms":"Local > Topical > Lotion: 1% Local > Topical > Cream: 5%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/163"},{"medicine":"pertussis vaccine","first_added":1999,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against pertussis alone","indication_count":1,"atc_codes":"J07AJ02","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/210"},{"medicine":"phenobarbital","first_added":1977,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines","section_count":1,"indications":"Status epilepticus; Epilepsy or seizures","indication_count":2,"atc_codes":"N03AA02","dosage_forms":"Parenteral > General injections > IV: 200 mg per mL (phenobarbital sodium); 30 mg per mL (phenobarbital sodium); 60 mg per mL (phenobarbital sodium) Oral > Liquid: 15 mg per 5 mL Oral > Solid > tablet: 15 mg; 30 mg; 60 mg; 100 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/53"},{"medicine":"phenoxymethylpenicillin","first_added":1977,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Bacterial pneumonia (Community-acquired pneumonia - mild to moderate); Periapical abscess without sinus; Acute pharyngitis","indication_count":3,"atc_codes":"J01CE02","dosage_forms":"Oral > Liquid: 250 mg per 5 mL (as potassium salt) powder for oral liquid Oral > Solid: 250 mg (as potassium salt); 500 mg (as potassium salt) Oral > Solid: 250 mg (as potassium salt) tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/308"},{"medicine":"phenytoin","first_added":1977,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines","section_count":1,"indications":"Epilepsy or seizures","indication_count":1,"atc_codes":"N03AB02","dosage_forms":"Oral > Liquid: 30 mg per 5 mL (phenytoin) Parenteral > General injections > unspecified: 50 mg per mL in vial (phenytoin sodium) Oral > Solid > tablet: 50 mg (phenytoin) (chewable) Oral > Solid > dosage form: 25 mg (phenytoin sodium); 50 mg (phenytoin sodium); 100 mg (phenytoin sodium)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/54"},{"medicine":"phytomenadione","first_added":1977,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors; Haemorrhagic or haematological disorders of fetus or newborn","indication_count":2,"atc_codes":"B02BA01","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL in ampoule; 1 mg per mL in ampoule; 2 mg per 0.2 mL in ampoule mixed micelle solution; 10 mg per mL in ampoule mixed micelle solution; 1 mg per 0.5 mL in ampoule Oral > Solid > tablet: 5 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/125"},{"medicine":"pilocarpine","first_added":1977,"main_section":"Ophthalmological preparations > Miotics and antiglaucoma medicines","sections":"Ophthalmological preparations > Miotics and antiglaucoma medicines","section_count":1,"indications":"Acute angle closure with pupillary block; Ocular hypertension; Primary open-angle glaucoma","indication_count":3,"atc_codes":"S01EB01","dosage_forms":"Local > Ophthalmological > Solution (eye drops): 2% (hydrochloride or nitrate); 4% (hydrochloride or nitrate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/236"},{"medicine":"piperacillin + tazobactam","first_added":2017,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics","section_count":1,"indications":"Other specified pneumonia (Hospital-acquired pneumonia); Necrotising fasciitis; Neutropaenia (high-risk); Peritoneal abscess (severe); Peritonitis (severe)","indication_count":5,"atc_codes":"J01CR05","dosage_forms":"Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection","combined_with":"clindamycin","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/320"},{"medicine":"platelets","first_added":2013,"main_section":"Blood and blood components","sections":"Blood and blood components","section_count":1,"indications":"Blood transfusion without reported diagnosis","indication_count":1,"atc_codes":"B05AX02","dosage_forms":"Parenteral > General injections > IV:","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/456"},{"medicine":"plazomicin","first_added":2019,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Carbapenem resistant Acinetobacter baumannii; Carbapenem-resistant Pseudomonas aeruginosa; Other carbapenem resistant Enterobacterales; Carbapenem resistant Escherichia coli; Carbapenem resistant Klebsiella pneumoniae","indication_count":5,"atc_codes":"J01GB14","dosage_forms":"Parenteral > General injections > IV: 500 mg per 10 mL","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/397"},{"medicine":"pneumococcal vaccine","first_added":2007,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against single bacterial diseases","indication_count":1,"atc_codes":"J07AL01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/211"},{"medicine":"podophyllotoxin","first_added":2021,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Plantar warts; Anogenital warts","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/520"},{"medicine":"podophyllum resin","first_added":1984,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Plantar warts; Anogenital warts","indication_count":2,"atc_codes":"D06BB04","dosage_forms":"Local > Topical > Solution: 10 to 25%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/159"},{"medicine":"poliomyelitis vaccine","first_added":1977,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against poliomyelitis","indication_count":1,"atc_codes":"J07BF01, J07BF02, J07BF03, J07BF04","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/212"},{"medicine":"polygeline","first_added":1989,"main_section":"Plasma substitutes","sections":"Plasma substitutes","section_count":1,"indications":"Hypovolaemia","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > General injections > IV: 3.5% injectable solution Parenteral > General injections > IV: 3.5% in solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/471"},{"medicine":"polymyxin B (injection)","first_added":2019,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Carbapenem-resistant Pseudomonas aeruginosa; Carbapenem resistant Acinetobacter baumannii; Other carbapenem resistant Enterobacterales; Carbapenem resistant Klebsiella pneumoniae; Carbapenem resistant Escherichia coli","indication_count":5,"atc_codes":"J01XB02","dosage_forms":"Parenteral > General injections > IV: 500000 IU in vial powder for injection (equivalent to 50 mg polymyxin B base)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/561"},{"medicine":"porcatant alfa","first_added":2009,"main_section":"Medicines administered to the neonate [c]","sections":"Medicines administered to the neonate [c]","section_count":1,"indications":"Respiratory distress syndrome of newborn","indication_count":1,"atc_codes":"R07AA02","dosage_forms":"Respiratory > Suspension: 80 mg per mL for intratracheal instillation","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/989"},{"medicine":"potassium chloride","first_added":1977,"main_section":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","sections":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral; Solutions correcting water, electrolyte and acid-base disturbances > Oral","section_count":2,"indications":"Hypokalaemia","indication_count":1,"atc_codes":"B05XA01, A12BA01","dosage_forms":"Parenteral > General injections > IV: 11.2% in 20 mL ampoule (equivalent to K+ 1.5 mmol/mL and Cl- 1.5 mmol/mL); 7.5% solution for dilution (equivalent to K+ 1 mmol/mL and Cl- 2 mmol/mL); 15% solution for dilution (equivalent to K+ 2 mmol/mL and Cl- 2 mmol/mL); Oral > Liquid: powder for solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/255"},{"medicine":"potassium ferric hexacyanoferrate (Prussian blue)","first_added":1989,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified","indication_count":1,"atc_codes":"V03AB31","dosage_forms":"Oral > Solid: Powder for oral administration","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/43"},{"medicine":"potassium iodide","first_added":1977,"main_section":"Thyroid hormones and antithyroid medicines","sections":"Thyroid hormones and antithyroid medicines; Antifungal medicines","section_count":2,"indications":"Thyrotoxicosis; Sporotrichosis","indication_count":2,"atc_codes":"V03AB21, D08AG03","dosage_forms":"Oral > Solid > tablet: 65 mg (scored); Local > Topical > Solution: Saturated solution","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/200"},{"medicine":"potassium permanganate","first_added":1995,"main_section":"Dermatological medicines > Anti-infective medicines","sections":"Dermatological medicines > Anti-infective medicines","section_count":1,"indications":"Tropical phagedaenic ulcer; Pemphigus; Other specified pyogenic bacterial infection of skin or subcutaneous tissue; Impetigo","indication_count":4,"atc_codes":"D08AX06","dosage_forms":"Local > Topical > Solution: aqueous solution: 1:10 000","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/153"},{"medicine":"povidone iodine","first_added":1993,"main_section":"Antiseptics","sections":"Antiseptics","section_count":1,"indications":"Povidone iodine","indication_count":1,"atc_codes":"D08AG02","dosage_forms":"Local > Topical > Solution: 10% (equivalent to 1% available iodine)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/172"},{"medicine":"pravastatin","first_added":2021,"main_section":"Lipid-lowering agents","sections":"Lipid-lowering agents","section_count":1,"indications":"Mixed hyperlipidaemia; Coronary atherosclerosis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/526"},{"medicine":"praziquantel","first_added":1979,"main_section":"Cysticidal medicines","sections":"Cysticidal medicines; Antischistosomals and other antitrematode medicines; Intestinal anthelminthics","section_count":3,"indications":"Cysticercosis of central nervous system; Paragonimiasis; Clonorchiasis; Opisthorchiasis; Schistosomiasis; Diphyllobothriasis; Taeniasis due to Taenia saginata; Hymenolepiasis; Taeniasis due to Taenia solium","indication_count":9,"atc_codes":"P02BA01","dosage_forms":"Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/62"},{"medicine":"precipitated sulfur","first_added":2021,"main_section":"Dermatological medicines > Scabicides and pediculicides","sections":"Dermatological medicines > Scabicides and pediculicides","section_count":1,"indications":"Pediculosis corporis; Pediculosis capitis; Pthiriasis; Scabies","indication_count":4,"atc_codes":null,"dosage_forms":"Local > Topical > Ointment:","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/650"},{"medicine":"prednisolone","first_added":1984,"main_section":"Anti-inflammatory medicines","sections":"Anti-inflammatory medicines; Hormones and antihormones; Antiallergics and medicines used in anaphylaxis; Ophthalmological preparations > Anti-inflammatory agents; Adrenal hormones and synthetic substitutes; Medicines for cluster headache; Antiseizure medicines","section_count":7,"indications":"Crohn disease site; Ulcerative colitis; Lymphoid leukaemia, not elsewhere classified; Diffuse large B-cell lymphoma, not otherwise specified; Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Plasma cell myeloma; Burkitt lymphoma including Burkitt leukaemia; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis; Hodgkin lymphoma; Malignant neoplasms of prostate; Follicular lymphoma; Allergic or hypersensitivity conditions of unspecified type; Scleritis; Anterior uveitis; Adrenocortical insufficiency; Trigeminal autonomic cephalalgias; Infantile spasms","indication_count":19,"atc_codes":"A07EA01, H02AB06, S01BA04","dosage_forms":"Local > Rectal > Retention enema: Local > Rectal > Retention enema: 20 mg per 100 mL (as sodium phosphate); Oral > Liquid: 5 mg per mL Oral > Solid: 5 mg; 25 mg; Local > Ophthalmological > Solution (eye drops): 0.5% (sodium phosphate); Oral > Solid > tablet: 1 mg; Oral > Solid > tablet: 5 mg; 25 mg; Oral > Liquid: 1 mg per mL Oral > Solid > tablet: 1 mg; 5 mg; 10 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/35"},{"medicine":"prednisone","first_added":2021,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones; Antiallergics and medicines used in anaphylaxis; Adrenal hormones and synthetic substitutes","section_count":3,"indications":"Lymphoid leukaemia, not elsewhere classified; Diffuse large B-cell lymphoma, not otherwise specified; Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Plasma cell myeloma; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis; Hodgkin lymphoma; Malignant neoplasms of prostate; Follicular lymphoma; Allergic or hypersensitivity conditions of unspecified type; Adrenocortical insufficiency","indication_count":12,"atc_codes":null,"dosage_forms":"Oral > Solid > tablet: 1 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/635"},{"medicine":"pretomanid","first_added":2023,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":"J04AK08","dosage_forms":"Oral > Solid > tablet: 200 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/919"},{"medicine":"primaquine","first_added":1977,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium ovale; Malaria due to Plasmodium falciparum; Malaria due to Plasmodium vivax","indication_count":3,"atc_codes":"P01BA03","dosage_forms":"Oral > Solid > tablet: 7.5 mg (as phosphate); 15 mg (as phosphate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/380"},{"medicine":"procaine benzylpenicillin","first_added":2017,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Congenital syphilis [children]; Syphilis","indication_count":2,"atc_codes":"J01CE09","dosage_forms":"Parenteral > General injections > IM: 1 g in vial (=1 million IU) powder for injection; 3 g in vial (=3 million IU) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/319"},{"medicine":"procarbazine","first_added":1979,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Hodgkin lymphoma","indication_count":1,"atc_codes":"L01XB01","dosage_forms":"Oral > Solid: 50 mg (as hydrochloride) Oral > Solid > capsule: 50 mg (as hydrochloride)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/103"},{"medicine":"progesterone vaginal ring","first_added":2015,"main_section":"Intravaginal contraceptives","sections":"Intravaginal contraceptives","section_count":1,"indications":"Contact with health services for contraceptive management","indication_count":1,"atc_codes":"G03DA04","dosage_forms":"Local > Vaginal > vaginal ring: 2.074 g micronized progesterone","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/193"},{"medicine":"propanol","first_added":2021,"main_section":"Antiseptics","sections":"Antiseptics","section_count":1,"indications":"Denatured alcohol","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/524"},{"medicine":"propofol","first_added":2011,"main_section":"General anaesthetics and oxygen > Injectable medicines","sections":"General anaesthetics and oxygen > Injectable medicines","section_count":1,"indications":"Anaesthetics and therapeutic gases","indication_count":1,"atc_codes":"N01AX10","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL; 20 mg per mL","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/6"},{"medicine":"propranolol","first_added":1977,"main_section":"Medicines for migraine prophylaxis","sections":"Medicines for migraine prophylaxis","section_count":1,"indications":"Migraine","indication_count":1,"atc_codes":"C07AA05","dosage_forms":"Oral > Solid > tablet: 40 mg (hydrochloride); 10 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/392"},{"medicine":"propylthiouracil","first_added":1977,"main_section":"Thyroid hormones and antithyroid medicines","sections":"Thyroid hormones and antithyroid medicines","section_count":1,"indications":"Thyrotoxicosis","indication_count":1,"atc_codes":"H03BA02","dosage_forms":"Oral > Solid: 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/201"},{"medicine":"protamine sulfate","first_added":1977,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors","indication_count":1,"atc_codes":"V03AB14","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL in 5 mL ampoule or vial","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/126"},{"medicine":"protionamide","first_added":2025,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid > tablet: 250 mg (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/637"},{"medicine":"pyrantel","first_added":1982,"main_section":"Intestinal anthelminthics","sections":"Intestinal anthelminthics","section_count":1,"indications":"Hookworm diseases; Trichuriasis; Ascariasis; Enterobiasis","indication_count":4,"atc_codes":"P02CC01","dosage_forms":"Oral > Solid > tablet: 250 mg (chewable) (as embonate or pamoate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/63"},{"medicine":"pyrazinamide","first_added":1982,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculosis","indication_count":1,"atc_codes":"J04AK01","dosage_forms":"Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 400 mg; 500 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/331"},{"medicine":"pyridostigmine","first_added":1977,"main_section":"Medicines for myasthenia gravis","sections":"Medicines for myasthenia gravis; Muscle relaxants (peripherally-acting) and cholinesterase inhibitors","section_count":2,"indications":"Myasthenia gravis","indication_count":1,"atc_codes":"N07AA02","dosage_forms":"Parenteral > General injections > IV: 5 mg per mL in ampoule or vial (pyridostigmine bromide) Oral > Solid > tablet: 60 mg scored (pyridostigmine bromide)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/204"},{"medicine":"pyridoxine","first_added":1977,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Other specified polyneuropathy; Vitamin B6 deficiency; Sideroblastic anaemia","indication_count":3,"atc_codes":"A11HA02","dosage_forms":"Oral > Solid > tablet: 25 mg (hydrochloride); 10 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/265"},{"medicine":"pyrimethamine","first_added":1997,"main_section":"Antipneumocystosis and antitoxoplasmosis medicines","sections":"Antipneumocystosis and antitoxoplasmosis medicines","section_count":1,"indications":"Toxoplasmosis","indication_count":1,"atc_codes":"P01BD01","dosage_forms":"Oral > Solid: 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/384"},{"medicine":"quetiapine","first_added":2023,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders; Medicines for bipolar disorders","section_count":2,"indications":"Schizophrenia or other primary psychotic disorders; Bipolar or related disorders","indication_count":2,"atc_codes":"N05AH04","dosage_forms":"Oral > Solid > tablet: 25 mg (immediate-release); 100 mg (immediate-release); 150 mg (immediate-release); 200 mg (immediate-release); 300 mg (immediate-release); 50 mg (modified-release); 150 mg (modified-release); 200 mg (modified-release); 300 mg (modified-release); 400 mg (modified-release)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/920"},{"medicine":"quinine","first_added":1977,"main_section":"Antimalarial medicines > Medicines for curative treatment","sections":"Antimalarial medicines > Medicines for curative treatment","section_count":1,"indications":"Malaria due to Plasmodium falciparum","indication_count":1,"atc_codes":"P01BC01","dosage_forms":"Parenteral > General injections > IV: 300 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion; 60 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/381"},{"medicine":"rabies vaccine","first_added":1977,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against rabies","indication_count":1,"atc_codes":"J07BG01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/218"},{"medicine":"raltegravir","first_added":2017,"main_section":"Antiretrovirals > Integrase inhibitors","sections":"Antiretrovirals > Integrase inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AJ01","dosage_forms":"Oral > Liquid: 100 mg granules for oral suspension Oral > Solid: 400 mg tablet; 25 mg tablet (chewable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/289"},{"medicine":"ranitidine","first_added":2003,"main_section":"Antiulcer medicines","sections":"Antiulcer medicines","section_count":1,"indications":"Peptic ulcer, site unspecified; Gastro-oesophageal reflux disease","indication_count":2,"atc_codes":"A02BA02","dosage_forms":"Oral > Liquid: 75 mg per 5 mL (as hydrochloride) Oral > Solid: 150 mg (as hydrochloride) Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (as hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/179"},{"medicine":"rasburicase","first_added":2021,"main_section":"Supportive medicines","sections":"Supportive medicines","section_count":1,"indications":"Tumour lysis syndrome","indication_count":1,"atc_codes":"V03AF07","dosage_forms":"Parenteral > General injections > IV: 1.5 mg in vial powder and 1 mL solvent for solution; 7.5 mg in vial powder and 5 mL solvent for solution","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/625"},{"medicine":"ravidasvir","first_added":2023,"main_section":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","sections":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","section_count":1,"indications":"Chronic hepatitis C","indication_count":1,"atc_codes":"J05AP13","dosage_forms":"Oral > Solid > tablet: 200 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/899"},{"medicine":"ready to use therapeutic food","first_added":2023,"main_section":"Therapeutic foods","sections":"Therapeutic foods","section_count":1,"indications":"Acute malnutrition in infants, children or adolescents","indication_count":1,"atc_codes":null,"dosage_forms":"Biscuit or paste of nutritional composition as determined by the UN joint statement on the community-based management of severe acute malnutrition and Codex alimentarius guidelines.","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/586"},{"medicine":"realgar-indigo naturalis formulation","first_added":2019,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Acute myeloid leukaemia with recurrent genetic abnormalities","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid: 270 mg (containing tetra-arsenic tetra-sulfide 30 mg)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/555"},{"medicine":"red blood cells","first_added":2013,"main_section":"Blood and blood components","sections":"Blood and blood components","section_count":1,"indications":"Blood transfusion without reported diagnosis","indication_count":1,"atc_codes":"B05AX01","dosage_forms":"Parenteral > General injections > IV:","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/457"},{"medicine":"resin-based composite (high-viscosity)","first_added":2023,"main_section":"Dental medicines and preparations","sections":"Dental medicines and preparations","section_count":1,"indications":"Dental caries","indication_count":1,"atc_codes":null,"dosage_forms":"Local > Topical > Other: Single-use capsule or multi-use syringe","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/923"},{"medicine":"resin-based composite (low-viscosity)","first_added":2023,"main_section":"Dental medicines and preparations","sections":"Dental medicines and preparations","section_count":1,"indications":"Dental caries","indication_count":1,"atc_codes":null,"dosage_forms":"Local > Topical > Other: Single-use applicator or multi-use bottle","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/922"},{"medicine":"respiratory syncytial virus vaccine","first_added":2025,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BX05","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/970"},{"medicine":"retinol","first_added":1977,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Vitamin A deficiency","indication_count":1,"atc_codes":"A11CA01","dosage_forms":"Parenteral > General injections > IM: 50000 IU per mL in 2 mL ampoule or vial water-miscible (as palmitate) Oral > Liquid: 100000 IU per mL (as palmitate or acetate) Oral > Solid > capsule: 200000 IU (as palmitate or acetate) soft capsule; 50000 IU (as palmitate); 100000 IU (as palmitate or acetate) soft capsule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/266"},{"medicine":"ribavirin","first_added":2007,"main_section":"Medicines for hepatitis C > Other antivirals for hepatitis C","sections":"Medicines for hepatitis C > Other antivirals for hepatitis C","section_count":1,"indications":"Chronic hepatitis C","indication_count":1,"atc_codes":"J05AP01","dosage_forms":"Parenteral > General injections > IV: 1000 mg per 10 mL phosphate buffer solution; 800 mg per 10 mL phosphate buffer solution Oral > Solid: 200 mg; 400 mg; 600 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/473"},{"medicine":"riboflavin","first_added":1979,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Vitamin B2 deficiency","indication_count":1,"atc_codes":"A11HA04","dosage_forms":"Oral > Solid: 5 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/267"},{"medicine":"rifabutin","first_added":2009,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Tuberculosis","indication_count":1,"atc_codes":"J04AB04","dosage_forms":"Oral > Solid: 150 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/335"},{"medicine":"rifampicin","first_added":1977,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines; Antileprosy medicines","section_count":2,"indications":"Tuberculosis; Leprosy","indication_count":2,"atc_codes":"J04AB02","dosage_forms":"Parenteral > General injections > IV: 600 mg in vial powder for injection Oral > Liquid: 20 mg per mL Oral > Solid: 150 mg; 300 mg; Oral > Liquid: 20 mg per mL Oral > Solid: 150 mg; 300 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/294"},{"medicine":"rifapentine","first_added":2015,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Latent tuberculosis; Tuberculosis","indication_count":2,"atc_codes":"J04AB05","dosage_forms":"Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 150 mg; 300 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/336"},{"medicine":"risperidone","first_added":2013,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":"N05AX08","dosage_forms":"Oral > Solid: 0.25 mg; 0.5 mg; 1 mg; 2 mg; 3 mg; 4 mg; 6 mg Parenteral > General injections > IM:","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/246"},{"medicine":"ritonavir","first_added":2002,"main_section":"Antiretrovirals > Protease inhibitors","sections":"Antiretrovirals > Protease inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AE03","dosage_forms":"Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/461"},{"medicine":"rituximab","first_added":2015,"main_section":"Targeted therapies","sections":"Targeted therapies; Medicines for multiple sclerosis","section_count":2,"indications":"Diffuse large B-cell lymphoma, not otherwise specified; Chronic lymphocytic leukaemia or small lymphocytic lymphoma; Burkitt lymphoma including Burkitt leukaemia; Follicular lymphoma; Multiple sclerosis","indication_count":5,"atc_codes":"L01FA01","dosage_forms":"Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial; Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/104"},{"medicine":"rivaroxaban","first_added":2019,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Other specified atrial fibrillation; Venous thromboembolism","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/481"},{"medicine":"rotavirus vaccine","first_added":2007,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BH01, J07BH02","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/213"},{"medicine":"rubella vaccine","first_added":1987,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against rubella alone","indication_count":1,"atc_codes":"J07BJ01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/214"},{"medicine":"salbutamol","first_added":1977,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Chronic obstructive pulmonary disease; Asthma","indication_count":2,"atc_codes":"R03AC02","dosage_forms":"Parenteral > General injections > IV: 500 µg per mL in 1 mL ampoule (as sulfate); 500 µg per mL in 5 mL ampoule (as sulfate) Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate); 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/254"},{"medicine":"salicylic acid","first_added":1979,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Seborrhoeic dermatitis; Psoriasis of unspecified type; Ichthyoses","indication_count":3,"atc_codes":"D01AE12","dosage_forms":"Local > Topical > Solution: 5%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/160"},{"medicine":"selenium sulfide","first_added":1989,"main_section":"Dermatological medicines > Antifungal medicines","sections":"Dermatological medicines > Antifungal medicines","section_count":1,"indications":"Seborrhoeic dermatitis; Pityriasis versicolor","indication_count":2,"atc_codes":"D01AE13","dosage_forms":"Local > Topical > Suspension: 2% detergent-based","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/150"},{"medicine":"semaglutide","first_added":2025,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":"A10BJ06","dosage_forms":"Parenteral > General injections > SC: 0.25 mg in pre-filled pen injection solution; 0.5 mg in pre-filled pen injection solution; 1 mg in pre-filled pen injection solution; 2 mg in pre-filled pen injection solution; 4 mg in pre-filled pen injection solution Oral > Solid > tablet: 3 mg Parenteral > General injections > SC: 0.68 mg per mL; 1.34 mg per mL; 2.68 mg per mL","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/973"},{"medicine":"senna","first_added":1977,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Laxatives","section_count":2,"indications":"Palliative care; Constipation","indication_count":2,"atc_codes":"A06AB06","dosage_forms":"Oral > Liquid: 7.5 mg per 5 mL oral liquid; Oral > Solid: 7.5 mg (sennosides) (or traditional dosage forms)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/31"},{"medicine":"sertraline","first_added":2023,"main_section":"Medicines for anxiety disorders","sections":"Medicines for anxiety disorders","section_count":1,"indications":"Generalised anxiety disorder","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/663"},{"medicine":"sevoflurane","first_added":2023,"main_section":"General anaesthetics and oxygen > Inhalational medicines","sections":"General anaesthetics and oxygen > Inhalational medicines","section_count":1,"indications":"Anaesthetics and therapeutic gases","indication_count":1,"atc_codes":"N01AB08","dosage_forms":"Respiratory > Inhalation > liquid:","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/897"},{"medicine":"silver diamine fluoride","first_added":2021,"main_section":"Dental medicines and preparations","sections":"Dental medicines and preparations","section_count":1,"indications":"Dental caries","indication_count":1,"atc_codes":null,"dosage_forms":"Local > Dental > Solution: 38% w/v","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/617"},{"medicine":"silver sulfadiazine","first_added":1987,"main_section":"Dermatological medicines > Anti-infective medicines","sections":"Dermatological medicines > Anti-infective medicines","section_count":1,"indications":"Burns","indication_count":1,"atc_codes":"D06BA01","dosage_forms":"Local > Topical > Cream: 1%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/154"},{"medicine":"simvastatin","first_added":2007,"main_section":"Lipid-lowering agents","sections":"Lipid-lowering agents","section_count":1,"indications":"Mixed hyperlipidaemia; Coronary atherosclerosis","indication_count":2,"atc_codes":"C10AA01","dosage_forms":"Oral > Solid: 5 mg; 10 mg; 20 mg; 40 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/148"},{"medicine":"sodium calcium edetate","first_added":1979,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified","indication_count":1,"atc_codes":"V03AB03","dosage_forms":"Parenteral > General injections > IV: 200 mg per mL in 5 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/47"},{"medicine":"sodium chloride","first_added":1977,"main_section":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","sections":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","section_count":1,"indications":"Other specified disorders of fluid, electrolyte or acid-base balance","indication_count":1,"atc_codes":"B05XA03","dosage_forms":"Parenteral > General injections > IV: 0.9% isotonic (equivalent to Na+ 154 mmol/L and Cl- 154 mmol/L)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/258"},{"medicine":"sodium hydrogen carbonate","first_added":1977,"main_section":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","sections":"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","section_count":1,"indications":"Acidosis","indication_count":1,"atc_codes":"B05XA02","dosage_forms":"Parenteral > General injections > IV: 1.4% isotonic (equivalent to Na+ 167 mmol/L and HCO3- 167 mmol/L); 8.4% in 10 mL ampoule (equivalent to Na+ 1000 mmol/L and HCO3- 1000 mmol/L)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/543"},{"medicine":"sodium nitrite","first_added":1979,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified","indication_count":1,"atc_codes":"V03AB08","dosage_forms":"Parenteral > General injections > IV: 30 mg per mL in 10 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/44"},{"medicine":"sodium nitroprusside","first_added":1979,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Hypertensive crisis","indication_count":1,"atc_codes":"C02DD01","dosage_forms":"Parenteral > General injections > IV: 50 mg in ampoule powder for infusion","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/142"},{"medicine":"sodium stibogluconate","first_added":1977,"main_section":"Antileishmaniasis medicines","sections":"Antileishmaniasis medicines","section_count":1,"indications":"Visceral leishmaniasis; Mucocutaneous leishmaniasis; Cutaneous leishmaniasis","indication_count":3,"atc_codes":"P01CB02","dosage_forms":"Parenteral > General injections > unspecified: 100 mg per mL in 30 mL vial","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/369"},{"medicine":"sodium thiosulfate","first_added":1979,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific; Dermatological medicines > Antifungal medicines","section_count":2,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified; Pityriasis versicolor","indication_count":2,"atc_codes":"V03AB06","dosage_forms":"Parenteral > General injections > IV: 250 mg per mL in 50 mL ampoule; Local > Topical > Solution: 15%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/45"},{"medicine":"sofosbuvir","first_added":2015,"main_section":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","sections":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","section_count":1,"indications":"Chronic hepatitis C","indication_count":1,"atc_codes":"J05AP08","dosage_forms":"Oral > Solid > tablet: 200 mg; 400 mg Oral > Solid > granules: 200 mg in sachet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/296"},{"medicine":"sofosbuvir + velpatasvir","first_added":2017,"main_section":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","sections":"Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations","section_count":1,"indications":"Chronic hepatitis C","indication_count":1,"atc_codes":"J05AP55","dosage_forms":"Oral > Solid > tablet: 200 mg + 50 mg; 400 mg + 100 mg Oral > Solid > granules: 150 mg + 37.5 mg in sachet; 200 mg + 50 mg in sachet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/290"},{"medicine":"spectinomycin","first_added":1982,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Gonococcal infection","indication_count":1,"atc_codes":"J01XX04","dosage_forms":"Parenteral > General injections > unspecified: 2 g in vial (as hydrochloride) powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/300"},{"medicine":"spironolactone","first_added":1977,"main_section":"Diuretics","sections":"Diuretics; Medicines used in heart failure","section_count":2,"indications":"Oedema; Ascites; Heart failure","indication_count":3,"atc_codes":"C03DA01","dosage_forms":"Oral > Liquid: 25 mg per 5 mL Oral > Solid > tablet: 25 mg; 12.5 mg; Oral > Solid > tablet: 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/144"},{"medicine":"streptokinase","first_added":1991,"main_section":"Thrombolytic medicines","sections":"Thrombolytic medicines","section_count":1,"indications":"Acute myocardial infarction","indication_count":1,"atc_codes":"B01AD01","dosage_forms":"Parenteral > General injections > IV: 1.5 million IU in vial powder for injection","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/147"},{"medicine":"streptomycin (injection)","first_added":1977,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":"J01GA01","dosage_forms":"Parenteral > General injections > IV: 1 g powder for injection (as sulfate) as vial","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/356"},{"medicine":"succimer","first_added":2011,"main_section":"Antidotes and other substances used in poisonings > Specific","sections":"Antidotes and other substances used in poisonings > Specific","section_count":1,"indications":"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid: 100 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/48"},{"medicine":"sulfadiazine","first_added":1977,"main_section":"Antipneumocystosis and antitoxoplasmosis medicines","sections":"Antipneumocystosis and antitoxoplasmosis medicines","section_count":1,"indications":"Toxoplasmosis","indication_count":1,"atc_codes":"J01EC02","dosage_forms":"Oral > Solid: 500 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/385"},{"medicine":"sulfadoxine + pyrimethamine","first_added":1979,"main_section":"Antimalarial medicines > Medicines for chemoprevention","sections":"Antimalarial medicines > Medicines for chemoprevention","section_count":1,"indications":"Malaria due to Plasmodium falciparum; Malaria","indication_count":2,"atc_codes":"P01BD51","dosage_forms":"Oral > Solid: 500 mg + 25 mg tablet Oral > Solid > dispersible tablet: 250 mg + 12.5 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/382"},{"medicine":"sulfamethoxazole + trimethoprim","first_added":1977,"main_section":"Antipneumocystosis and antitoxoplasmosis medicines","sections":"Antipneumocystosis and antitoxoplasmosis medicines; Access group antibiotics","section_count":2,"indications":"Pneumocystosis; Infectious cystitis; Infectious gastroenteritis or colitis without specification of infectious agent","indication_count":3,"atc_codes":"J01EE01","dosage_forms":"Parenteral > General injections > IV: 80 mg + 16 mg per mL in 5 mL ampoule; 80 mg + 16 mg per mL in 10 mL ampoule Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid Oral > Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet Oral > Solid > dispersible tablet: 100 mg + 20 mg; Parenteral > General injections > IV: 80 mg + 16 mg per mL in 10 mL ampoule; 80 mg + 16 mg per mL in 5 mL ampoule Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid Oral > Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet Oral > Solid > dispersible tablet: 100 mg + 20 mg Parenteral > General injections > IV: 80 mg + 16 mg per mL in 5 mL ampoule; 80 mg + 16 mg per mL in 10 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/334"},{"medicine":"sulfasalazine","first_added":1977,"main_section":"Disease-modifying anti-rheumatic drugs (DMARDs)","sections":"Disease-modifying anti-rheumatic drugs (DMARDs); Anti-inflammatory medicines","section_count":2,"indications":"Rheumatoid arthritis, serology unspecified; Crohn disease site; Ulcerative colitis","indication_count":3,"atc_codes":"A07EC01","dosage_forms":"Oral > Solid: 500 mg; Oral > Solid: 500 mg Local > Rectal > Suppository: 500 mg Local > Rectal > Retention enema: 3 g per 100 mL","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/180"},{"medicine":"sumatriptan","first_added":2021,"main_section":"Medicines for cluster headache","sections":"Medicines for cluster headache; Medicines for acute migraine attacks","section_count":2,"indications":"Trigeminal autonomic cephalalgias; Migraine","indication_count":2,"atc_codes":"N02CC01","dosage_forms":"Parenteral > General injections > SC: 6 mg per 0.5 mL in pre-filled pen; 6 mg per 0.5 mL in pre-filled syringe; Oral > Solid > tablet: 50 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/571"},{"medicine":"sunscreen, broad-spectrum","first_added":2025,"main_section":"Dermatological medicines > Sunscreens","sections":"Dermatological medicines > Sunscreens","section_count":1,"indications":"Albinism or other specified genetically-determined hypomelanotic disorders","indication_count":1,"atc_codes":null,"dosage_forms":"Topical: Therapeutic broad-spectrum sunscreens should contain proven active ingredients in appropriate amounts to absorb or filter UVA and UVB radiation, and have a high sun protection factor (SPF).","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/943"},{"medicine":"suramin sodium","first_added":1977,"main_section":"Medicines for the treatment of 1st stage African trypanosomiasis","sections":"Medicines for the treatment of 1st stage African trypanosomiasis","section_count":1,"indications":"Rhodesiense trypanosomiasis","indication_count":1,"atc_codes":"P01CX02","dosage_forms":"Parenteral > General injections > IV: 1 g in vial","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/387"},{"medicine":"suxamethonium","first_added":1977,"main_section":"Muscle relaxants (peripherally-acting) and cholinesterase inhibitors","sections":"Muscle relaxants (peripherally-acting) and cholinesterase inhibitors","section_count":1,"indications":"Muscle relaxants","indication_count":1,"atc_codes":"M03AB01","dosage_forms":"Parenteral > General injections > IV: 50 mg per mL in 2 mL ampoule (chloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/224"},{"medicine":"tacalcitol","first_added":2021,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Psoriasis of unspecified type","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/610"},{"medicine":"tacrolimus","first_added":2021,"main_section":"Immunomodulators for non-malignant disease","sections":"Immunomodulators for non-malignant disease","section_count":1,"indications":"Failure or rejection of transplanted organs or tissues","indication_count":1,"atc_codes":"L04AD02","dosage_forms":"Parenteral > General injections > IV: 5 mg per mL in 1 mL vial Oral > Liquid: 0.2 mg granules for oral suspension; 1 mg granules for oral suspension Oral > Solid: 0.5 mg (immediate-release); 0.75 mg (immediate-release); 1 mg (immediate-release); 2 mg (immediate-release); 5 mg (immediate-release)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/553"},{"medicine":"tamoxifen","first_added":1984,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of breast; Other specified malignant neoplasms of breast","indication_count":2,"atc_codes":"L02BA01","dosage_forms":"Oral > Solid: 10 mg (as citrate); 20 mg (as citrate)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/115"},{"medicine":"tedizolid","first_added":2023,"main_section":"Reserve group antibiotics","sections":"Reserve group antibiotics","section_count":1,"indications":"Methicillin resistant Staphylococcus aureus; Vancomycin resistant Staphylococcus aureus; Vancomycin resistant Enterococcus","indication_count":3,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/784"},{"medicine":"telmisartan + amlodipine","first_added":2019,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Essential hypertension","indication_count":1,"atc_codes":"C09DB04","dosage_forms":"Oral > Solid: 40 mg + 5 mg; 80 mg + 5 mg; 80 mg + 10 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/533"},{"medicine":"telmisartan + hydrochlorothiazide","first_added":2019,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Essential hypertension","indication_count":1,"atc_codes":"C09DA07","dosage_forms":"Oral > Solid: 40 mg + 12.5 mg; 80 mg + 12.5 mg; 80 mg + 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/534"},{"medicine":"tenofovir disoproxil fumarate","first_added":2007,"main_section":"Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors","sections":"Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors; Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors","section_count":2,"indications":"Contact with or exposure to human immunodeficiency virus; Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified; Chronic hepatitis B","indication_count":3,"atc_codes":"J05AF07","dosage_forms":"Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/365"},{"medicine":"terbinafine","first_added":2011,"main_section":"Dermatological medicines > Antifungal medicines","sections":"Dermatological medicines > Antifungal medicines","section_count":1,"indications":"Fungal infection of the skin","indication_count":1,"atc_codes":"D01AE15","dosage_forms":"Local > Topical > Cream: 1% terbinafine hydrochloride Local > Topical > Ointment: 1% terbinafine hydrochloride","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/151"},{"medicine":"terbutaline","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Chronic obstructive pulmonary disease; Asthma","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/673"},{"medicine":"terizidone","first_added":2025,"main_section":"Antituberculosis medicines","sections":"Antituberculosis medicines","section_count":1,"indications":"Multi-drug resistant Mycobacterium tuberculosis","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid > capsule: 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/636"},{"medicine":"testosterone","first_added":1977,"main_section":"Androgens","sections":"Androgens","section_count":1,"indications":"Testicular dysfunction or testosterone-related disorders","indication_count":1,"atc_codes":"G03BA03","dosage_forms":"Parenteral > General injections > IM: 200 mg per mL in 1 mL ampoule (enantate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/183"},{"medicine":"tetanus vaccine","first_added":1977,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against tetanus alone","indication_count":1,"atc_codes":"J07AM01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/215"},{"medicine":"tetracaine","first_added":1977,"main_section":"Ophthalmological preparations > Local anaesthetics","sections":"Ophthalmological preparations > Local anaesthetics","section_count":1,"indications":"Local anaesthetics","indication_count":1,"atc_codes":"S01HA03","dosage_forms":"Local > Ophthalmological > Solution (eye drops): 0.5% (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/233"},{"medicine":"tetracycline","first_added":1977,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents","section_count":1,"indications":"Other specified conjunctivitis; Infectious keratitis; Infectious blepharitis; Trachoma","indication_count":4,"atc_codes":"S01AA09","dosage_forms":"Local > Ophthalmological > Ointment: 1% (tetracycline hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/232"},{"medicine":"thalidomide","first_added":2019,"main_section":"Immunomodulators","sections":"Immunomodulators","section_count":1,"indications":"Plasma cell myeloma","indication_count":1,"atc_codes":"L04AX02","dosage_forms":"Oral > Solid: 50 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/409"},{"medicine":"thiamine","first_added":1979,"main_section":"Vitamins and minerals","sections":"Vitamins and minerals","section_count":1,"indications":"Vitamin B1 deficiency","indication_count":1,"atc_codes":"A11DA01","dosage_forms":"Parenteral > General injections > IV: 50 mg per mL in ampoule or vial (hydrochloride) Oral > Solid > tablet: 50 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/269"},{"medicine":"thiopental","first_added":2021,"main_section":"General anaesthetics and oxygen > Injectable medicines","sections":"General anaesthetics and oxygen > Injectable medicines","section_count":1,"indications":"Anaesthetics and therapeutic gases","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/628"},{"medicine":"tick-borne encephalitis vaccine","first_added":2015,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against arthropod-borne viral encephalitis","indication_count":1,"atc_codes":"J07BA01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/437"},{"medicine":"timolol","first_added":1984,"main_section":"Ophthalmological preparations > Miotics and antiglaucoma medicines","sections":"Ophthalmological preparations > Miotics and antiglaucoma medicines","section_count":1,"indications":"Ocular hypertension; Primary open-angle glaucoma","indication_count":2,"atc_codes":"S01ED01","dosage_forms":"Local > Ophthalmological > Solution (eye drops): 0.25% (hydrogen maleate); 0.5% (hydrogen maleate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/237"},{"medicine":"tinidazole","first_added":2023,"main_section":"Antiamoebic and antigiardiasis medicines","sections":"Antiamoebic and antigiardiasis medicines","section_count":1,"indications":"Amoebiasis","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/639"},{"medicine":"tioguanine","first_added":2011,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Lymphoid leukaemia, not elsewhere classified","indication_count":1,"atc_codes":"L01BB03","dosage_forms":"Oral > Solid: 40 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/105"},{"medicine":"tiotropium bromide","first_added":2019,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Chronic obstructive pulmonary disease","indication_count":1,"atc_codes":"R03BB04","dosage_forms":"Respiratory > Inhalation > powder: 18 µg in capsule Respiratory > Inhalation > solution: 1.25 µg per actuation in soft mist inhaler; 2.5 µg per actuation in soft mist inhaler","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/539"},{"medicine":"tirzepatide","first_added":null,"main_section":"Hypoglycaemic agents","sections":"Hypoglycaemic agents","section_count":1,"indications":"Type 2 diabetes mellitus","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/976"},{"medicine":"tobramycin","first_added":2021,"main_section":"Ophthalmological preparations > Anti-infective agents","sections":"Ophthalmological preparations > Anti-infective agents","section_count":1,"indications":"Other specified conjunctivitis; Infectious blepharitis","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/654"},{"medicine":"torasemide","first_added":2023,"main_section":"Diuretics","sections":"Diuretics; Medicines used in heart failure","section_count":2,"indications":"Anuria or oliguria; Oedema; Heart failure","indication_count":3,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/649"},{"medicine":"tranexamic acid","first_added":2011,"main_section":"Other medicines administered to the mother","sections":"Other medicines administered to the mother; Medicines affecting coagulation","section_count":2,"indications":"Postpartum haemorrhage; Haemorrhage, not elsewhere classified","indication_count":2,"atc_codes":"B02AA02","dosage_forms":"Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/127"},{"medicine":"trastuzumab","first_added":2015,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Carcinoma of breast, specialised type","indication_count":1,"atc_codes":"L01FD01","dosage_forms":"Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection","combined_with":null,"cancer":true,"biological":true,"url":"https://list.essentialmeds.org/medicines/106"},{"medicine":"triamcinolone hexacetonide","first_added":2023,"main_section":"Medicines for juvenile joint diseases","sections":"Medicines for juvenile joint diseases","section_count":1,"indications":"Juvenile idiopathic arthritis","indication_count":1,"atc_codes":"H02AB08","dosage_forms":"Parenteral > Locoregional injections > Intra-articular: 20 mg per mL in vial","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/893"},{"medicine":"triclabendazole","first_added":1997,"main_section":"Antischistosomals and other antitrematode medicines","sections":"Antischistosomals and other antitrematode medicines","section_count":1,"indications":"Paragonimiasis; Fascioliasis","indication_count":2,"atc_codes":"P02BX04","dosage_forms":"Oral > Solid > tablet: 250 mg (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/65"},{"medicine":"trihexyphenidyl","first_added":1977,"main_section":"Medicines for parkinsonism","sections":"Medicines for parkinsonism","section_count":1,"indications":"Parkinson disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/410"},{"medicine":"trimethoprim","first_added":1987,"main_section":"Access group antibiotics","sections":"Access group antibiotics","section_count":1,"indications":"Infectious cystitis","indication_count":1,"atc_codes":"J01EA01","dosage_forms":"Oral > Liquid: 50 mg per mL Oral > Solid: 100 mg; 200 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/599"},{"medicine":"triptorelin","first_added":2021,"main_section":"Hormones and antihormones","sections":"Hormones and antihormones","section_count":1,"indications":"Malignant neoplasms of breast; Malignant neoplasms of prostate","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/874"},{"medicine":"tropicamide","first_added":1987,"main_section":"Diagnostic agents > Ophthalmic medicines","sections":"Diagnostic agents > Ophthalmic medicines","section_count":1,"indications":"Cycloplegic drug","indication_count":1,"atc_codes":"S01FA06","dosage_forms":"Local > Ophthalmological > Solution (eye drops): 0.5%","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/165"},{"medicine":"tropisetron","first_added":2025,"main_section":"Medicines for other common symptoms in palliative care","sections":"Medicines for other common symptoms in palliative care; Antiemetic medicines","section_count":2,"indications":"Palliative care; Nausea or vomiting","indication_count":2,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/632"},{"medicine":"tuberculin, purified protein derivative","first_added":1977,"main_section":"Immunologicals > Diagnostic agents","sections":"Immunologicals > Diagnostic agents","section_count":1,"indications":"Mycobacterial diseases","indication_count":1,"atc_codes":"V04CF01","dosage_forms":"Parenteral > Locoregional injections > Intradermal:","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/203"},{"medicine":"typhoid vaccine","first_added":1977,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against typhoid-paratyphoid alone","indication_count":1,"atc_codes":"J07AP03","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/219"},{"medicine":"ulipristal","first_added":2017,"main_section":"Oral hormonal contraceptives","sections":"Oral hormonal contraceptives","section_count":1,"indications":"Contact with health services for postcoital contraception","indication_count":1,"atc_codes":"G03AD02","dosage_forms":"Oral > Solid: 30 mg tablet (ulipristal acetate)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/187"},{"medicine":"umeclidinium","first_added":2025,"main_section":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","sections":"Antiasthmatic and medicines for chronic obstructive pulmonary disease","section_count":1,"indications":"Chronic obstructive pulmonary disease","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/676"},{"medicine":"urea","first_added":1995,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation; Dermatological medicines > Moisturizers","section_count":2,"indications":"Xerosis cutis or asteatosis; Atopic eczema","indication_count":2,"atc_codes":"D02AE01","dosage_forms":"Local > Topical > Cream: 10%; 5% Local > Topical > Ointment: 10%; 5%; Local > Topical > Cream: 5 per %","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/161"},{"medicine":"ustekinumab","first_added":2025,"main_section":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","sections":"Dermatological medicines > Medicines affecting skin differentiation and proliferation","section_count":1,"indications":"Psoriasis of unspecified type","indication_count":1,"atc_codes":"L04AC05","dosage_forms":"Parenteral > General injections > SC: 45 mg per 0.5 mL in vial; 45 mg per 0.5 mL in pre-filled syringe; 45 mg per 0.5 mL in pre-filled pen; 90 mg per mL in pre-filled syringe; 90 mg per mL in pre-filled pen","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/946"},{"medicine":"valaciclovir","first_added":2025,"main_section":"Medicines for viral central nervous system infections","sections":"Medicines for viral central nervous system infections","section_count":1,"indications":"Zoster; Herpes simplex infections; Varicella","indication_count":3,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/563"},{"medicine":"valganciclovir","first_added":2015,"main_section":"Other antivirals","sections":"Other antivirals","section_count":1,"indications":"Cytomegaloviral retinitis","indication_count":1,"atc_codes":"J05AB14","dosage_forms":"Oral > Liquid: 50 mg per mL (as hydrochloride) powder for oral solution Oral > Solid > tablet: 450 mg (as hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/474"},{"medicine":"valproic acid (sodium valproate)","first_added":1979,"main_section":"Antiseizure medicines","sections":"Antiseizure medicines; Medicines for bipolar disorders","section_count":2,"indications":"Epilepsy or seizures; Status epilepticus; Bipolar or related disorders","indication_count":3,"atc_codes":"N03AG01","dosage_forms":"Oral > Liquid: 200 mg per 5 mL Oral > Solid: 200 mg tablet (enteric-coated); 500 mg tablet (enteric-coated); 100 mg tablet (crushable) Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule; 100 mg per mL in 3 mL ampoule; Oral > Solid: 200 mg tablet (enteric-coated); 500 mg tablet (enteric-coated)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/55"},{"medicine":"valsartan + amlodipine + hydrochlorothiazide","first_added":2025,"main_section":"Antihypertensive medicines","sections":"Antihypertensive medicines","section_count":1,"indications":"Essential hypertension","indication_count":1,"atc_codes":"C09DX01","dosage_forms":"Oral > Solid > dosage form: 160 mg + 5 mg + 12.5 mg; 160 mg + 5 mg + 25 mg; 160 mg + 10 mg + 12.5 mg; 160 mg + 10 mg + 25 mg; 320 mg + 10 mg + 25 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/962"},{"medicine":"vancomycin","first_added":1995,"main_section":"Watch group antibiotics","sections":"Watch group antibiotics","section_count":1,"indications":"Necrotising fasciitis; Endophthalmitis; Intestinal infections due to Clostridioides difficile; Neutropaenia (high-risk)","indication_count":4,"atc_codes":"J01XA01, A07AA09","dosage_forms":"Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride) Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection","combined_with":"ceftazidime; ceftriaxone","cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/333"},{"medicine":"varenicline","first_added":2021,"main_section":"Medicines for nicotine use disorders","sections":"Medicines for nicotine use disorders","section_count":1,"indications":"Nicotine dependence","indication_count":1,"atc_codes":"N07BA03","dosage_forms":"Oral > Solid: 0.5 mg; 1 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/607"},{"medicine":"varicella vaccine","first_added":2007,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BK01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/221"},{"medicine":"vecuronium","first_added":1991,"main_section":"Muscle relaxants (peripherally-acting) and cholinesterase inhibitors","sections":"Muscle relaxants (peripherally-acting) and cholinesterase inhibitors","section_count":1,"indications":"Muscle relaxants","indication_count":1,"atc_codes":"M03AC03","dosage_forms":"Parenteral > General injections > IV: 10 mg in vial powder for injection (vecuronium bromide)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/225"},{"medicine":"verapamil","first_added":1982,"main_section":"Antianginal medicines","sections":"Antianginal medicines; Medicines for cluster headache; Antiarrhythmic medicines","section_count":3,"indications":"Angina pectoris; Trigeminal autonomic cephalalgias; Supraventricular tachyarrhythmia","indication_count":3,"atc_codes":"C08DA01","dosage_forms":"Oral > Solid: 40 mg (hydrochloride); 80 mg (hydrochloride); Oral > Solid > tablet: 120 mg (hydrochloride) (immediate-release); 40 mg (hydrochloride) (immediate-release); 80 mg (hydrochloride) (immediate-release); 120 mg (hydrochloride) (extended-release); 180 mg (hydrochloride) (extended-release); 240 mg (hydrochloride) (extended-release); Parenteral > General injections > IV: 2.5 mg per mL in 2 mL ampoule (hydrochloride) Oral > Solid: 40 mg (hydrochloride); 80 mg (hydrochloride)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/133"},{"medicine":"vinblastine","first_added":1984,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Other specified gliomas of brain; Anaplastic large cell lymphoma, ALK-negative; Anaplastic large cell lymphoma, ALK-positive; Langerhans cell histiocytosis; Kaposi sarcoma of unspecified primary site; Germ cell tumour of testis; Other specified malignant neoplasms of the ovary; Hodgkin lymphoma","indication_count":8,"atc_codes":"L01CA01","dosage_forms":"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate) Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/107"},{"medicine":"vincristine","first_added":1977,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Other specified gliomas of brain; Diffuse large B-cell lymphoma, not otherwise specified; Burkitt lymphoma including Burkitt leukaemia; Lymphoid leukaemia, not elsewhere classified; Langerhans cell histiocytosis; Kaposi sarcoma of unspecified primary site; Rhabdomyosarcoma primary site; Hodgkin lymphoma; Malignant trophoblastic neoplasms of placenta; Follicular lymphoma; Ewing sarcoma of bone or articular cartilage of unspecified sites; Retinoblastoma; Malignant neoplasms of kidney, except renal pelvis","indication_count":13,"atc_codes":"L01CA02","dosage_forms":"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate) Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/108"},{"medicine":"vinorelbine","first_added":2015,"main_section":"Cytotoxic medicines","sections":"Cytotoxic medicines","section_count":1,"indications":"Rhabdomyosarcoma primary site; Other specified malignant neoplasms of bronchus or lung; Other specified malignant neoplasms of breast","indication_count":3,"atc_codes":"L01CA04","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial Oral > Solid > capsule: 20 mg; 30 mg; 80 mg Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/109"},{"medicine":"voriconazole","first_added":2017,"main_section":"Antifungal medicines","sections":"Antifungal medicines","section_count":1,"indications":"Chronic pulmonary aspergillosis; Invasive aspergillosis","indication_count":2,"atc_codes":"J02AC03","dosage_forms":"Parenteral > General injections > IV: 200 mg in vial powder for injection Oral > Liquid: 40 mg per mL powder for oral liquid Oral > Solid: 50 mg tablet; 200 mg tablet","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/288"},{"medicine":"warfarin","first_added":1977,"main_section":"Medicines affecting coagulation","sections":"Medicines affecting coagulation","section_count":1,"indications":"Venous thromboembolism; Cerebral ischaemic stroke due to embolic occlusion; Atrial fibrillation; Other specified diseases of arteries or arterioles","indication_count":4,"atc_codes":"B01AA03","dosage_forms":"Oral > Solid > tablet: 5 mg (scored) (sodium); 1 mg (scored) (sodium); 2 mg (scored) (sodium); 0.5 mg (scored) (sodium); 3 mg (scored) (sodium) Oral > Solid > tablet: 5 mg (scored) (sodium); 1 mg (scored) (sodium); 2 mg (scored) (sodium); 0.5 mg (scored) (sodium); 3 mg (scored) (sodium)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/128"},{"medicine":"water for injection","first_added":1977,"main_section":"Solutions correcting water, electrolyte and acid-base disturbances > Miscellaneous","sections":"Solutions correcting water, electrolyte and acid-base disturbances > Miscellaneous","section_count":1,"indications":"Unspecified appropriateness of dosing or administration without injury or harm","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > General injections > unspecified: 2 mL ampoule; 5 mL ampoule; 10 mL ampoule","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/587"},{"medicine":"whole blood","first_added":2013,"main_section":"Blood and blood components","sections":"Blood and blood components","section_count":1,"indications":"Blood transfusion without reported diagnosis","indication_count":1,"atc_codes":null,"dosage_forms":"Parenteral > General injections > IV:","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/459"},{"medicine":"xylometazoline","first_added":2009,"main_section":"Ear, nose and throat medicines [c]","sections":"Ear, nose and throat medicines [c]","section_count":1,"indications":"Nasal congestion","indication_count":1,"atc_codes":"R01AA07","dosage_forms":"Local > Nasal > Spray: 0.05% equivalent to 0.5 mg per mL Local > Nasal > Drops: 0.05% equivalent to 0.5 mg per mL","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/272"},{"medicine":"yellow fever vaccine","first_added":1979,"main_section":"Immunologicals > Vaccines","sections":"Immunologicals > Vaccines","section_count":1,"indications":"Need for immunization against certain single viral diseases","indication_count":1,"atc_codes":"J07BL01","dosage_forms":"All vaccines should comply with the WHO requirements for biological substances.","combined_with":null,"cancer":false,"biological":true,"url":"https://list.essentialmeds.org/medicines/216"},{"medicine":"zanubrutinib","first_added":null,"main_section":"Targeted therapies","sections":"Targeted therapies","section_count":1,"indications":"Chronic lymphocytic leukaemia or small lymphocytic lymphoma","indication_count":1,"atc_codes":null,"dosage_forms":"Oral > Solid: 80 mg Oral > Solid > capsule: 80 mg","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/895"},{"medicine":"zidovudine","first_added":1997,"main_section":"Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors","sections":"Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors","section_count":1,"indications":"Human immunodeficiency virus disease without mention of tuberculosis or malaria, clinical stage unspecified","indication_count":1,"atc_codes":"J05AF01","dosage_forms":"Parenteral > General injections > IV: 10 mg per mL in 20 mL vial solution for IV infusion Oral > Liquid: 50 mg per 5 mL Oral > Solid > tablet: 300 mg Oral > Solid > capsule: 250 mg","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/366"},{"medicine":"zinc sulfate","first_added":2005,"main_section":"Medicines for diarrhoea","sections":"Medicines for diarrhoea","section_count":1,"indications":"Diarrhoea","indication_count":1,"atc_codes":"A12CB01","dosage_forms":"Oral > Solid > dispersible tablet: 20 mg (scored)","combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/181"},{"medicine":"zoledronic acid","first_added":2017,"main_section":"Supportive medicines","sections":"Supportive medicines","section_count":1,"indications":"Malignant neoplasm metastasis in bone or bone marrow","indication_count":1,"atc_codes":"M05BA08","dosage_forms":"Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle","combined_with":null,"cancer":true,"biological":false,"url":"https://list.essentialmeds.org/medicines/110"},{"medicine":"zuclopenthixol decanoate","first_added":2023,"main_section":"Medicines for psychotic disorders","sections":"Medicines for psychotic disorders","section_count":1,"indications":"Schizophrenia or other primary psychotic disorders","indication_count":1,"atc_codes":null,"dosage_forms":null,"combined_with":null,"cancer":false,"biological":false,"url":"https://list.essentialmeds.org/medicines/925"}]